| 1 | 0 MG prednisone | - | - | - | - | 1件: 44 44 💬
|
| 2 | 0 MG tropicamide | - | - | - | - | 1件: 6 6 💬
|
| 3 | 0,25 MG RPC1063 | - | - | - | - | 1件: 96 96 💬
|
| 4 | 0,5 MG fingolimod | - | - | - | - | 1件: 13 13 💬
|
| 5 | 0.04 MG LU AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 6 | 0.08 MG LU AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 7 | 0.2 MG LU AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 8 | 0.25 MG RPC103 | - | - | - | - | 1件: 97 97 💬
|
| 9 | 0.25 MG RPC1063 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 10 | 0.3 MG tropicamide | - | - | - | - | 1件: 6 6 💬
|
| 11 | 0.4 MG LU AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 12 | 0.5 MG budesonide effervescent tablet FOR orodispersible USE | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 13 | 0.5 MG RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
| 14 | 0.6 MG LU AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 15 | 0.8 MG LU AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 16 | 0109-0012A 100 MG/ML | - | - | - | - | 1件: 46 46 💬
|
| 17 | 0109-0012A 25 MG/ML | - | - | - | - | 1件: 46 46 💬
|
| 18 | 0109-0012A 50 MG/ML | - | - | - | - | 1件: 46 46 💬
|
| 19 | 1 MG budesonide effervescent tablet FOR orodispersible USE | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 20 | 1 MG QD TO 15 MG QD PF-06649751 | 1件: Tavapadon Tavapadon | 1件: Tavapadon
Tavapadon
💬
| 2件: DRD1 DRD1, DRD5 💬
| 12件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 21 | 1 MG RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
| 22 | 1 MG tropicamide | - | - | - | - | 1件: 6 6 💬
|
| 23 | 1 MG/KG cnto 136 | - | - | - | - | 1件: 49 49 💬
|
| 24 | 1.0 MG LU AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 25 | 1.0 MG rasagiline mesylate | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 26 | 1.0 MG RPC103 | - | - | - | - | 1件: 97 97 💬
|
| 27 | 1.0 MG RPC1063 | - | - | - | - | 1件: 97 97 💬
|
| 28 | 1.2 MG LU AE04621 | - | - | - | - | 1件: 6 6 💬
|
| 29 | 1.2 MG ZGN-440 FOR injectable suspension | - | - | - | - | 1件: 193 193 💬
|
| 30 | 1.8 MG ZGN-440 FOR injectable suspension | - | - | - | - | 1件: 193 193 💬
|
| 31 | 10 MG | - | - | - | - | 1件: 96 96 💬
|
| 32 | 10 MG natura-alpha capsule | - | - | - | - | 1件: 97 97 💬
|
| 33 | 10 MG/KG CM-101 | - | - | - | - | 1件: 51 51 💬
|
| 34 | 10 MG/KG cnto 136 | - | - | - | - | 1件: 49 49 💬
|
| 35 | 10-MG dose OF E5501 2G tablet | - | - | - | - | 1件: 63 63 💬
|
| 36 | 10-MG dose OF E5501 cyclodextrin oral solution | - | - | - | - | 1件: 63 63 💬
|
| 37 | 10-MG dose OF E5501 lipid-based oral | - | - | - | - | 1件: 63 63 💬
|
| 38 | 10-MG dose OF E5501-P21% powder | - | - | - | - | 1件: 63 63 💬
|
| 39 | 100 MG | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 40 | 100 MG AP1189 | - | - | - | - | 2件: 46 46, 222 💬
|
| 41 | 100 MG ELX (VX-445) / 50 MG TEZ / 75 MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 42 | 100 MG ELX /50 MG TEZ /75 MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 43 | 100 MG ELX/50 MG TEZ /75 MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 44 | 100 MG ELX/50 MG TEZ/75 MG IVA fixed dose combination | - | - | - | - | 1件: 299 299 💬
|
| 45 | 100 MG LX3305 QD | - | - | - | - | 1件: 46 46 💬
|
| 46 | 100 MG TEZ/150 MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 47 | 100 MG VX-445 /50 MG TEZ/75 MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 48 | 100 MG VX-445/50 MG TEZ /75 MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 49 | 100 MG/M2 dose | - | - | - | - | 1件: 299 299 💬
|
| 50 | 100-MG ELX (VX-445) / 50-MG TEZ / 75-MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 51 | 100-MG ELX (VX-455) / 50-MG TEZ / 75-MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 52 | 100-MG ELX / 50-MG TEZ / 75 -MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 53 | 100-MG VX-445 / 50-MG TEZ / 75- MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 54 | 100-MG VX-445 / 50-MG TEZ / 75-MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 55 | 100-MG VX-445 /50-MG TEZ/75-MG | - | - | - | - | 1件: 299 299 💬
|
| 56 | 100-MG VX-445/50-MG TEZ/75-MG IVA FDC | - | - | - | - | 1件: 299 299 💬
|
| 57 | 12 MG/KG GSK2402968 | - | - | - | - | 1件: 113 113 💬
|
| 58 | 120 MG sodium nitrite inhalation solution | - | - | - | - | 1件: 86 86 💬
|
| 59 | 15 MG QD DE-escalated TO 7 MG QD PF-06649751 IN parent study remain AT 7 MG QD | 1件: Tavapadon Tavapadon | 1件: Tavapadon
Tavapadon
💬
| 2件: DRD1 DRD1, DRD5 💬
| 12件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 60 | 15 MG sodium nitrite inhalation solution | - | - | - | - | 1件: 86 86 💬
|
| 61 | 15 or 45 MG | - | - | - | - | 1件: 67 67 💬
|
| 62 | 15-DAY taper prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 46 46 💬
|
| 63 | 150 MG double-blinded secukinumab | - | - | - | - | 1件: 271 271 💬
|
| 64 | 150 MG FHND1002 | - | - | - | - | 1件: 2 2 💬
|
| 65 | 150 MG GSK1265744B | - | - | - | - | 1件: 265 265 💬
|
| 66 | 150 MG LX3305 QD | - | - | - | - | 1件: 46 46 💬
|
| 67 | 150 MG OPEN-label secukinumab | - | - | - | - | 1件: 271 271 💬
|
| 68 | 150-DAY taper prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 46 46 💬
|
| 69 | 150-MG ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 70 | 2 MG perampanel | - | - | - | - | 1件: 6 6 💬
|
| 71 | 2 X 10 MG natura-alpha capsules | - | - | - | - | 1件: 97 97 💬
|
| 72 | 20 MG | - | - | - | - | 1件: 97 97 💬
|
| 73 | 20 MG BID OF PF-02545920 | - | - | - | - | 1件: 8 8 💬
|
| 74 | 20 MG GA | - | - | - | - | 1件: 13 13 💬
|
| 75 | 20 MG mitoq | - | - | - | - | 1件: 13 13 💬
|
| 76 | 20 MG/ML treprostinil | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
| 77 | 200 MG BIA 6-512 | - | - | - | - | 1件: 6 6 💬
|
| 78 | 200 MG LX3305 QD | - | - | - | - | 1件: 46 46 💬
|
| 79 | 200 MG/M2 dose | - | - | - | - | 1件: 299 299 💬
|
| 80 | 25 MG BIA9 1067 | - | - | - | - | 1件: 6 6 💬
|
| 81 | 25 MG ongentys | - | - | - | - | 1件: 6 6 💬
|
| 82 | 25 MG ontamalimab | - | - | - | - | 2件: 96 96, 97 💬
|
| 83 | 250 MG CK-2017357 | - | - | - | - | 2件: 2 2, 11 💬
|
| 84 | 250 MG LX3305 BID | - | - | - | - | 1件: 46 46 💬
|
| 85 | 250 MG LX3305 QD | - | - | - | - | 1件: 46 46 💬
|
| 86 | 3 MG | - | - | - | - | 1件: 299 299 💬
|
| 87 | 3 MG [14C]-A4250 capsule | - | - | - | - | 3件: 93 93, 297, 338 💬
|
| 88 | 3 MG melatonin | - | - | - | - | 1件: 13 13 💬
|
| 89 | 3 MG QD TO 15 MG QD PF-06649751 | 1件: Tavapadon Tavapadon | 1件: Tavapadon
Tavapadon
💬
| 2件: DRD1 DRD1, DRD5 💬
| 12件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 90 | 3 MG/KG GSK2402968 | - | - | - | - | 1件: 113 113 💬
|
| 91 | 30 or 60 MG | - | - | - | - | 1件: 67 67 💬
|
| 92 | 30 or 90 MG | - | - | - | - | 1件: 67 67 💬
|
| 93 | 300 MG double-blinded secukinumab | - | - | - | - | 1件: 271 271 💬
|
| 94 | 300 MG LX3305 QD | - | - | - | - | 1件: 46 46 💬
|
| 95 | 4 MG perampanel | - | - | - | - | 1件: 6 6 💬
|
| 96 | 4 MG/KG cnto 136 | - | - | - | - | 1件: 49 49 💬
|
| 97 | 4.5 MG naltrexone | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 98 | 40 MG | - | - | - | - | 1件: 96 96 💬
|
| 99 | 40 MG GA | - | - | - | - | 2件: 2 2, 13 💬
|
| 100 | 40 MG glatiramer acetate | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 2件: 2 2, 13 💬
|
| 101 | 40 MG glatiramer acetato | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 102 | 40 MG MSB11022 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
| 103 | 40 MG- soluzione iniettabile IN siringhe PRE-riempite- USO sottocutaneo- siringa preriempita (0,4ML)- 2 siringhe PRE-riempite + 2 tamponi imbevuti DI alcool | - | - | - | - | 1件: 107 107 💬
|
| 104 | 400 MG BIA 5-1058 | - | - | - | - | 1件: 86 86 💬
|
| 105 | 400 MG LX3305 QD | - | - | - | - | 1件: 46 46 💬
|
| 106 | 45 MG sodium nitrite inhalation solution | - | - | - | - | 1件: 86 86 💬
|
| 107 | 5 MG melatonin | - | - | - | - | 1件: 13 13 💬
|
| 108 | 5 MG montelukast | 1件: Montelukast Montelukast | 2件: Montelukast sodium
Montelukast sodium
,
Montelukast
💬
| 1件: CYSLTR1 CYSLTR1 💬
| 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 109 | 5 MG prednisone | - | - | - | - | 1件: 44 44 💬
|
| 110 | 5% lidocaine/5 MG/ML 0.02% estradiol compound cream | - | - | - | - | 1件: 226 226 💬
|
| 111 | 5-aminosalicylic acid(5-ASA) and/or prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 112 | 50 MG | - | - | - | - | 1件: 97 97 💬
|
| 113 | 50 MG AP1189 | - | - | - | - | 1件: 46 46 💬
|
| 114 | 50 MG BIA 9 1067 | - | - | - | - | 1件: 6 6 💬
|
| 115 | 50 MG ELX/25 MG TEZ/37.5 MG IVA | - | - | - | - | 1件: 299 299 💬
|
| 116 | 50 MG ELX/25 MG TEZ/37.5 MG IVA fixed dose combination | - | - | - | - | 1件: 299 299 💬
|
| 117 | 50 MG etanercept | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 118 | 50 MG LX3305 QD | - | - | - | - | 1件: 46 46 💬
|
| 119 | 50 MG ongentys | - | - | - | - | 1件: 6 6 💬
|
| 120 | 500 MG CK-2017357 | - | - | - | - | 2件: 2 2, 11 💬
|
| 121 | 500 MG LX3305 QD | - | - | - | - | 1件: 46 46 💬
|
| 122 | 6 MG/KG GSK2402968 | - | - | - | - | 1件: 113 113 💬
|
| 123 | 7 MG QD TO 15 MG QD PF-06649751 | 1件: Tavapadon Tavapadon | 1件: Tavapadon
Tavapadon
💬
| 2件: DRD1 DRD1, DRD5 💬
| 12件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 124 | 75 MG ontamalimab | - | - | - | - | 2件: 96 96, 97 💬
|
| 125 | 75-MG ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 126 | 80 MG DR-6MP | - | - | - | - | 1件: 96 96 💬
|
| 127 | 800 MG ibuprofen/26.6 MG famotidine | - | - | - | - | 1件: 107 107 💬
|
| 128 | 9 MG/KG GSK2402968 | - | - | - | - | 1件: 113 113 💬
|
| 129 | 90 MG hydrocortisone acetate suppository with sephure suppository applicator | 3件: Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | 2件: Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 130 | 90 MG idrocortisone acetato IN supposta CON applicatore PER supposte sephure | - | - | - | - | 1件: 97 97 💬
|
| 131 | 90 MG sodium nitrite inhalation solution | - | - | - | - | 1件: 86 86 💬
|
| 132 | A fixed-dose combination OF 95 MG clarithromycin, 45 MG rifabutin, and 10 MG clofazimine | - | - | - | - | 1件: 96 96 💬
|
| 133 | Abituzumab 1500 MG | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 💬
|
| 134 | Abituzumab 500 MG | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 💬
|
| 135 | Abrocitinib 200 MG | 1件: Abrocitinib Abrocitinib | 1件: Abrocitinib
Abrocitinib
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 84 84 💬
|
| 136 | Accordion pill carbidopa/levodopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 137 | Accordion pill ¿ carbidopa/levodopa 50/400 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 138 | Accordion pill ¿ carbidopa/levodopa 50/500 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 139 | Accordion pill? carbidopa/levodopa 50/400 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 140 | Accordion pill? carbidopa/levodopa 50/500 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 141 | Accordion pill¿ carbidopa/levodopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 142 | Accordion pill™ carbidopa/levodopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 143 | Accordion pill™ carbidopa/levodopa 50/400 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 144 | Accordion pill™ carbidopa/levodopa 50/500 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 145 | ACE-031 0.5 MG/KG Q4WK | - | - | - | - | 1件: 113 113 💬
|
| 146 | ACE-031 1.0 MG/KG Q2WK | - | - | - | - | 1件: 113 113 💬
|
| 147 | ACER-002 (celiprolol) 200 MG BID | - | - | - | - | 1件: 168 168 💬
|
| 148 | Aclasta 5 MG infusionslösung | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 149 | Acomplia 20 MG FILM-coated tablets | - | - | - | - | 1件: 193 193 💬
|
| 150 | ACR16 10 MG | - | - | - | - | 1件: 8 8 💬
|
| 151 | ACR16 22.5 MG | - | - | - | - | 1件: 8 8 💬
|
| 152 | ACR16 45 MG | - | - | - | - | 1件: 8 8 💬
|
| 153 | Actonel once A week 35 MG FILM-coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
| 154 | Actos 15 MG | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 💬
|
| 155 | Actos 30 MG | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 💬
|
| 156 | Actos 45 MG | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 💬
|
| 157 | AD 452 18 MG tablet | - | - | - | - | 1件: 46 46 💬
|
| 158 | AD 452 4.5 MG tablet | - | - | - | - | 1件: 46 46 💬
|
| 159 | AD 452 9 MG tablet | - | - | - | - | 1件: 46 46 💬
|
| 160 | Adalimumab 40 MG | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 161 | Adalimumab 40 MG EOW or EW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 162 | Adalimumab 40 MG SC every other week | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
| 163 | Adalimumab 80 MG | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 164 | Adalimumab, plus prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 165 | Adalimumab, solution FOR injection 40 MG/ (0.8 ML) PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 166 | Adcirca 20 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 167 | Adderall XR 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 168 | Adempas 0.125 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬
|
| 169 | Adempas 0.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 💬
|
| 170 | Adempas 1 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 171 | Adempas 1.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 💬
|
| 172 | Adempas 1.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 173 | Adempas 1.5 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 174 | Adempas 2 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 175 | Adempas 2.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 💬
|
| 176 | Adempas 2.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 177 | Adempas 2.5 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 178 | Adempas® 0.5 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 179 | Adempas® 1.0 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 180 | Adempas® 1.5 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 181 | Adempas® 2.0 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 182 | Adempas® 2.5 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 183 | Adempas¿ 0.5 MG compressa rivestita CON film | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 184 | Adempas¿ 1.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 185 | Adempas¿ 2.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 186 | Adempas¿ 2.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 187 | Administration OF carbidopa/levodopa (CARBIDOPA TABLETS, 25 MG) | - | - | - | - | 2件: 6 6, 17 💬
|
| 188 | Administration OF methylprednisolone + prednisone + mycophenolate mofetil (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 49 49 💬
|
| 189 | ADS-5102, 137 MG | - | - | - | - | 1件: 13 13 💬
|
| 190 | ADS-5102, 274 MG | - | - | - | - | 1件: 13 13 💬
|
| 191 | AERO-RED 100 MG/ML gotas orales EN solucióN | - | - | - | - | 2件: 96 96, 97 💬
|
| 192 | Afamelanotide 16 MG | 1件: Afamelanotide Afamelanotide | 2件: Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| 1件: MC1R MC1R 💬
| 3件: Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 1件: 254 254 💬
|
| 193 | Agalsidase beta from biosidus 1 MG/KG | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 194 | AIN457 150 MG | - | - | - | - | 1件: 271 271 💬
|
| 195 | AIN457, 150 MG | - | - | - | - | 1件: 271 271 💬
|
| 196 | AIN457, 75 MG | - | - | - | - | 1件: 271 271 💬
|
| 197 | Alemtuzumab 0.2 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 2件: 65 65, 164 💬
|
| 198 | Alemtuzumab 0.3 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 2件: 65 65, 164 💬
|
| 199 | Alemtuzumab 12 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 200 | Alemtuzumab 24 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 201 | Algucosidase alfa 20 MG/KG once every 4 weeks instead OF once every 2 weeks | - | - | - | - | 1件: 256 256 💬
|
| 202 | Allopurinol sandoz 100 MG, tabletten | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 1件: 96 96 💬
|
| 203 | Alpha-1 HC 100 MG | - | - | - | - | 1件: 299 299 💬
|
| 204 | Alpha-1 HC 200 MG | - | - | - | - | 1件: 299 299 💬
|
| 205 | ALX-0061 150 MG/ML | - | - | - | - | 1件: 49 49 💬
|
| 206 | Amantadine 300 MG | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 207 | Amantadine hydrochloride 100 MG (milligrams) oral capsule | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 208 | Ambrisentan 5 MG | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 88 88 💬
|
| 209 | Ambrisentan 5 MG FILM-coated tablets | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 210 | Ambroxol hydrochloride 30 MG tablet - 18 MG/KG/DAY | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 1件: 19 19 💬
|
| 211 | Ambroxol hydrochloride 30 MG tablet - 27 MG/KG/DAY | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 1件: 19 19 💬
|
| 212 | Ambroxol hydrochloride 30 MG tablet - 9 MG/KG/DAY | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 1件: 19 19 💬
|
| 213 | AMG 827 140 MG | - | - | - | - | 1件: 46 46 💬
|
| 214 | AMG 827 210 MG | - | - | - | - | 2件: 46 46, 96 💬
|
| 215 | AMG 827 350 MG | - | - | - | - | 1件: 96 96 💬
|
| 216 | AMG 827 70 MG | - | - | - | - | 1件: 46 46 💬
|
| 217 | AMG 827 700 MG | - | - | - | - | 1件: 96 96 💬
|
| 218 | Amgevita 40 MG injektionslösung IM fertigpen | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 219 | Amgevita 40 MG injektionslösung IN einer fertigspritze | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 220 | Amifampridine phosphate 10 MG oral tablet | 1件: Amifampridine Amifampridine | 2件: Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 3 3 💬
|
| 221 | Amoxicillin, metronidazole and doxycycline (METRONIDAZOLE250 MG, METRONIDAZOLE500 MG) | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 1件: 97 97 💬
|
| 222 | Androgel 10 grams OF GEL containing 100 MG OF testosterone | 1件: Testosterone Testosterone | 1件: Testosterone
Testosterone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 13 13 💬
|
| 223 | Anhydrous carbidopa (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 224 | Anifrolumab 1000 MG | 1件: Anifrolumab Anifrolumab | 1件: Anifrolumab
Anifrolumab
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 49 49 💬
|
| 225 | Anifrolumab 300 MG | 1件: Anifrolumab Anifrolumab | 1件: Anifrolumab
Anifrolumab
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 49 49 💬
|
| 226 | AP1189, 100 MG | - | - | - | - | 1件: 46 46 💬
|
| 227 | AP1189, 40 MG | - | - | - | - | 1件: 46 46 💬
|
| 228 | AP1189, 60 MG | - | - | - | - | 1件: 46 46 💬
|
| 229 | AP1189, 70 MG | - | - | - | - | 1件: 46 46 💬
|
| 230 | AP1189, 80 MG | - | - | - | - | 1件: 46 46 💬
|
| 231 | Apixaban 5 MG | 1件: Apixaban Apixaban | 1件: Apixaban
Apixaban
💬
| 1件: F10 F10 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 222 222 💬
|
| 232 | Apomorphine hydrochloride 4.0 MG inhalation powder, PRE-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 233 | Apomorphine hydrochloride 5.8 MG inhalation powder, PRE-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 234 | Apremilast 10 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 💬
|
| 235 | Apremilast 20 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 💬
|
| 236 | Apremilast 30 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 💬
|
| 237 | Apremilast tablet 20 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 💬
|
| 238 | Apremilast tablet 30 MG BID | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 💬
|
| 239 | Apriso 375 MG extended-release capsules | - | - | - | - | 1件: 97 97 💬
|
| 240 | Aprovel 150 MG tablets | 1件: Irbesartan Irbesartan | 1件: Irbesartan
Irbesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
| 241 | APT-1011 - 3 MG | - | - | - | - | 1件: 98 98 💬
|
| 242 | APT-1011 3 MG HS | - | - | - | - | 1件: 98 98 💬
|
| 243 | AQX-1125 100 MG | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 💬
|
| 244 | AQX-1125 200 MG | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 💬
|
| 245 | Arava 20 MG filmdrasjerte tabletter | - | - | - | - | 1件: 46 46 💬
|
| 246 | Arbaclofen placarbil 15 MG BID | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 247 | Arbaclofen placarbil 30 MG BID | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 248 | Arbaclofen placarbil 45 MG BID | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 249 | ARC1905 20 MG/ML | - | - | - | - | 1件: 301 301 💬
|
| 250 | Arcoxia 90 MG comprimidos recubiertos CON PELícula | - | - | - | - | 1件: 271 271 💬
|
| 251 | Aricept 10 MG filmdragerade tabletter | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 13 13 💬
|
| 252 | Aricept 5 MG filmdragerade tabletter | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 13 13 💬
|
| 253 | Aricept 5 MG-filmtabletten | - | - | - | - | 1件: 6 6 💬
|
| 254 | Arikayce™ 140 MG | - | - | - | - | 1件: 299 299 💬
|
| 255 | Arikayce™ 560 MG | - | - | - | - | 1件: 299 299 💬
|
| 256 | Arikayce™ 70 MG | - | - | - | - | 1件: 299 299 💬
|
| 257 | Artamin 150 MG | - | - | - | - | 1件: 171 171 💬
|
| 258 | Artamin 250 MG | - | - | - | - | 1件: 171 171 💬
|
| 259 | Arzerra - 100 MG - concentrato PER soluzione PER infusione - USO endovenoso - flacone(vetro) - 5 ML(20MG/ML) 3 flaconi | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 260 | Arzerra - 1000 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) - 50 ML (20 MG/ML) 1 flaconcino + 2 KIT DI prolunga | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 261 | Asacol 400 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 262 | Asacol 400 MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 263 | Asacol 800 MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 264 | Asacol® 400 MG | - | - | - | - | 1件: 97 97 💬
|
| 265 | ASC42 10 MG | - | - | - | - | 1件: 93 93 💬
|
| 266 | ASC42 15 MG | - | - | - | - | 1件: 93 93 💬
|
| 267 | ASC42 5 MG | - | - | - | - | 1件: 93 93 💬
|
| 268 | Asendis 50 MG | - | - | - | - | 1件: 46 46 💬
|
| 269 | AT1001 150 MG | - | - | - | - | 1件: 19 19 💬
|
| 270 | AT2221 65 MG formulated capsules | 1件: Miglustat Miglustat | 1件: Miglustat
Miglustat
💬
| 1件: UGCG UGCG 💬
| 2件: Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | 1件: 256 256 💬
|
| 271 | Atacicept 150 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 💬
|
| 272 | Atacicept 25 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 13 13, 66 💬
|
| 273 | Atacicept 75 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 💬
|
| 274 | Ataluren 1000 MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
| 275 | Ataluren 125 MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
| 276 | Ataluren 250 MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
| 277 | Atgam 50 MG/ML, solution à diluer pour perfusion | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | 1件: Anti-human thymocyte immunoglobulin, equine
Anti-human thymocyte immunoglobulin, equine
💬
| - | - | 1件: 60 60 💬
|
| 278 | ATI-450 20 MG oral tablet BID | - | - | - | - | 1件: 46 46 💬
|
| 279 | ATI-450 50 MG oral tablet BID | - | - | - | - | 1件: 46 46 💬
|
| 280 | ATN-103 10 MG Q4WKS | - | - | - | - | 1件: 46 46 💬
|
| 281 | ATN-103 10 MG Q8WKS | - | - | - | - | 1件: 46 46 💬
|
| 282 | ATN-103 30 MG Q4WKS | - | - | - | - | 1件: 46 46 💬
|
| 283 | ATN-103 80 MG Q4WKS | - | - | - | - | 1件: 46 46 💬
|
| 284 | ATN-103 80 MG Q8WKS | - | - | - | - | 1件: 46 46 💬
|
| 285 | Atorvastatin 20 MG oral tablet | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 67 67 💬
|
| 286 | Atorvastatin 40 MG oral tablet + N-acetylcysteine 400 MG oral tablet | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 63 63 💬
|
| 287 | Atorvastatin tablet 20 MG | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 46 46 💬
|
| 288 | ATYR1923 1.0 MG/KG | - | - | - | - | 1件: 84 84 💬
|
| 289 | ATYR1923 3.0 MG/KG | - | - | - | - | 1件: 84 84 💬
|
| 290 | ATYR1923 5.0 MG/KG | - | - | - | - | 1件: 84 84 💬
|
| 291 | Aubagio - 14 MG - compressa rivestita CON film - USO orale - bister (ALU/ALU) perforato monodose - 10 X 1 compressa | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 292 | Aubagio - 14 MG - compressa rivestita CON film - USO orale - blister (ALU/ALU) - 28 compresse | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 293 | Aubagio 14 MG FILM-coated tablets | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 294 | Avastin 25 MG/ML - konzentrat ZUR herstellung einer infusionsloesung | 1件: Bevacizumab Bevacizumab | 1件: Bevacizumab
Bevacizumab
💬
| 1件: VEGFA VEGFA 💬
| 23件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 227 227 💬
|
| 295 | Avatrombopag 20 MG | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
| 296 | Avatrombopag 20 MG oral tablet | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
| 297 | Avelox- moxifloxacin (MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG) | 1件: Moxifloxacin Moxifloxacin | 3件: Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
(MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG),
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | 1件: 46 46 💬
|
| 298 | Azafor - 50 MG compresse rivestite CON film 50 compresse IN blister PVC/pvdc/AL | - | - | - | - | 1件: 97 97 💬
|
| 299 | Azathioprin-ratiopharm 25 MG | - | - | - | - | 1件: 96 96 💬
|
| 300 | Azathioprin-ratiopharm® 25 MG filmtabletten | - | - | - | - | 1件: 44 44 💬
|
| 301 | Azathioprine (imuran) 50 MG overencapsulated tablet | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
| 302 | Azathioprine - ratiopharm 50 MG | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 303 | Azathioprine 25 MG | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 44 44 💬
|
| 304 | Azathioprine/prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 85 85 💬
|
| 305 | AZD3241 300 MG BID | - | - | - | - | 1件: 6 6 💬
|
| 306 | AZD3241 600 MG BID | - | - | - | - | 1件: 6 6 💬
|
| 307 | AZD3241 extended release tablets 100 MG | - | - | - | - | 1件: 6 6 💬
|
| 308 | AZD3241 extended release tablets 25 MG | - | - | - | - | 1件: 6 6 💬
|
| 309 | AZD9567 10 MG | - | - | - | - | 1件: 46 46 💬
|
| 310 | AZD9567 125 MG | - | - | - | - | 1件: 46 46 💬
|
| 311 | AZD9567 155 MG | - | - | - | - | 1件: 46 46 💬
|
| 312 | AZD9567 20 MG | - | - | - | - | 1件: 46 46 💬
|
| 313 | AZD9567 40 MG | - | - | - | - | 1件: 46 46 💬
|
| 314 | AZD9567 80 MG | - | - | - | - | 1件: 46 46 💬
|
| 315 | Azilect 1 MG comprimidos | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
| 316 | Azilect® 1 MG tabletten | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 2 2 💬
|
| 317 | Azithromycin + metronidazole (METRONIDAZOLE250 MG, METRONIDAZOLE500 MG) | 2件: Azithromycin Azithromycin, Metronidazole | 5件: Metronidazole
Metronidazole
(METRONIDAZOLE250 MG, METRONIDAZOLE500 MG),
Azithromycin hydrate
,
Metronidazole hydrochloride
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 96 96 💬
|
| 318 | Azithromycin 250 MG tablets | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 299 299 💬
|
| 319 | Azithromycin 500 MG FILM-coated tablet | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 299 299 💬
|
| 320 | Azithromycine 250 MG | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 228 228 💬
|
| 321 | Azithromycine CF 250 MG | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 340 340 💬
|
| 322 | Azitromycine CF 250 MG | - | - | - | - | 1件: 340 340 💬
|
| 323 | Baclofen 20 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 324 | Baclofen ER capsules (GRS) 10 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 325 | Baclofen ER capsules (GRS) 20 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 326 | Baclofen ER capsules (GRS) 50 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 327 | Baclofen tablets USP 10 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 328 | BAF312 0,25 MG tablet | - | - | - | - | 1件: 13 13 💬
|
| 329 | BAF312 0,5 MG tablet | - | - | - | - | 1件: 50 50 💬
|
| 330 | BAF312 0.25 MG | - | - | - | - | 1件: 50 50 💬
|
| 331 | BAF312 0.25 MG tablet | - | - | - | - | 1件: 50 50 💬
|
| 332 | BAF312 0.5 MG | - | - | - | - | 1件: 50 50 💬
|
| 333 | BAF312 0.50 MG | - | - | - | - | 1件: 50 50 💬
|
| 334 | BAF312 1 MG | - | - | - | - | 1件: 50 50 💬
|
| 335 | BAF312 1 MG tablet | - | - | - | - | 2件: 13 13, 50 💬
|
| 336 | BAF312 2 MG | - | - | - | - | 1件: 50 50 💬
|
| 337 | BAF312 2 MG tablet | - | - | - | - | 1件: 50 50 💬
|
| 338 | BAF312 4 MG tablet | - | - | - | - | 1件: 13 13 💬
|
| 339 | BAF312 5 MG tablet | - | - | - | - | 1件: 50 50 💬
|
| 340 | Bardoxolone methyl 10 MG | 2件: Bardoxolone Bardoxolone, Bardoxolone methyl | 2件: Bardoxolone
Bardoxolone
,
Bardoxolone methyl
💬
| - | - | 1件: 67 67 💬
|
| 341 | Bardoxolone methyl 15 MG | 2件: Bardoxolone Bardoxolone, Bardoxolone methyl | 2件: Bardoxolone
Bardoxolone
,
Bardoxolone methyl
💬
| - | - | 1件: 67 67 💬
|
| 342 | Bardoxolone methyl 20 MG | 2件: Bardoxolone Bardoxolone, Bardoxolone methyl | 2件: Bardoxolone
Bardoxolone
,
Bardoxolone methyl
💬
| - | - | 1件: 67 67 💬
|
| 343 | Bardoxolone methyl 5 MG | 2件: Bardoxolone Bardoxolone, Bardoxolone methyl | 2件: Bardoxolone
Bardoxolone
,
Bardoxolone methyl
💬
| - | - | 1件: 67 67 💬
|
| 344 | Baricitinib (LY3009104) 4 MG | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
💬
| 2件: JAK1 JAK1, JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 84 💬
|
| 345 | Baricitinib 2 MG | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
💬
| 2件: JAK1 JAK1, JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 53 💬
|
| 346 | Baricitinib 4 MG | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
💬
| 2件: JAK1 JAK1, JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 40 40, 46 💬
|
| 347 | Baricitinib 4 MG oral tablet | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
💬
| 2件: JAK1 JAK1, JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 348 | Bassado - 100 MG compresse 10 compresse | - | - | - | - | 1件: 28 28 💬
|
| 349 | Batoclimab 340 MG SC BI-weekly | 1件: Batoclimab Batoclimab | 1件: Batoclimab
Batoclimab
💬
| - | - | 1件: 11 11 💬
|
| 350 | Batoclimab 340 MG SC weekly | 1件: Batoclimab Batoclimab | 1件: Batoclimab
Batoclimab
💬
| - | - | 2件: 11 11, 14 💬
|
| 351 | Batoclimab 680 MG SC weekly | 1件: Batoclimab Batoclimab | 1件: Batoclimab
Batoclimab
💬
| - | - | 1件: 11 11 💬
|
| 352 | Batoclimab 680 milligrams (MG) subcutaneous (SC) weekly | 1件: Batoclimab Batoclimab | 1件: Batoclimab
Batoclimab
💬
| - | - | 1件: 14 14 💬
|
| 353 | BAY 63-2521 coated tablets 0.5 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 354 | BAY 63-2521 coated tablets 1 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 355 | BAY 63-2521 coated tablets 1.5 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 356 | BAY 63-2521 coated tablets 2 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 357 | BAY 63-2521 coated tablets 2.5 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 358 | BAY 63-2521 IR coated tablet 1.0 MG | - | - | - | - | 1件: 88 88 💬
|
| 359 | BAY 63-2521 IR coated tablet 1.5 MG | - | - | - | - | 1件: 88 88 💬
|
| 360 | BAY 63-2521 IR coated tablet 2.0 MG | - | - | - | - | 1件: 88 88 💬
|
| 361 | BAY 63-2521 IR coated tablet 2.5 MG | - | - | - | - | 1件: 88 88 💬
|
| 362 | BAY 63-2521 IR tablet 0.5 MG | - | - | - | - | 1件: 88 88 💬
|
| 363 | BAY 63-2521 IR tablet 1.0 MG | - | - | - | - | 1件: 88 88 💬
|
| 364 | BAY 63-2521 IR tablet 1.5 MG | - | - | - | - | 1件: 88 88 💬
|
| 365 | BAY 63-2521 IR tablet 2.0 MG | - | - | - | - | 1件: 88 88 💬
|
| 366 | BAY 63-2521 IR tablet 2.5 MG | - | - | - | - | 1件: 88 88 💬
|
| 367 | BAY 63-2521 IR tablets 0.5 MG | - | - | - | - | 1件: 86 86 💬
|
| 368 | BAY 63-2521 IR tablets 1 MG | - | - | - | - | 1件: 86 86 💬
|
| 369 | BAY 63-2521 IR tablets 1.0 MG | - | - | - | - | 1件: 86 86 💬
|
| 370 | BAY 63-2521 IR tablets 1.5 MG | - | - | - | - | 1件: 86 86 💬
|
| 371 | BAY 63-2521 IR tablets 2.0 MG | - | - | - | - | 1件: 86 86 💬
|
| 372 | BAY 63-2521 IR tablets 2.5 MG | - | - | - | - | 1件: 86 86 💬
|
| 373 | BAY 63-2521 tablets 0.5 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 374 | BAY 63-2521 tablets 1 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 375 | BAY 63-2521 tablets 1.5 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 376 | BAY 63-2521 tablets 2 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 377 | BAY 63-2521 tablets 2.5 MG | - | - | - | - | 2件: 86 86, 88 💬
|
| 378 | BCD-089, 162 MG, S/C, Q2W | - | - | - | - | 1件: 46 46 💬
|
| 379 | BCD-089, 162 MG, S/C, QW | - | - | - | - | 1件: 46 46 💬
|
| 380 | BCD-132, 125 MG | - | - | - | - | 1件: 13 13 💬
|
| 381 | BCD-132, 500 MG | - | - | - | - | 1件: 13 13 💬
|
| 382 | Befizal L.P. 400 MG, comprimé enrobé à LIBération prolongéE | - | - | - | - | 1件: 94 94 💬
|
| 383 | Belimumab 1 MG/KG | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 46 46, 49 💬
|
| 384 | Belimumab 10 MG | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 222 222 💬
|
| 385 | Belimumab 10 MG/KG | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 43 43, 46, 49 💬
|
| 386 | Belimumab 10 MG/KG plus standard therapy | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬
|
| 387 | Belimumab 100 MG SC | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬
|
| 388 | Belimumab 200 MG SC | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬
|
| 389 | Belimumab 200 MG/ML | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬
|
| 390 | Belimumab 4 MG/KG | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 46 46, 49 💬
|
| 391 | Benazepril hydrochloride 10 milligram (MG) TAB | 1件: Benazepril Benazepril | 2件: Benazepril hydrochloride
Benazepril hydrochloride
,
Benazepril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 218 218 💬
|
| 392 | Benlysta 400 MG powder FOR concentrate FOR solution FOR infusion | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 43 43, 49 💬
|
| 393 | Benlysta 400 MG powder FOR concentrate FOR solution FOR infusions | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 49 49 💬
|
| 394 | Betaferon - 15 flaconcini 0.25 MG + 15 flaconcini 2 ML | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 395 | Betaloc ZOK 100, 95 MG | - | - | - | - | 1件: 113 113 💬
|
| 396 | Betaloc ZOK 25, 23,75 MG | - | - | - | - | 1件: 113 113 💬
|
| 397 | Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 MG IM once A DAY FOR four days | 1件: Betamethasone Betamethasone | 6件: Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 💬
|
| 398 | Bezafibrat genericon retard 400 MG | - | - | - | - | 1件: 93 93 💬
|
| 399 | Bezafibrate (400MG) IN addition TO standard 15-20 MG/KG/jour udca therapy | 2件: Bezafibrate Bezafibrate, Ursodeoxycholic acid | 2件: Ursodiol
Ursodiol
,
Bezafibrate
💬
| 2件: NR1C1 NR1C1, NR1H4 💬
| 11件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 94 94 💬
|
| 400 | Bezafibrate 100 MG | 1件: Bezafibrate Bezafibrate | 1件: Bezafibrate
Bezafibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 401 | Bezafibrate 200 MG | 1件: Bezafibrate Bezafibrate | 1件: Bezafibrate
Bezafibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 402 | Bezafibrate 200 MG IN addition TO udca therapy | 2件: Bezafibrate Bezafibrate, Ursodeoxycholic acid | 2件: Ursodiol
Ursodiol
,
Bezafibrate
💬
| 2件: NR1C1 NR1C1, NR1H4 💬
| 11件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 403 | Bezafibrate 200 MG oral tablet | 1件: Bezafibrate Bezafibrate | 1件: Bezafibrate
Bezafibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 404 | Bezafibrate 400 MG | 1件: Bezafibrate Bezafibrate | 1件: Bezafibrate
Bezafibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 405 | Bezafibrate 400 MG IN addition TO udca therapy | 2件: Bezafibrate Bezafibrate, Ursodeoxycholic acid | 2件: Ursodiol
Ursodiol
,
Bezafibrate
💬
| 2件: NR1C1 NR1C1, NR1H4 💬
| 11件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 406 | BF 2.649 10 MG | - | - | - | - | 1件: 6 6 💬
|
| 407 | BF 2.649 20 MG | - | - | - | - | 1件: 6 6 💬
|
| 408 | BF 2.649 40 MG | - | - | - | - | 1件: 6 6 💬
|
| 409 | BF 2.649 5 MG | - | - | - | - | 1件: 6 6 💬
|
| 410 | BHT-3009 0.5 MG | - | - | - | - | 1件: 13 13 💬
|
| 411 | BHT-3009 1.5 MG | - | - | - | - | 1件: 13 13 💬
|
| 412 | BI 1015550 18 MG film coated tablet | - | - | - | - | 1件: 85 85 💬
|
| 413 | BI 1015550 9 MG film coated tablet | - | - | - | - | 1件: 85 85 💬
|
| 414 | BI 655066 10 MG/ML | - | - | - | - | 1件: 96 96 💬
|
| 415 | BI 655066 90 MG/ML | - | - | - | - | 2件: 96 96, 271 💬
|
| 416 | BIA 28-6156 10 MG | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 417 | BIA 28-6156 60 MG | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 418 | BIA 6-512 100 MG | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 419 | BIA 6-512 100 MG dose | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 420 | BIA 6-512 200 MG dose | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 421 | BIA 6-512 25 MG | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 422 | BIA 6-512 25 MG dose | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 423 | BIA 6-512 400 MG | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 424 | BIA 6-512 50 MG dose | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 425 | BIA 9-1067 15 MG | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 426 | BIA 9-1067 25 MG | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 427 | BIA 9-1067 30 MG | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 428 | BIA 9-1067 5 MG | 1件: BIA BIA | - | - | - | 1件: 6 6 💬
|
| 429 | Bibr 796 BS, 20 MG | - | - | - | - | 1件: 96 96 💬
|
| 430 | Bibr 796 BS, 5 MG | - | - | - | - | 1件: 96 96 💬
|
| 431 | BIIB122 225 MG | - | - | - | - | 1件: 6 6 💬
|
| 432 | Blinded cdca 250 MG TID | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: Chenodiol
Chenodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 263 263 💬
|
| 433 | Blokium 50 MG comprimidos | - | - | - | - | 1件: 167 167 💬
|
| 434 | BMN 044 IV 6 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
| 435 | BMN 044 IV 9 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
| 436 | BMN 044 SC 6 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
| 437 | BMS-986004 1500 MG IV | - | - | - | - | 1件: 63 63 💬
|
| 438 | BMS-986004 225 MG IV | - | - | - | - | 1件: 63 63 💬
|
| 439 | BMS-986004 675 MG IV | - | - | - | - | 1件: 63 63 💬
|
| 440 | BMS-986004 75 MG IV | - | - | - | - | 1件: 63 63 💬
|
| 441 | Bosentan 125 MG | 1件: Bosentan Bosentan | 2件: Bosentan
Bosentan
,
Bosentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 442 | Bosentan 62.5 MG | 1件: Bosentan Bosentan | 2件: Bosentan
Bosentan
,
Bosentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 443 | Bramicil - 100 MG/ 2 ML soluzione iniettabile 10 fiale DA 2 ML | - | - | - | - | 1件: 299 299 💬
|
| 444 | Brensocatib 10 MG | 1件: Brensocatib Brensocatib | 1件: Brensocatib
Brensocatib
💬
| 1件: CTSC CTSC 💬
| 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 💬
|
| 445 | Brensocatib 25 MG | 1件: Brensocatib Brensocatib | 1件: Brensocatib
Brensocatib
💬
| 1件: CTSC CTSC 💬
| 2件: Apoptosis Apoptosis, Lysosome 💬 | 1件: 299 299 💬
|
| 446 | Brepocitinib 25 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 447 | Brepocitinib 5 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 448 | Brintellix - 20 MG/ML - gocce orali, soluzione - USO orale - flacone (vetro) 15 ML - 1 flacone | 1件: Vortioxetine Vortioxetine | 2件: Vortioxetine
Vortioxetine
,
Vortioxetine hydrobromide
💬
| 7件: HTR1 HTR1, HTR3, HTR3, HTR3, HTR3, HTR3, SLC6A4 💬
| 6件: Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 449 | Brivaracetam 25 MG | 1件: Brivaracetam Brivaracetam | 1件: Brivaracetam
Brivaracetam
💬
| 1件: SV2 SV2 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 309 309 💬
|
| 450 | Brivaracetam 50 MG | 1件: Brivaracetam Brivaracetam | 1件: Brivaracetam
Brivaracetam
💬
| 1件: SV2 SV2 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 309 309 💬
|
| 451 | BRV 2.5 MG | - | - | - | - | 1件: 309 309 💬
|
| 452 | BRV 25 MG | - | - | - | - | 1件: 309 309 💬
|
| 453 | BRV 50 MG | - | - | - | - | 1件: 309 309 💬
|
| 454 | BT-11 500 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 455 | BT-11 880 MG | - | - | - | - | 1件: 96 96 💬
|
| 456 | BT051 200 MG | - | - | - | - | 1件: 97 97 💬
|
| 457 | BT051 3200 MG | - | - | - | - | 1件: 97 97 💬
|
| 458 | BT051 800 MG | - | - | - | - | 1件: 97 97 💬
|
| 459 | BTT1023 IV infusion 20 MG/ML, 5 ML drug product | - | - | - | - | 1件: 94 94 💬
|
| 460 | Budesonide 0.5 MG compresse orodispersibili | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 461 | Budesonide 0.5 MG orodispersible tablets | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 462 | Budesonide 1 MG compresse orodispersibili | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 463 | Budesonide 1 MG orodispersible tablets | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 464 | Budesonide MMX 6 MG tablet | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 465 | Budesonide MMX® 6 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 466 | Budesonide MMX® 9 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 467 | Budesonide-MMX® 6 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 468 | Budesonide-MMX® 9 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 469 | Buet 0.5 MG | - | - | - | - | 1件: 98 98 💬
|
| 470 | Buet 1 MG | - | - | - | - | 1件: 98 98 💬
|
| 471 | BUL 0.5 MG | - | - | - | - | 1件: 98 98 💬
|
| 472 | BUL 1 MG | - | - | - | - | 1件: 98 98 💬
|
| 473 | Busilvex - 6 MG/ML - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino - 10 ML 8 flaconcini | 1件: Busulfan Busulfan | 1件: Busulfan
Busulfan
💬
| - | - | 2件: 19 19, 65 💬
|
| 474 | Bydureon 2 MG powder and solvent FOR prolonged-release suspension | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 475 | C2L-OCT-01 PR 30 MG | - | - | - | - | 1件: 77 77 💬
|
| 476 | C2L-OCT-01 PR, 10 or 20 MG | - | - | - | - | 1件: 77 77 💬
|
| 477 | C2L-OCT-01 PR, 20 MG | - | - | - | - | 1件: 77 77 💬
|
| 478 | C2L-OCT-01 PR, 30 MG | - | - | - | - | 1件: 77 77 💬
|
| 479 | Cabaseril, 1,0 MG tablette | - | - | - | - | 1件: 6 6 💬
|
| 480 | Cabaseril, 2,0 MG tablette | - | - | - | - | 1件: 6 6 💬
|
| 481 | Cacit D3 effervescent granules, 500 MG/440 IU | - | - | - | - | 1件: 97 97 💬
|
| 482 | Caffeine 100 MG | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 483 | Caffeine 100-200 MG BID | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 484 | Calcium carbonate 600 MG once daily | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 97 97 💬
|
| 485 | Calcium D3 sandoz - 1000 MG + 880 U.I. compresse effervescenti 30 compresse divisibili | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 274 274 💬
|
| 486 | Calvan® 100 MG | - | - | - | - | 1件: 8 8 💬
|
| 487 | Cannabidiol / dronabinol capsule 5 MG+2,5 MG | 2件: Cannabidiol Cannabidiol, Dronabinol | 2件: Dronabinol
Dronabinol
,
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 488 | Cannabidiol 100 MG/ML | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
| 489 | Cannabidiol 300 MG/ML | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
| 490 | Cannabidiol 400 MG/ML | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
| 491 | Cannabidiol capsule 5 MG | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 492 | Cannabidiol tablet 10 MG | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 46 46, 271 💬
|
| 493 | Capsule DI prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 494 | Carbidopa (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 5件: 6 6, 13, 17, 140, 201 💬
|
| 495 | Carbidopa 20 MG | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 496 | Carbidopa 200MG oral dose (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
| 497 | Carbidopa 25/levodopa 100MG TAB (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 498 | Carbidopa 27.5 MG | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 499 | Carbidopa 65 MG capsule | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 500 | Carbidopa and levodopa controlled release tablets (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 501 | Carbidopa and levodopa tablets, USP (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 502 | Carbidopa anidra (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 503 | Carbidopa INN (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 504 | Carbidopa levodopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 505 | Carbidopa monohydrate (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 506 | Carbidopa pill (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 507 | Carbidopa, levodopa, entacapone (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 508 | Carbidopa- levodopa (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 509 | Carbidopa-4'-monophosphate (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 510 | Carbidopa-levodopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 511 | Carbidopa-levodopa 25 MG-100 MG oral tablet | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 512 | Carbidopa/L-dopa/entacapone (CARBIDOPA TABLETS, 25 MG) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG),
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 513 | Carbidopa/levodopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 514 | Carbidopa/levodopa, AS prescribed BY treating physician (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 515 | Carbidopa/levodopa, immediate release (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 516 | Carbidopa/levodopa/entacapone (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 517 | Cayston 75 MG pulver UND Lösungsmittel ZUR herstellung einer Lösung FüR einen vernebler | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 1件: 299 299 💬
|
| 518 | Cayston aztreonam 75 MG powder and solvent FOR nebuliser solution | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 1件: 299 299 💬
|
| 519 | CC-220 0.3 MG daily | - | - | - | - | 1件: 84 84 💬
|
| 520 | Ceftazidim fresenius kabi 2000 MG poeder voor oplossing voor injectie OF infusie | 1件: Ceftazidime Ceftazidime | 2件: Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | 1件: 299 299 💬
|
| 521 | Celebrex 200 MG | - | - | - | - | 1件: 46 46 💬
|
| 522 | Celebrex 200 MG capsule, hard | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
(CELECOXIB 200 MG) 💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 523 | Celebrex 200 MG hartkapseln | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
(CELECOXIB 200 MG) 💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 524 | Celecoxib (CELECOXIB 200 MG) | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
(CELECOXIB 200 MG) 💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 13件: 2 2, 3, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
|
| 525 | Celecoxib 200 milligrams (CELECOXIB 200 MG) | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
(CELECOXIB 200 MG) 💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
| 526 | Celecoxib 200MG (CELECOXIB 200 MG) | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
(CELECOXIB 200 MG) 💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 6 6 💬
|
| 527 | Celecoxib 200MG capsule (CELECOXIB 200 MG) | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
(CELECOXIB 200 MG) 💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 528 | Celecoxib 400 milligrams (CELECOXIB 200 MG) | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
(CELECOXIB 200 MG) 💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
| 529 | Cellcept 500 MG | - | - | - | - | 1件: 11 11 💬
|
| 530 | Cellcept 500 MG comprimidos recubiertos | - | - | - | - | 1件: 35 35 💬
|
| 531 | Cellcept 500 MG FILM-coated tablets | 1件: Mycophenolate mofetil Mycophenolate mofetil | 2件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 11 11 💬
|
| 532 | Cellcept 500 MG tablets | 1件: Mycophenolate mofetil Mycophenolate mofetil | 2件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 11 11 💬
|
| 533 | Cellcept®500 MG comprimidos | - | - | - | - | 1件: 35 35 💬
|
| 534 | Cellcept®500 MG tablets | 1件: Mycophenolate mofetil Mycophenolate mofetil | 2件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 11 11 💬
|
| 535 | Cenerimod 0.5 MG | 1件: Cenerimod Cenerimod | 1件: Cenerimod
Cenerimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 49 49 💬
|
| 536 | Cenerimod 1 MG | 1件: Cenerimod Cenerimod | 1件: Cenerimod
Cenerimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 49 49 💬
|
| 537 | Cenerimod 2 MG | 1件: Cenerimod Cenerimod | 1件: Cenerimod
Cenerimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 49 49 💬
|
| 538 | Cenerimod 4 MG | 1件: Cenerimod Cenerimod | 1件: Cenerimod
Cenerimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 49 49 💬
|
| 539 | Cenicriviroc 150 MG | 1件: Cenicriviroc Cenicriviroc | 2件: Cenicriviroc
Cenicriviroc
,
Cenicriviroc mesylate
💬
| 2件: CCR2 CCR2, CCR5 💬
| 11件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | 1件: 94 94 💬
|
| 540 | Certican 0,5 MG tabletten | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 228 228 💬
|
| 541 | Certican 1 MG tablets | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 158 158 💬
|
| 542 | Certolizumab pegol (CZP) 200 MG | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 543 | Certolizumab pegol (CZP) 400 MG | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 544 | Certolizumab pegol 400 MG | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 545 | CF101 1 MG | - | - | - | - | 1件: 46 46 💬
|
| 546 | CF101 2 MG | - | - | - | - | 1件: 46 46 💬
|
| 547 | Chinese herb prescription granule plus prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 66 66 💬
|
| 548 | Chronic- PF-06480605 150 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
| 549 | Chronic- PF-06480605 450 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
| 550 | Chronic- PF-06480605 50 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
| 551 | Chronocort® 10 MG | - | - | - | - | 1件: 81 81 💬
|
| 552 | Chronocort® 20 MG | - | - | - | - | 1件: 81 81 💬
|
| 553 | Chronocort® 5 MG | - | - | - | - | 1件: 81 81 💬
|
| 554 | Cialis - 20 MG 2 compresse rivestite CON film IN blister USO orale | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 75 75, 77 💬
|
| 555 | Cialis 10 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
| 556 | Cialis 2.5 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
| 557 | Cialis 20 MG comprimidos recubiertos CON PELícula | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 558 | Cialis 20 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
| 559 | Cialis 5 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
| 560 | Cilostazol 100 MG | 1件: Cilostazol Cilostazol | 1件: Cilostazol
Cilostazol
💬
| 3件: PDE3A PDE3A, PDE3B, TBXA2R 💬
| 13件: Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬
|
| 561 | Cimzia 200 MG injeksjonsvæSKE, oppløsning | - | - | - | - | 1件: 46 46 💬
|
| 562 | Cimzia 200 MG solution FOR injection | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 271 💬
|
| 563 | Cimzia certolizumab pegol 200 MG/ML solution FOR injection | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
| 564 | Circadin 2 MG comprimidos DE liberacióN prolongada | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 💬
|
| 565 | Citicolina 1000 MG/DIE | 1件: Citicoline Citicoline | 2件: Citicoline
Citicoline
,
Citicoline sodium
💬
| - | - | 1件: 6 6 💬
|
| 566 | Cladribine 10 MG oral tablet | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 567 | Cladribine 3.5 MG/KG | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 568 | Cladribine 5.25 MG/KG | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 569 | Clarium 50 MG retardtabletten | - | - | - | - | 1件: 6 6 💬
|
| 570 | Clemastine milstein 1 MG, tabletten | 1件: Clemastine Clemastine | 2件: Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 571 | Cnto 136 100 MG | - | - | - | - | 1件: 46 46 💬
|
| 572 | Cnto 136 25 MG | - | - | - | - | 1件: 46 46 💬
|
| 573 | Cnto 136 50 MG | - | - | - | - | 1件: 46 46 💬
|
| 574 | Cnto 6785 100 MG | - | - | - | - | 1件: 46 46 💬
|
| 575 | Cnto 6785 15 MG | - | - | - | - | 1件: 46 46 💬
|
| 576 | Cnto 6785 200 MG | - | - | - | - | 1件: 46 46 💬
|
| 577 | Cnto 6785 50 MG | - | - | - | - | 1件: 46 46 💬
|
| 578 | Cnto 888 1 MG/KG | - | - | - | - | 1件: 85 85 💬
|
| 579 | Cnto 888 15 MG/KG | - | - | - | - | 1件: 85 85 💬
|
| 580 | Cnto 888 5 MG/KG | - | - | - | - | 1件: 85 85 💬
|
| 581 | Cobitolimod 250 MG | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
| 582 | Cobitolimod 500 MG | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
| 583 | Colchicina lirca - 1 MG compresse 60 compresse | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 💬
|
| 584 | Colchicine 1 MG oral tablet | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 💬
|
| 585 | Colistimethate 75 MG inhaled TWO times daily | 1件: Colistimethate Colistimethate | 1件: Colistimethate sodium
Colistimethate sodium
💬
| - | - | 1件: 299 299 💬
|
| 586 | Compressa effervescente 0,5 MG DI budesonide PER USO orodispersibile | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 587 | Compressa effervescente 1 MG DI budesonide PER USO orodispersibile | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 588 | Comtan 200* 60 CPR 200 MG | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 589 | Conjugated equine estrogens 0.625 MG/D + MPA 5 MG/D/10D | 1件: Conjugated estrogens Conjugated estrogens | 1件: Estrogens, conjugated
Estrogens, conjugated
💬
| - | - | 1件: 49 49 💬
|
| 590 | Continuous intrajejunal infusion OF levodopa-carbidopa (CARBIDOPA TABLETS, 25 MG) | - | - | - | - | 1件: 6 6 💬
|
| 591 | Controlled-release levodopa / carbidopa (CARBIDOPA TABLETS, 25 MG) | - | - | - | - | 1件: 6 6 💬
|
| 592 | Copaxone - 20 MG/ML soluzione iniettabile 28 siringhe preriempite | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 593 | Copaxone - 20 MG/ML soluzione iniettabile IN siringhe preriempite 30 siringhe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 594 | Copaxone - 40 MG/ML soluzione iniettabile IN | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 595 | Copaxone - 40 MG/ML soluzione iniettabile IN siringa preriempita 12 siringhe preriempite DA 1 ML CON AGO | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 596 | Copaxone 20 MG | - | - | - | - | 1件: 13 13 💬
|
| 597 | Copaxone 20 MG/ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 598 | Copaxone 20 MG/ML solucióN inyectable EN jeringa precargada | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 599 | Copaxone 20 MG/ML solucióN para inyeccióN EN jeringa precargada | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 600 | Copaxone 20 MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 601 | Copaxone 20 MG/ML, solution FOR injection, PRE-filled syringes | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 602 | Copaxone 40 MG/ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 603 | Copaxone 40 MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 604 | Cormeto - 250 MG capsule molli 50 capsule IN flacone hdpe | - | - | - | - | 1件: 75 75 💬
|
| 605 | Cortancyl 20 MG | 1件: Prednisone acetate Prednisone acetate | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 35 35, 162 💬
|
| 606 | Cortancyl ® 1 MG | 1件: Prednisone acetate Prednisone acetate | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 607 | Cortancyl ® 20 MG | 1件: Prednisone acetate Prednisone acetate | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 608 | Cortancyl ® 5 MG | 1件: Prednisone acetate Prednisone acetate | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 609 | Cortef 5 MG | - | - | - | - | 1件: 83 83 💬
|
| 610 | Cortimentmmx 9 MG | - | - | - | - | 1件: 97 97 💬
|
| 611 | Cosentyx - 150 MG - soluzione iniettabile IN siringa preriempita -USO sottocutaneo - siringa (vetro) 1 ML (150MG/ML)- 2 siringhe preriempite | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 107 107 💬
|
| 612 | Cosentyx 300 MG solution FOR injection IN PRE-filled syringe | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬
|
| 613 | Cosyntropin injectable suspension 1 MG/ML + vigabatrin | 2件: Tetracosactide Tetracosactide, Vigabatrin | 3件: Cosyntropin
Cosyntropin
,
Vigabatrin
,
Tetracosactide acetate
💬
| 2件: ABAT ABAT, MC2R 💬
| 12件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Hormone signaling, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬 | 1件: 145 145 💬
|
| 614 | Cosyntropin injectable suspension, 1 MG/ML | 1件: Tetracosactide Tetracosactide | 2件: Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 145 145 💬
|
| 615 | Cozaar 50 MG comprimidos recubierto CON pelicula | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 179 179 💬
|
| 616 | Cozaar inicio 12,5 MG comprimidos recubiertos CON pelicula | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
| 617 | CP-690,500 5 MG | - | - | - | - | 1件: 97 97 💬
|
| 618 | CP-690,550 10 MG | - | - | - | - | 1件: 97 97 💬
|
| 619 | CR845 1.0 MG | - | - | - | - | 1件: 93 93 💬
|
| 620 | Cuprior 150 MG | 1件: Triethylenetetramine Triethylenetetramine | 2件: Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | 1件: 171 171 💬
|
| 621 | Cuprior 150 MG FILM-coated tablets | 1件: Triethylenetetramine Triethylenetetramine | 2件: Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | 1件: 171 171 💬
|
| 622 | Curcuma longa extract CPL formaat 00 23,2 X 8,5 MM 723 MG | 1件: Turmeric Turmeric | - | - | - | 1件: 299 299 💬
|
| 623 | Cuvitru 200 MG/ML solution FOR subcutaneous injection | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 1件: 65 65 💬
|
| 624 | CV-MG01 | 1件: CV-MG01 CV-MG01 (CV-MG01) | - | - | - | 1件: 11 11 💬
|
| 625 | CVN424 150 MG | - | - | - | - | 1件: 6 6 💬
|
| 626 | CVN424 75 MG | - | - | - | - | 1件: 6 6 💬
|
| 627 | Cyclophosphamide 100 MG/KG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 19 19, 222 💬
|
| 628 | Cyclophosphamide 1200 MG/KG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 19 19, 222 💬
|
| 629 | Cyclophosphamide, azathioprine,prednisone,methylprednisolone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 2件: Cyclophosphamide Cyclophosphamide, Prednisone | 3件: Cyclophosphamide
Cyclophosphamide
,
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG),
Cyclophosphamide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 42 42, 43, 45 💬
|
| 630 | Cyclophosphamide-prednisone-azathioprine (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 49 49 💬
|
| 631 | Cyclophosphamidum 500 MG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 44 44 💬
|
| 632 | Cápsulas DE laquinimod 0.6 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 633 | D-penicillamine 250 MG | 1件: Penicillamine Penicillamine | 1件: Penicillamine
Penicillamine
💬
| - | - | 1件: 171 171 💬
|
| 634 | D.3.6.2.1 - valore: 45 / 0.45 MG/ML | - | - | - | - | 1件: 97 97 💬
|
| 635 | D9421-C capsule 3 MG | - | - | - | - | 1件: 96 96 💬
|
| 636 | Dacepton 5 MG/ML infuusioneste, liuos | - | - | - | - | 1件: 6 6 💬
|
| 637 | Dalfampridine ER, 10 MG oral tablet, extended release | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 638 | Darifenacin 7.5 MG extended release oral tablet | 1件: Darifenacin Darifenacin | 2件: Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 2 2 💬
|
| 639 | Data collection FOR prednisone metabolism (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 41 41 💬
|
| 640 | Dazucorilant 150 MG | 1件: Dazucorilant Dazucorilant | 1件: Dazucorilant
Dazucorilant
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 💬
|
| 641 | Dazucorilant 300 MG | 1件: Dazucorilant Dazucorilant | 1件: Dazucorilant
Dazucorilant
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 💬
|
| 642 | DB adalimumab 40 MG EOW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 643 | DB adalimumab 40 MG EW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 644 | Decortin (prednisona) 5 MG comprimidos | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 645 | Decortin 20 MG | - | - | - | - | 1件: 96 96 💬
|
| 646 | Decortin 5 MG | - | - | - | - | 1件: 96 96 💬
|
| 647 | Decortin H 1 MG | - | - | - | - | 1件: 97 97 💬
|
| 648 | Decortin H 50 MG | - | - | - | - | 1件: 97 97 💬
|
| 649 | Defanyl 50 and 100 MG | - | - | - | - | 1件: 46 46 💬
|
| 650 | Deferiprone 600 MG delayed release tablet | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
| 651 | Deferiprone 80 MG/ML oral solution | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 121 121 💬
|
| 652 | Deflazacort 6 MG tablets | 1件: Deflazacort Deflazacort | 1件: Deflazacort
Deflazacort
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 653 | Dehydroepiandrosterone 100 and 400 MG | 1件: Prasterone Prasterone | 1件: Prasterone
Prasterone
💬
| 3件: AR AR, ESR1, ESR2 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 113 113 💬
|
| 654 | Depakine chrono 500 MG | - | - | - | - | 1件: 233 233 💬
|
| 655 | Depakine chrono® 500 MG | - | - | - | - | 1件: 233 233 💬
|
| 656 | Depot leuprolide acetate 3.75 MG | - | - | - | - | 1件: 51 51 💬
|
| 657 | Desmopressine nasal spray 10 MG/ML, flacon 60 doses | 1件: Desmopressin Desmopressin | 2件: Desmopressin
Desmopressin
,
Desmopressin acetate
💬
| 2件: AVPR2 AVPR2, F8 💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 225 225 💬
|
| 658 | Desmotabs® 0,2 MG tabletten | - | - | - | - | 1件: 6 6 💬
|
| 659 | Dexamethasone 0,1 MG tablets | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 660 | Dexamethasone 1,5 MG tablets | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 661 | Dexamethasone 4 MG jenapharm | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
| 662 | Dexamethasone 4 MG/ML injectable solution | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 💬
|
| 663 | Dexamethasone oral, 10 MG | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
| 664 | Dexamethasone oral, 20 MG | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
| 665 | Dexamethasone sodium phosphate 250 MG/ 10 ML | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 666 | Dexamethasone sodium phosphate 250 MG/10 ML solution | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 💬
|
| 667 | Dexamethasone, 40 MG | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
| 668 | Dextromethorphan 30 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 669 | Dextromethorphan hydrobromide 20 MG and quinidine sulfate 10 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 2 2, 13 💬
|
| 670 | Dextromethorphan hydrobromide 30 MG and quinidine sulfate 10 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 2 2, 13 💬
|
| 671 | Dificlir 200 MG compresse rivestite CON film | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
| 672 | Dificlir 200 MG FILM-coated tablets | 1件: Fidaxomicin Fidaxomicin | 1件: Fidaxomicin
Fidaxomicin
💬
| - | - | 1件: 97 97 💬
|
| 673 | Digoxin 0.25 MG | 1件: Digoxin Digoxin | 1件: Digoxin
Digoxin
💬
| 4件: ATP1A ATP1A, ATP1A, ATP1A, ATP1A 💬
| 19件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬
|
| 674 | Dimethyl fumarate 240 MG | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 675 | Diosminex, 500 MG, tabletki powlekane | - | - | - | - | 1件: 265 265 💬
|
| 676 | Diovan 160 MG | 1件: Valsartan Valsartan | 1件: Valsartan
Valsartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
| 677 | Diovan 40 MG | 1件: Valsartan Valsartan | 1件: Valsartan
Valsartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
| 678 | Diovan 80 MG | 1件: Valsartan Valsartan | 1件: Valsartan
Valsartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
| 679 | Dipyridamole TAB 25 MG | 1件: Dipyridamole Dipyridamole | 1件: Dipyridamole
Dipyridamole
💬
| 2件: PDE4 PDE4, PDE5 💬
| 5件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 224 224 💬
|
| 680 | Docosahexaenoic acid administration: 50 MG/KG/DAY during 12 months | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 💬
|
| 681 | Dolutegravir 50 MG | 1件: Dolutegravir Dolutegravir | 2件: Dolutegravir
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | 1件: 265 265 💬
|
| 682 | Doptelet 20 MG FILM-coated tablets | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
| 683 | Dose OF 60 MG/KG alpha1-proteinase inhibitor | - | - | - | - | 1件: 231 231 💬
|
| 684 | Dose OF 60 MG/KG fraction IV-1 alpha1-proteinase inhibitor | - | - | - | - | 1件: 231 231 💬
|
| 685 | Dostinex 0,5 MG tabletten | - | - | - | - | 1件: 77 77 💬
|
| 686 | Doxycycline 100 MG capsules | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 1件: 89 89 💬
|
| 687 | Doxyhexal® tabs 100 MG tabletten | - | - | - | - | 1件: 28 28 💬
|
| 688 | Dronabinol 25 MG/ML, oral drops | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 689 | Dronabinol capsule 2,5 MG | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 690 | Dronabinol capsule 2.5. MG | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 46 46, 271 💬
|
| 691 | DSP-9632P 27.5 MG | - | - | - | - | 1件: 6 6 💬
|
| 692 | DSP-9632P 55.0 MG | - | - | - | - | 1件: 6 6 💬
|
| 693 | DSP-9632P 82.5 MG | - | - | - | - | 1件: 6 6 💬
|
| 694 | Duchenne muscular dystrophy group with prednisone/predisolone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 113 113 💬
|
| 695 | Duodopa LD/CD 20/5 MG/ML | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 696 | Duodopa, 20 MG/ML + 5 MG/ML, intestinal GEL | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 697 | Duodopa, levodopa 20 MG/ML + carbidopa 5 MG/ML, intestinal GEL | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 698 | E5501 40 MG 2 X 20-MG tablets, orally, fasted | - | - | - | - | 1件: 63 63 💬
|
| 699 | E5501 40 MG 2 X 20-MG tablets, orally, with food | - | - | - | - | 1件: 63 63 💬
|
| 700 | E5501 40MG 2 X 20-MG tablets, orally, fasted | - | - | - | - | 1件: 63 63 💬
|
| 701 | E6011 10 MG/KG | - | - | - | - | 1件: 96 96 💬
|
| 702 | E6011 15 MG/KG | - | - | - | - | 1件: 96 96 💬
|
| 703 | E6011 2 MG/KG | - | - | - | - | 1件: 96 96 💬
|
| 704 | E6011 5 MG/KG | - | - | - | - | 1件: 96 96 💬
|
| 705 | Ebetrex 15 MG = 0,75 ML, oplossing voor injectie IN voorgevulde injectiespuit 20 MG/ML | - | - | - | - | 2件: 96 96, 97 💬
|
| 706 | Efexor XL 75 MG | - | - | - | - | 1件: 46 46 💬
|
| 707 | Efgartigimod concentrate FOR solution FOR infusion 20 MG/ML | - | - | - | - | 1件: 11 11 💬
|
| 708 | Efmody 10 MG modified release hard capsules | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 709 | Efmody 5 MG modified release hard capsules | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 710 | Efzofitimod 270 MG | 1件: Efzofitimod Efzofitimod | 1件: Efzofitimod
Efzofitimod
💬
| 2件: HARS HARS, HARS 💬
| 1件: Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis 💬 | 1件: 51 51 💬
|
| 711 | Efzofitimod 3 MG/KG | 1件: Efzofitimod Efzofitimod | 1件: Efzofitimod
Efzofitimod
💬
| 2件: HARS HARS, HARS 💬
| 1件: Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis 💬 | 1件: 84 84 💬
|
| 712 | Efzofitimod 450 MG | 1件: Efzofitimod Efzofitimod | 1件: Efzofitimod
Efzofitimod
💬
| 2件: HARS HARS, HARS 💬
| 1件: Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis 💬 | 1件: 51 51 💬
|
| 713 | Efzofitimod 5 MG/KG | 1件: Efzofitimod Efzofitimod | 1件: Efzofitimod
Efzofitimod
💬
| 2件: HARS HARS, HARS 💬
| 1件: Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis 💬 | 1件: 84 84 💬
|
| 714 | EGB 761 (R) 120 MG | - | - | - | - | 1件: 18 18 💬
|
| 715 | EGB 761 120 MG | - | - | - | - | 1件: 18 18 💬
|
| 716 | Egcg 300 MG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 1件: 85 85 💬
|
| 717 | Egcg 300 MG + nintedanib | 2件: Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
| 718 | Egcg 300 MG + pirfenidone | 2件: Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
| 719 | Egcg 600 MG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 1件: 85 85 💬
|
| 720 | Egcg 600 MG + nintedanib | 2件: Epigallocatechin gallate Epigallocatechin gallate, Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
| 721 | Egcg 600 MG + pirfenidone | 2件: Epigallocatechin gallate Epigallocatechin gallate, Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
| 722 | EHP-101 25 MG BID | - | - | - | - | 1件: 13 13 💬
|
| 723 | EHP-101 25 MG OD | - | - | - | - | 1件: 13 13 💬
|
| 724 | EHP-101 50 MG BID | - | - | - | - | 1件: 13 13 💬
|
| 725 | EHP-101 50 MG OD | - | - | - | - | 1件: 13 13 💬
|
| 726 | Elafibranor 120 MG | 1件: Elafibranor Elafibranor | 1件: Elafibranor
Elafibranor
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 2件: 93 93, 94 💬
|
| 727 | Elafibranor 80 MG | 1件: Elafibranor Elafibranor | 1件: Elafibranor
Elafibranor
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 2件: 93 93, 94 💬
|
| 728 | Eleclazine pink 6 MG tablets | 1件: Eleclazine Eleclazine | 1件: Eleclazine
Eleclazine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 58 58 💬
|
| 729 | Eleclazine white 10 MG tablets | 1件: Eleclazine Eleclazine | 1件: Eleclazine
Eleclazine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 58 58 💬
|
| 730 | Eleclazine white 3 MG tablets | 1件: Eleclazine Eleclazine | 1件: Eleclazine
Eleclazine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 58 58 💬
|
| 731 | Eleclazine white 6 MG tablets | 1件: Eleclazine Eleclazine | 1件: Eleclazine
Eleclazine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 58 58 💬
|
| 732 | Elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG, 2 tablets each morning + ivacaftor 150 MG ONE tablet each evening | 1件: Elexacaftor Elexacaftor | 1件: Elexacaftor
Elexacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 733 | Eligard® 45 MG | - | - | - | - | 1件: 76 76 💬
|
| 734 | Eltrombopag 12.5 MG | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
| 735 | Eltrombopag 25 MG | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
|
| 736 | Empagliflozin 10 MG | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬
| - | - | 4件: 58 58, 67, 86, 97 💬
|
| 737 | Empagliflozin 25 MG | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬
| - | - | 1件: 72 72 💬
|
| 738 | Emselex 15 MG retardtabletten | 1件: Darifenacin Darifenacin | 2件: Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 13 13 💬
|
| 739 | Emselex 7,5 MG retardtabletten | 1件: Darifenacin Darifenacin | 2件: Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 13 13 💬
|
| 740 | Enalhexal®, 5 MG | - | - | - | - | 1件: 113 113 💬
|
| 741 | Enbrel - 50 MG polv soluz iniet sottoc. polv. flac vetro solv. siri. VET. solv 1 ML (50 MG/ML) 12 flac+12 siri. PRE+12 aghi+12 adat PER flac+24 tamp. PRE iniez | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 742 | Enbrel - 50 MG soluzione iniettabile IN siringa (vetro DA 1 ML) preriempita - USO sottocutaneo 12 siringhe preriempite + 24 tamponi imbevuti DI alcol | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 743 | Enbrel 25 MG | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 744 | Enbrel 25 MG powder and solvent FOR solution FOR injection | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 745 | Enbrel 25 MG/ML polvo Y disolvente para solucióN inyectable para USO pediátrico | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 107 107 💬
|
| 746 | Enbrel 50 MG | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 747 | Enbrel 50 MG powder and solvent FOR solution FOR injection | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 748 | Enbrel 50 MG solucióN inyectable EN jeringas precargadas | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 107 107 💬
|
| 749 | Enbrel 50 MG solution FOR injection IN PRE-filled syringe | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 750 | Enbrel® 50 MG solution FOR injection IN PRE-filled syringe | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 751 | Encapsulated baclofen 20 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 752 | Encorton, 5 MG, tablets | - | - | - | - | 1件: 46 46 💬
|
| 753 | Endoprost - 0.05 MG/0.5 ML concentrato PER soluzione PER infusione 1 fiala | - | - | - | - | 1件: 51 51 💬
|
| 754 | Endoxan® 500 MG | - | - | - | - | 1件: 44 44 💬
|
| 755 | Entacapone and carbidopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Entacapone | 2件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG),
Entacapone
💬
| 2件: COMT COMT, DDC 💬
| 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 756 | Entocort EC® 3 MG | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 757 | Entyvio - 300 MG - polvere PE rconcentrato PER soluzione PER infu | - | - | - | - | 1件: 97 97 💬
|
| 758 | Entyvio 300 MG | - | - | - | - | 1件: 97 97 💬
|
| 759 | EPI-743 15 MG/KG | - | - | - | - | 1件: 21 21 💬
|
| 760 | EPI-743 5 MG/KG | - | - | - | - | 1件: 21 21 💬
|
| 761 | Epidiolex 100 MG/ML oral solution | - | - | - | - | 3件: 140 140, 144, 158 💬
|
| 762 | Epratuzumab 100 MG | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
💬
| 1件: CD22 CD22 💬
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬
|
| 763 | Epratuzumab 1200 MG | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
💬
| 1件: CD22 CD22 💬
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬
|
| 764 | Epratuzumab 400 MG | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
💬
| 1件: CD22 CD22 💬
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬
|
| 765 | Epratuzumab 600 MG | 1件: Epratuzumab Epratuzumab | 1件: Epratuzumab
Epratuzumab
💬
| 1件: CD22 CD22 💬
| 3件: B cell receptor signaling pathway B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬 | 1件: 49 49 💬
|
| 766 | Equfina 50 MG | - | - | - | - | 1件: 6 6 💬
|
| 767 | ER tablet 100 MG AZD3241 | - | - | - | - | 1件: 6 6 💬
|
| 768 | ER tablet 25 MG AZD3241 | - | - | - | - | 1件: 6 6 💬
|
| 769 | Ergocalciferol 1.25 MG tablet | 1件: Ergocalciferol Ergocalciferol | 1件: Ergocalciferol
Ergocalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 46 46 💬
|
| 770 | Esbriet - 267 MG - capsula rigida - USO orale - flacone (hdpe) 270 capsule | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
| 771 | Esbriet 267 MG oral capsule | - | - | - | - | 1件: 85 85 💬
|
| 772 | Escitalopram 10 MG | 1件: Escitalopram Escitalopram | 2件: Escitalopram oxalate
Escitalopram oxalate
,
Escitalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 77 77 💬
|
| 773 | Escitalopram hexal 10 MG | 1件: Escitalopram Escitalopram | 2件: Escitalopram oxalate
Escitalopram oxalate
,
Escitalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 77 77 💬
|
| 774 | Esidrex-R 25 MG | - | - | - | - | 1件: 235 235 💬
|
| 775 | Esomeprazole 20 MG | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 46 46 💬
|
| 776 | Estradiol 2 MG | 1件: Estradiol Estradiol | 2件: Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 299 299 💬
|
| 777 | Etanercept 50 MG SC DAY 1 and DAY 4 | 1件: Etanercept Etanercept | 1件: Etanercept
Etanercept
💬
| 2件: LTA LTA, TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 38 38, 39 💬
|
| 778 | Etoricoxib 60 MG | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 779 | Etoricoxib 90 MG | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 780 | EXCL-100, 600 MG oral tablet | - | - | - | - | 1件: 85 85 💬
|
| 781 | Exelon 1,5 MG hartkapseln | 1件: Rivastigmine Rivastigmine | 2件: Rivastigmine tartrate
Rivastigmine tartrate
,
Rivastigmine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 5 5 💬
|
| 782 | Exelon 3,0 MG hartkapseln | 1件: Rivastigmine Rivastigmine | 2件: Rivastigmine tartrate
Rivastigmine tartrate
,
Rivastigmine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 5 5 💬
|
| 783 | Exelon 4.6 MG/24 H transdermal patch | 1件: Rivastigmine Rivastigmine | 2件: Rivastigmine tartrate
Rivastigmine tartrate
,
Rivastigmine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 6 6 💬
|
| 784 | Exelon 6,0 MG hartkapseln | 1件: Rivastigmine Rivastigmine | 2件: Rivastigmine tartrate
Rivastigmine tartrate
,
Rivastigmine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 5 5 💬
|
| 785 | Exelon 9.5 MG/24 H transdermal patch | 1件: Rivastigmine Rivastigmine | 2件: Rivastigmine tartrate
Rivastigmine tartrate
,
Rivastigmine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 6 6 💬
|
| 786 | Fabrazyme (agalsidase beta) 1 MG/KG | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 787 | Fabrazyme - 35 MG polvere PER concentrato PER soluzione PER infusione endovenosa 1 flaconcino | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 788 | Fabrazyme 35 MG | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 789 | Fabrazyme 5 MG | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 790 | Famotidine 20 MG | 1件: Famotidine Famotidine | 1件: Famotidine
Famotidine
💬
| 1件: HRH2 HRH2 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 86 86 💬
|
| 791 | Fampyra 10 MG prolonged-release tablets | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 792 | Ferinject - 50 MG/ML soluzione iniettabile O PER infusione 1 flaconcino IN vetro DA 10 ML | - | - | - | - | 1件: 97 97 💬
|
| 793 | Ferinject 50 MG /ML. solucióN inyectable Y para perfusióN | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
| 794 | Ferinject 50 MG eisen/ML | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
| 795 | Ferinject 50 MG iron/ML solution FOR injection and infusion | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
| 796 | Ferlixit - 62.5 MG/5 ML soluzione PER USO orale E USO endovenoso 5 fiale DA 5 ML | - | - | - | - | 1件: 97 97 💬
|
| 797 | Ferriprox 500 MG | 1件: Deferiprone Deferiprone | 1件: Deferiprone
Deferiprone
💬
| - | - | 1件: 6 6 💬
|
| 798 | Ferrous sulphate with 65 MG iron++ PER tablet | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 1件: 97 97 💬
|
| 799 | Fidrisertib (IPN60130) 10 MG capsules | 1件: Fidrisertib Fidrisertib | 1件: Fidrisertib
Fidrisertib
💬
| 1件: ACVR1 ACVR1 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hormone signaling, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 272 272 💬
|
| 800 | Fidrisertib (IPN60130) 50 MG capsules | 1件: Fidrisertib Fidrisertib | 1件: Fidrisertib
Fidrisertib
💬
| 1件: ACVR1 ACVR1 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hormone signaling, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 272 272 💬
|
| 801 | Fingolimod 0.5 MG | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 802 | Fingolimod 1.25 MG | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 803 | Fipamezole hydrochloride 30 MG oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
| 804 | Fipamezole hydrochloride 60 MG oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
| 805 | Fipamezole hydrochloride 90 MG oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 💬
|
| 806 | Firategrast 150 MG | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 807 | Firategrast 300 MG | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 808 | Firazyr (icatibant) 30 MG solution FOR injection IN PRE filled syringe | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
| 809 | Firazyr 30 MG solucióN inyectable EN jeringa precargada | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
| 810 | Firazyr 30 MG solution FOR injection IN PRE-filled syringe | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
| 811 | Firazyr® 30 MG subcutaneous injection syringe: 3.0 ML×1 syringe | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
| 812 | Firdapse - 10 MG - compresse - USO orale - blister(ALU/PVC/pvdc) 100 X 1 compresse | - | - | - | - | 2件: 3 3, 11 💬
|
| 813 | Fixed dose combination ciprofloxacin/celecoxib (CELECOXIB 200 MG) | - | - | - | - | 1件: 2 2 💬
|
| 814 | Fludarabina accord - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 5 flaconcini IN vetro DA 2 ML | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 19 19 💬
|
| 815 | Fludarabina teva - 25 MG/ML concentrato PER soluzione iniettabile O PER infusione 1 flaconcino DI vetro DA 2 ML | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 65 65 💬
|
| 816 | Fludarabine phosphate 30 MG | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 2件: 65 65, 164 💬
|
| 817 | Fludarabine phosphate 40 MG | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 2件: 65 65, 164 💬
|
| 818 | Fluimucil® 600 MG effervescent tablets | - | - | - | - | 1件: 85 85 💬
|
| 819 | Folic acid 1 MG | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 1件: 6 6 💬
|
| 820 | Formistin - 10 MG compresse rivestite CON film 20 compresse | - | - | - | - | 1件: 13 13 💬
|
| 821 | Formistin 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 822 | Forteo 20 MG | - | - | - | - | 1件: 235 235 💬
|
| 823 | Fostamatinib 100 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
| 824 | Fostamatinib 100 MG tablet | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
| 825 | Fostamatinib 150 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
| 826 | Fostamatinib 150 MG BID | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 61 61 💬
|
| 827 | Fostamatinib 150 MG tablet | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
| 828 | Fostamatinib 50 MG blue FILM-coated tablet | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 829 | Fostamatinib disodium 100 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
| 830 | Fostamatinib disodium 150 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 63 63 💬
|
| 831 | Fostamatinib disodium tablet 100 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
| 832 | Fostamatinib disodium tablet 150 MG | 1件: Fostamatinib Fostamatinib | 2件: Fostamatinib
Fostamatinib
,
Fostamatinib disodium
💬
| 1件: SYK SYK 💬
| 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 💬
|
| 833 | FT011 100 MG | - | - | - | - | 1件: 51 51 💬
|
| 834 | FT011 200 MG | - | - | - | - | 1件: 51 51 💬
|
| 835 | GA 20 MG/ML | - | - | - | - | 1件: 13 13 💬
|
| 836 | GA 40 MG/ML | - | - | - | - | 1件: 13 13 💬
|
| 837 | GA depot 40 MG | - | - | - | - | 1件: 13 13 💬
|
| 838 | GA depot 80 MG | - | - | - | - | 1件: 13 13 💬
|
| 839 | Gaboxadol monohydrate 0.5 MG | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 840 | Gaboxadol monohydrate 0.5 MG capsule | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 841 | Gaboxadol monohydrate 2 MG | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 842 | Gaboxadol monohydrate 2 MG capsule | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 843 | Gaboxadol monohydrate 5 MG | 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol
Gaboxadol
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 201 201 💬
|
| 844 | Gammanorm 165 MG/ML | - | - | - | - | 1件: 65 65 💬
|
| 845 | Gazyvaro - 1000 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino - 1000MG/40ML - 1 flaconcino | - | - | - | - | 1件: 222 222 💬
|
| 846 | GBT440 300 MG capsule | - | - | - | - | 1件: 85 85 💬
|
| 847 | GBT440 300 MG tablet | - | - | - | - | 1件: 85 85 💬
|
| 848 | GCK 100 MG | - | - | - | - | 1件: 46 46 💬
|
| 849 | GCK 200 MG | - | - | - | - | 1件: 46 46 💬
|
| 850 | GCK 300 MG | - | - | - | - | 1件: 46 46 💬
|
| 851 | GED-0507-34-levo 160 MG | 1件: GED-0507-34-Levo GED-0507-34-Levo | - | - | - | 1件: 97 97 💬
|
| 852 | GED-0507-34-levo 80 MG | 1件: GED-0507-34-Levo GED-0507-34-Levo | - | - | - | 1件: 97 97 💬
|
| 853 | Genisteine plus 150 MG CPL formaat 1 18,7 X 6,4 MM 438 MG | - | - | - | - | 1件: 299 299 💬
|
| 854 | Genotonorm miniquick 0,2 MG | - | - | - | - | 1件: 193 193 💬
|
| 855 | Gernebcin 80 MG | - | - | - | - | 1件: 299 299 💬
|
| 856 | Gilenya - 0.25 MG - capsule rigide - USO orale | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 857 | Gilenya - 0.5 MG - capsule rigide - USO orale | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 858 | Gilenya - 0.5 MG - capsule rigide - USO orale - blister divisibile PER dose unitaria(PVC/pvdc/ALU) scatola DA 7x1 capsule | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 859 | Gilenya - 0.5 MG - capsule rigide - USO orale - blister(PVC/pvdc/ALU) scatola DA 28 capsule | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 860 | Gilenya 0,5 MG Cápsulas duras | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 14 14 💬
|
| 861 | Gilenya 0,5 MG hartkapseln | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 862 | Glatiramer acetate (GA) 40 MG | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 863 | Glatiramer acetate 20 MG | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 864 | Glatiramer acetate 20 MG, with mitoxantrone | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 865 | Glatiramer acetate 20 MG/0.5 ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 866 | Glatiramer acetate 40 MG | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 867 | Glivec 100 MG comprimidos recubiertos CON PELícula | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1, KIT, PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 2件: 34 34, 86 💬
|
| 868 | Glivec 100 MG filmtabletten | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1, KIT, PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 2件: 51 51, 86 💬
|
| 869 | Glivec 100 MG hartkapsel | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1, KIT, PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 86 86 💬
|
| 870 | Glivec 400 MG comprimidos recubiertos CON PELícula | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1, KIT, PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 34 34 💬
|
| 871 | Glivec® 100 MG filmtabletten | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1, KIT, PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 86 86 💬
|
| 872 | GLPG1690 600 MG QD | - | - | - | - | 1件: 85 85 💬
|
| 873 | GLPG2222 100 MG | - | - | - | - | 1件: 299 299 💬
|
| 874 | GLPG2222 200 MG | - | - | - | - | 1件: 299 299 💬
|
| 875 | GLPG2222 400 MG | - | - | - | - | 1件: 299 299 💬
|
| 876 | GLPG2222 50 MG | - | - | - | - | 1件: 299 299 💬
|
| 877 | GM-CSF, fosfomycin and metronidazole (METRONIDAZOLE250 MG, METRONIDAZOLE500 MG) | - | - | - | - | 1件: 97 97 💬
|
| 878 | GNR-055 1.0-2.0-3.0 MG/KG | - | - | - | - | 1件: 19 19 💬
|
| 879 | GNR-055 2.0 MG/KG | - | - | - | - | 1件: 19 19 💬
|
| 880 | GNR-055 3.0 MG/KG | - | - | - | - | 1件: 19 19 💬
|
| 881 | Golimumab 1 MG PER KG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 882 | Golimumab 100 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
| 883 | Golimumab 100 MG injections | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 884 | Golimumab 2 MG PER KG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 885 | Golimumab 2 MG/KG IV | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 886 | Golimumab 200 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 887 | Golimumab 4 MG PER KG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 888 | Golimumab 400 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 889 | Golimumab 50 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
| 890 | Golimumab 50 MG IN patients <80 KG and golimumab 100 MG IN patients >80 KG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 891 | Golimumab 50 MG injections | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 892 | Golimumab 50 MG SC | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 893 | Granulocyte-colony stimulating factor (G-CSF) and prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 13 13 💬
|
| 894 | Group 2 ustekinumab 130 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 895 | Group 3: ustekinumab approximately 6 MG/KG | - | - | - | - | 2件: 96 96, 97 💬
|
| 896 | GS-4997 18 MG | - | - | - | - | 1件: 86 86 💬
|
| 897 | GS-4997 2 MG | - | - | - | - | 1件: 86 86 💬
|
| 898 | GS-4997 6 MG | - | - | - | - | 1件: 86 86 💬
|
| 899 | GS-6155 white 6 MG tablets | - | - | - | - | 1件: 58 58 💬
|
| 900 | GS-6615 3 MG | - | - | - | - | 1件: 58 58 💬
|
| 901 | GS-6615 3 MG pink | - | - | - | - | 1件: 58 58 💬
|
| 902 | GS-6615 3 MG white | - | - | - | - | 1件: 58 58 💬
|
| 903 | GS-6615 6 MG | - | - | - | - | 1件: 58 58 💬
|
| 904 | GS-6615 6 MG white | - | - | - | - | 1件: 58 58 💬
|
| 905 | GS-6615 pink 6 MG tablets | - | - | - | - | 1件: 58 58 💬
|
| 906 | GS-6615 white 10 MG tablets | - | - | - | - | 1件: 58 58 💬
|
| 907 | GS-6615 white 3 MG tablets | - | - | - | - | 1件: 58 58 💬
|
| 908 | GS-9674 100 MG | - | - | - | - | 1件: 93 93 💬
|
| 909 | GS-9674 30 MG | - | - | - | - | 1件: 93 93 💬
|
| 910 | GSK1605786 500 MG | - | - | - | - | 1件: 96 96 💬
|
| 911 | GSK2330672/linerixibat 40 MG | 1件: Linerixibat Linerixibat | 1件: Linerixibat
Linerixibat
💬
| 1件: SLC10A2 SLC10A2 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬
|
| 912 | GSK2402968 6 MG/KG/week | - | - | - | - | 1件: 113 113 💬
|
| 913 | GSK2586184 100 MG | - | - | - | - | 1件: 49 49 💬
|
| 914 | GSK2586184 200 MG | - | - | - | - | 1件: 49 49 💬
|
| 915 | GSK2586184 400 MG | - | - | - | - | 1件: 49 49 💬
|
| 916 | GSK2586184 50 MG | - | - | - | - | 1件: 49 49 💬
|
| 917 | GSK2982772 60 MG | - | - | - | - | 1件: 46 46 💬
|
| 918 | Guselkumab 100 MG | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 37 37 💬
|
| 919 | GWP42003-P 10 MG/KG/DAY dose | - | - | - | - | 1件: 140 140 💬
|
| 920 | GWP42003-P 20 MG/KG/DAY dose | - | - | - | - | 2件: 140 140, 144 💬
|
| 921 | GWP42003-P 5 MG/KG/DAY dose | - | - | - | - | 1件: 140 140 💬
|
| 922 | Gylenia 0,5 MG | - | - | - | - | 1件: 13 13 💬
|
| 923 | Hemay007 1200 MG QD group | - | - | - | - | 1件: 46 46 💬
|
| 924 | Hemay007 600 MG QD group | - | - | - | - | 1件: 46 46 💬
|
| 925 | Hemay007 800 MG QD group | - | - | - | - | 1件: 46 46 💬
|
| 926 | HMPL-004 1800 MG/DAY | - | - | - | - | 1件: 97 97 💬
|
| 927 | HMPL-004 2400 MG/DAY | - | - | - | - | 1件: 97 97 💬
|
| 928 | Humira (adalimumab) 40 MG IN 0.4 ML S.C. injection | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 929 | Humira (adalimumab) 40 MG S.C. injection | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 930 | Humira - 40 MG soluzione iniettabile USO sottocutaneo 1 siringa preriempita 0.8 ML + 1 tampone imbevuto DI alcol IN UN blister | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 56 56, 97 💬
|
| 931 | Humira - 40 MG soluzione iniettabile USO sottocutaneo 2 siringhe preriempite 0.8 ML + 2 tamponi imbevuti DI alcol IN 1 blister | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 932 | Humira 20 MG solution FOR injection IN PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 933 | Humira 40 MG injekcní roztok V predplnené injekcní STRíkacce | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 934 | Humira 40 MG injeksjonsvæSKE, oppløsning, I ferdigfylt SPRøYTE | - | - | - | - | 1件: 46 46 💬
|
| 935 | Humira 40 MG solucióN inyectable EN jeringa precargada | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 💬
|
| 936 | Humira 40 MG solution FOR injection IN PRE-filled PEN | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 937 | Humira 40 MG solution FOR injection IN PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
| 938 | Humira 40 MG solution FOR injection IN PRE-filled syringes | - | - | - | - | 1件: 97 97 💬
|
| 939 | Humira 40 MG/0.8 ML solution FOR injection | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 💬
|
| 940 | Humira 40 MG/0.8 ML solution FOR injection FOR paediatric USE | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 941 | Humira, 40 MG solution FOR injection IN PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 942 | Humira® 40 MG injektionslösung IN fertigspritze | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 943 | Humira® 40 MG solution FOR injection IN PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 944 | Humira® 40 MG/ 0.8 ML solution FOR injection IN PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 945 | Hydrochlorothiazide 25 MG | 1件: Hydrochlorothiazide Hydrochlorothiazide | 1件: Hydrochlorothiazide
Hydrochlorothiazide
💬
| 1件: SLC12A3 SLC12A3 💬
| 1件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬 | 1件: 67 67 💬
|
| 946 | Hydrocortison 100 MG (pfizer®) IN 2 ML solvent | - | - | - | - | 1件: 83 83 💬
|
| 947 | Hydrocortisone tablet 2.5 MG | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 948 | Hydrokortison APL kapsel 2,5 MG | - | - | - | - | 1件: 83 83 💬
|
| 949 | Hydrokortison glostrup 5 MG | - | - | - | - | 1件: 78 78 💬
|
| 950 | Hydroxychloroquine + LOW-dose prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 2件: Hydroxychloroquine Hydroxychloroquine, Prednisone | 3件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG),
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 💬
|
| 951 | Hydroxychloroquine + prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 2件: Hydroxychloroquine Hydroxychloroquine, Prednisone | 3件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG),
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 💬
|
| 952 | Hydroxychloroquine sulfate 100 milligram (MG) TAB | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 1件: 218 218 💬
|
| 953 | Hyqvia 100 MG/ML solution FOR infusion FOR subcutaneous USE | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 1件: 65 65 💬
|
| 954 | Ibrutinib 420 MG | 1件: Ibrutinib Ibrutinib | 1件: Ibrutinib
Ibrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 61 61 💬
|
| 955 | Ibuprofen sandoz 400 MG filmtabletten | 1件: Ibuprofen Ibuprofen | 5件: Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
| 956 | Icatibant acetate solution FOR injection 10 MG/ML | 1件: Icatibant Icatibant | 1件: Icatibant acetate
Icatibant acetate
💬
| 1件: BDKRB2 BDKRB2 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Chagas disease, Complement and coagulation cascades, Endocrine and other factor-regulated calcium reabsorption, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
| 957 | Idebenone 150 MG FILM-coated tablets | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 1件: 113 113 💬
|
| 958 | Igsc 20% 150 MG/KG | - | - | - | - | 1件: 65 65 💬
|
| 959 | Ilofotase alfa, 0.8 MG/KG | 1件: Recombinant human alkaline phosphatase Recombinant human alkaline phosphatase | 1件: Ilofotase alfa
Ilofotase alfa
💬
| 1件: E3.1.3.1 E3.1.3.1 💬
| 2件: Folate biosynthesis Folate biosynthesis, Thiamine metabolism 💬 | 1件: 172 172 💬
|
| 960 | Ilofotase alfa, 3.2 MG/KG | 1件: Recombinant human alkaline phosphatase Recombinant human alkaline phosphatase | 1件: Ilofotase alfa
Ilofotase alfa
💬
| 1件: E3.1.3.1 E3.1.3.1 💬
| 2件: Folate biosynthesis Folate biosynthesis, Thiamine metabolism 💬 | 1件: 172 172 💬
|
| 961 | Immediate release carbidopa/levodopa (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 962 | Immediate release carbidopa/levodopa 10/100 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 963 | Immediate release carbidopa/levodopa 25/100 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 964 | Imnovid 1 MG | 1件: Pomalidomide Pomalidomide | 1件: Pomalidomide
Pomalidomide
💬
| 2件: IL6 IL6, TNF 💬
| 78件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 28 28 💬
|
| 965 | Imnovid 1 MG hard capsules | 1件: Pomalidomide Pomalidomide | 1件: Pomalidomide
Pomalidomide
💬
| 2件: IL6 IL6, TNF 💬
| 78件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 51 51 💬
|
| 966 | Imnovid 2 MG | 1件: Pomalidomide Pomalidomide | 1件: Pomalidomide
Pomalidomide
💬
| 2件: IL6 IL6, TNF 💬
| 78件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 28 28 💬
|
| 967 | Imnovid 4 MG | 1件: Pomalidomide Pomalidomide | 1件: Pomalidomide
Pomalidomide
💬
| 2件: IL6 IL6, TNF 💬
| 78件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 28 28 💬
|
| 968 | Imurel 25 MG | - | - | - | - | 3件: 44 44, 45, 96 💬
|
| 969 | INCB050465 0.3 MG | 1件: Parsaclisib Parsaclisib | 1件: Parsaclisib
Parsaclisib
💬
| 1件: PIK3CA_B_D PIK3CA_B_D 💬
| 103件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 35 35 💬
|
| 970 | INCB050465 1 MG | 1件: Parsaclisib Parsaclisib | 1件: Parsaclisib
Parsaclisib
💬
| 1件: PIK3CA_B_D PIK3CA_B_D 💬
| 103件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 61 61 💬
|
| 971 | INCB050465 1.0 MG | 1件: Parsaclisib Parsaclisib | 1件: Parsaclisib
Parsaclisib
💬
| 1件: PIK3CA_B_D PIK3CA_B_D 💬
| 103件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 35 35 💬
|
| 972 | INCB050465 2.5 MG | 1件: Parsaclisib Parsaclisib | 1件: Parsaclisib
Parsaclisib
💬
| 1件: PIK3CA_B_D PIK3CA_B_D 💬
| 103件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 61 61 💬
|
| 973 | Induction- PF-06480605 150 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
| 974 | Induction- PF-06480605 450 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
| 975 | Induction- PF-06480605 50 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
| 976 | Infigratinib 0.016 MG/KG | 1件: Infigratinib Infigratinib | 2件: Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| 3件: FGFR1 FGFR1, FGFR2, FGFR3 💬
| 20件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | 1件: 276 276 💬
|
| 977 | Infigratinib 0.032 MG/KG | 1件: Infigratinib Infigratinib | 2件: Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| 3件: FGFR1 FGFR1, FGFR2, FGFR3 💬
| 20件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | 1件: 276 276 💬
|
| 978 | Infigratinib 0.064 MG/KG | 1件: Infigratinib Infigratinib | 2件: Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| 3件: FGFR1 FGFR1, FGFR2, FGFR3 💬
| 20件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | 1件: 276 276 💬
|
| 979 | Infigratinib 0.128 MG/KG | 1件: Infigratinib Infigratinib | 2件: Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| 3件: FGFR1 FGFR1, FGFR2, FGFR3 💬
| 20件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | 1件: 276 276 💬
|
| 980 | Infigratinib 0.25 MG/KG | 1件: Infigratinib Infigratinib | 2件: Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| 3件: FGFR1 FGFR1, FGFR2, FGFR3 💬
| 20件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | 1件: 276 276 💬
|
| 981 | Infigratinib 0.25 MG/KG/DAY | 1件: Infigratinib Infigratinib | 2件: Infigratinib
Infigratinib
,
Infigratinib phosphate
💬
| 3件: FGFR1 FGFR1, FGFR2, FGFR3 💬
| 20件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬 | 1件: 276 276 💬
|
| 982 | Inflectra - 100 MG - polvere PER concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) - 1 flaconcino | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 56 56 💬
|
| 983 | Inflectra 100 MG | - | - | - | - | 1件: 97 97 💬
|
| 984 | Inflectra 100 MG powder FOR concentrate FOR solution FOR infusion | - | - | - | - | 2件: 96 96, 97 💬
|
| 985 | Infliximab (remicade): 100 MG OF lyophilized infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 986 | Infliximab 10 MG/KG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
| 987 | Infliximab 20 MG/KG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 988 | Infliximab 3 MG/KG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 989 | Infliximab 5 MG/KG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 990 | Infliximab 5 MG/KG body weight infused over 2 hours | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 991 | Infliximab 5 MG/KG every 6 weeks | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 992 | Infliximab 7 MG/KG every 8 weeks | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 993 | Injectafer 50 MG ijzer / ML oplossing voor injectie/infusie | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 1件: 97 97 💬
|
| 994 | Intelence - 200 MG - compressa -USO orale - flacone (hdpe) 60 compresse | 1件: Etravirine Etravirine | 1件: Etravirine
Etravirine
💬
| - | - | 1件: 18 18 💬
|
| 995 | Intravenous (I.V.) methylprednisolone 1000 MG, total 9 | - | - | - | - | 1件: 222 222 💬
|
| 996 | Intravenous dexamethasone 1 MG | - | - | - | - | 1件: 46 46 💬
|
| 997 | IPN60130 10 MG capsules | - | - | - | - | 1件: 272 272 💬
|
| 998 | IPN60130 50 MG capsules | - | - | - | - | 1件: 272 272 💬
|
| 999 | Ipstyl - 60 MG soluzione iniettabile PER USO sottocutaneo 1 siringa preriempita | - | - | - | - | 1件: 77 77 💬
|
| 1000 | Ipstyl - 90 MG soluzione iniettabile PER USO sottocutaneo 1 siringa preriempita | - | - | - | - | 1件: 77 77 💬
|
| 1001 | Ipstyl 120 MG | - | - | - | - | 1件: 77 77 💬
|
| 1002 | Ipstyl 90 MG | - | - | - | - | 1件: 77 77 💬
|
| 1003 | Iptcaopan 200 MG | - | - | - | - | 1件: 109 109 💬
|
| 1004 | IPX054 100 MG | - | - | - | - | 1件: 6 6 💬
|
| 1005 | IPX054 150 MG | - | - | - | - | 1件: 6 6 💬
|
| 1006 | IPX054 200 MG | - | - | - | - | 1件: 6 6 💬
|
| 1007 | IPX054 250 MG | - | - | - | - | 1件: 6 6 💬
|
| 1008 | IPX054 300 MG | - | - | - | - | 1件: 6 6 💬
|
| 1009 | IPX056 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 1010 | IPX056 20 MG | - | - | - | - | 1件: 13 13 💬
|
| 1011 | IPX056 30 MG | - | - | - | - | 1件: 13 13 💬
|
| 1012 | IPX056 35 MG | - | - | - | - | 1件: 13 13 💬
|
| 1013 | IPX056 40 MG | - | - | - | - | 1件: 13 13 💬
|
| 1014 | IPX056-10 MG | - | - | - | - | 1件: 13 13 💬
|
| 1015 | IPX056-20 MG | - | - | - | - | 1件: 13 13 💬
|
| 1016 | IPX056-25 MG | - | - | - | - | 1件: 13 13 💬
|
| 1017 | IPX056-30 MG | - | - | - | - | 1件: 13 13 💬
|
| 1018 | IPX056-35 MG | - | - | - | - | 1件: 13 13 💬
|
| 1019 | IPX056-40 MG | - | - | - | - | 1件: 13 13 💬
|
| 1020 | IPX066 145 MG | - | - | - | - | 1件: 6 6 💬
|
| 1021 | IPX066 145 MG LD | - | - | - | - | 1件: 6 6 💬
|
| 1022 | IPX066 195 MG | - | - | - | - | 1件: 6 6 💬
|
| 1023 | IPX066 195 MG LD | - | - | - | - | 1件: 6 6 💬
|
| 1024 | IPX066 245 MG | - | - | - | - | 1件: 6 6 💬
|
| 1025 | IPX066 245 MG LD | - | - | - | - | 1件: 6 6 💬
|
| 1026 | IPX066 95 MG | - | - | - | - | 1件: 6 6 💬
|
| 1027 | IPX066 95 MG LD | - | - | - | - | 1件: 6 6 💬
|
| 1028 | IPX203 140 MG | - | - | - | - | 1件: 6 6 💬
|
| 1029 | IPX203 180 MG | - | - | - | - | 1件: 6 6 💬
|
| 1030 | IPX203 210 MG | - | - | - | - | 1件: 6 6 💬
|
| 1031 | IPX203 270 MG | - | - | - | - | 1件: 6 6 💬
|
| 1032 | IPX203 280 MG | - | - | - | - | 1件: 6 6 💬
|
| 1033 | IPX203 350 MG | - | - | - | - | 1件: 6 6 💬
|
| 1034 | IR CD-LD (carbidopa-levodopa) tablets (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1035 | IR prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 46 46 💬
|
| 1036 | Iron supplement 300-600 MG/DAY | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 2件: 96 96, 97 💬
|
| 1037 | Isis 443139 10 MG | - | - | - | - | 1件: 8 8 💬
|
| 1038 | Isis 443139 120 MG | - | - | - | - | 1件: 8 8 💬
|
| 1039 | Isis 443139 30 MG | - | - | - | - | 1件: 8 8 💬
|
| 1040 | Isis 443139 60 MG | - | - | - | - | 1件: 8 8 💬
|
| 1041 | Isis 443139 90 MG | - | - | - | - | 1件: 8 8 💬
|
| 1042 | Isosorbide dinitrate 20 MG | 2件: Isosorbide Isosorbide, Isosorbide dinitrate | 2件: Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | 1件: 113 113 💬
|
| 1043 | Isosorbide dinitrate 40 MG | 2件: Isosorbide Isosorbide, Isosorbide dinitrate | 2件: Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | 1件: 113 113 💬
|
| 1044 | Isosorbide dinitrate 60 MG | 2件: Isosorbide Isosorbide, Isosorbide dinitrate | 2件: Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | 1件: 113 113 💬
|
| 1045 | Isosorbide dinitrate 80 MG | 2件: Isosorbide Isosorbide, Isosorbide dinitrate | 2件: Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | 1件: 113 113 💬
|
| 1046 | Istradefylline 20 MG | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1047 | Istradefylline 20 MG or 40 MG | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1048 | Istradefylline 40 MG | 1件: Istradefylline Istradefylline | 1件: Istradefylline
Istradefylline
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1049 | ITF2357 10 MG/ML | - | - | - | - | 1件: 113 113 💬
|
| 1050 | Itraconazole 65 MG | 1件: Itraconazole Itraconazole | 1件: Itraconazole
Itraconazole
💬
| - | - | 1件: 299 299 💬
|
| 1051 | Ivacaftor 150 MG | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1052 | Ivacaftor 150 MG or 250 MG | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1053 | Ivacaftor 25 MG/75 MG | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1054 | Ivacaftor 75 MG | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1055 | Ivacaftor 75 MG/150 MG | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1056 | Jinarc - 15 MG - compressa - USO orale - blister (ALU/PVC) - 28 compresse | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 1057 | Jinarc - 30 MG - compressa - USO orale - blister (ALU/PVC) - 28 compresse | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 1058 | Jinarc 15 MG tablets, jinarc 45 MG tablets | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 1059 | Jinarc 30 MG tablet | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 1060 | Jinarc 30 MG tablets, 90 MG tablets | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 1061 | Jinarc 30 MG tablets, jinarc 60 MG tablets | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 1062 | JNJ-38518168 50-MG over encapsulated tablet | - | - | - | - | 1件: 46 46 💬
|
| 1063 | JNJ-38518168-AEK - over encapsulated tablet - 50 MG | - | - | - | - | 1件: 46 46 💬
|
| 1064 | JNJ-38518168-ZBQ - FILM-coated tablet - 10 MG | - | - | - | - | 1件: 46 46 💬
|
| 1065 | JNJ-38518168-ZBQ - FILM-coated tablet - 3 MG | - | - | - | - | 1件: 46 46 💬
|
| 1066 | JNJ-38518168-ZBQ - FILM-coated tablet - 30 MG | - | - | - | - | 1件: 46 46 💬
|
| 1067 | JNJ-39758979-AAC - enteric coated tablet - 10 MG | 1件: JNJ-39758979 JNJ-39758979 | - | - | - | 1件: 46 46 💬
|
| 1068 | JNJ-39758979-AAC - enteric coated tablet - 100 MG | 1件: JNJ-39758979 JNJ-39758979 | - | - | - | 1件: 46 46 💬
|
| 1069 | JNJ-39758979-AAC - enteric coated tablet - 30 MG | 1件: JNJ-39758979 JNJ-39758979 | - | - | - | 1件: 46 46 💬
|
| 1070 | JNJ-40346527-AAC - capsule - 50 MG | 1件: JNJ-40346527 JNJ-40346527 | - | - | - | 1件: 46 46 💬
|
| 1071 | JNJ-54781532 150 MG once daily | - | - | - | - | 1件: 97 97 💬
|
| 1072 | JNJ-54781532 25 MG once daily | - | - | - | - | 1件: 97 97 💬
|
| 1073 | JNJ-54781532 75 MG once daily | - | - | - | - | 1件: 97 97 💬
|
| 1074 | JNJ-54781532 75 MG twice daily | - | - | - | - | 1件: 97 97 💬
|
| 1075 | JNJ-54781532-AAD-10 MG | - | - | - | - | 1件: 97 97 💬
|
| 1076 | JNJ-54781532-AAD-30 MG | - | - | - | - | 1件: 97 97 💬
|
| 1077 | JNJ-54781532-AAD-5 MG | - | - | - | - | 1件: 97 97 💬
|
| 1078 | Jorveza 0.5 MG compresse orodispersibili | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 1079 | Jorveza 0.5 MG orodispersible tablets | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 1080 | Jorveza 1 MG compresse orodispersibili | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 1081 | Jorveza 1 MG orodispersible tablets | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
| 1082 | Jyseleca 100 MG FILM-coated tablets | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 1083 | Jyseleca 200 MG FILM-coated tablets | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 1084 | Kalydeco 150 MG FILM-C | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1085 | Kalydeco 150 MG FILM-coated tablets | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1086 | Kenacort - 40 MG/ ML sospensione iniettabile 3 flaconcini DA 1 ML | - | - | - | - | 1件: 90 90 💬
|
| 1087 | Kesimpta 20 MG injektionslösung IM fertigpen | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1088 | Kesimpta 20 MG solution FOR injection IN PRE-filled PEN | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1089 | Kineret 100 MG injection | 1件: Anakinra Anakinra | 1件: Anakinra
Anakinra
💬
| 2件: IL1R1 IL1R1, IL1R2 💬
| 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 54 54 💬
|
| 1090 | Kiovig 100 MG/ML solution FOR infusion | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 2件: 14 14, 65 💬
|
| 1091 | KL1333 100 MG | 1件: KL1333 KL1333 | - | - | - | 1件: 21 21 💬
|
| 1092 | KL1333 200 MG | 1件: KL1333 KL1333 | - | - | - | 1件: 21 21 💬
|
| 1093 | KL1333 25 MG | 1件: KL1333 KL1333 | - | - | - | 1件: 21 21 💬
|
| 1094 | KL1333 400 MG | 1件: KL1333 KL1333 | - | - | - | 1件: 21 21 💬
|
| 1095 | KL1333 50 MG | 1件: KL1333 KL1333 | - | - | - | 1件: 21 21 💬
|
| 1096 | KL1333 600 MG | 1件: KL1333 KL1333 | - | - | - | 1件: 21 21 💬
|
| 1097 | KL1333 800 MG | 1件: KL1333 KL1333 | - | - | - | 1件: 21 21 💬
|
| 1098 | KN019, 10 MG/KG | - | - | - | - | 1件: 46 46 💬
|
| 1099 | KVD824 300 MG compresse A rilascio modificato | - | - | - | - | 1件: 65 65 💬
|
| 1100 | KVD824 300 MG modified release tablets | - | - | - | - | 1件: 65 65 💬
|
| 1101 | KVD900 100 MG film coated tablet | - | - | - | - | 1件: 65 65 💬
|
| 1102 | KVD900 150 MG | - | - | - | - | 1件: 65 65 💬
|
| 1103 | KVD900 300 MG | - | - | - | - | 1件: 65 65 💬
|
| 1104 | KVD900 300 MG compressa rivestita CON film | - | - | - | - | 1件: 65 65 💬
|
| 1105 | KVD900 300 MG film coated tablet | - | - | - | - | 1件: 65 65 💬
|
| 1106 | KVD900 600 MG | - | - | - | - | 1件: 65 65 💬
|
| 1107 | KVD900 75 MG | - | - | - | - | 1件: 65 65 💬
|
| 1108 | KW-0761 0.3 MG/KG IV | - | - | - | - | 1件: 26 26 💬
|
| 1109 | L-citrulline and metformin & L-citrulline (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬
|
| 1110 | L-dopa 140 MG | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1111 | L-dopa 35 MG | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1112 | L-dopa 70MG/carbidopa 7MG (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1113 | Lamotrigin ”nordic prime 100 MG | - | - | - | - | 1件: 114 114 💬
|
| 1114 | Lamotrigin ”nordic prime 25 MG | - | - | - | - | 1件: 114 114 💬
|
| 1115 | Lamotrigin ”nordic prime 50 MG | - | - | - | - | 1件: 114 114 💬
|
| 1116 | Lanadelumab 150 MG | 1件: Lanadelumab Lanadelumab | 1件: Lanadelumab
Lanadelumab
💬
| 1件: KLKB1 KLKB1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 65 65 💬
|
| 1117 | Lanadelumab 300 MG | 1件: Lanadelumab Lanadelumab | 1件: Lanadelumab
Lanadelumab
💬
| 1件: KLKB1 KLKB1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 65 65 💬
|
| 1118 | Lanreotida autogel 120 MG | 1件: Lanreotide Lanreotide | 1件: Lanreotide acetate
Lanreotide acetate
💬
| 2件: SSTR2 SSTR2, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1119 | Lanreotide autogel 120 MG | 1件: Lanreotide Lanreotide | 1件: Lanreotide acetate
Lanreotide acetate
💬
| 2件: SSTR2 SSTR2, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1120 | Lanreotide-autogel 120 MG | 1件: Lanreotide Lanreotide | 1件: Lanreotide acetate
Lanreotide acetate
💬
| 2件: SSTR2 SSTR2, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1121 | Laquinimod capsulas 0.6 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1122 | Laquinimod capsules 0.3 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1123 | Laquinimod capsules 0.5 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 2件: 8 8, 96 💬
|
| 1124 | Laquinimod capsules 0.6 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1125 | Laquinimod Cápsulas 0.5 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 96 96 💬
|
| 1126 | Laquinimod tablets 0.3 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1127 | LCI699, 1 MG | - | - | - | - | 1件: 75 75 💬
|
| 1128 | LCI699, 10 MG | - | - | - | - | 1件: 75 75 💬
|
| 1129 | LCI699, 20 MG | - | - | - | - | 1件: 75 75 💬
|
| 1130 | LCI699, 5 MG | - | - | - | - | 1件: 75 75 💬
|
| 1131 | LCZ696 100 MG | - | - | - | - | 1件: 58 58 💬
|
| 1132 | LCZ696 200 MG | - | - | - | - | 1件: 58 58 💬
|
| 1133 | LCZ696 50 MG | - | - | - | - | 1件: 58 58 💬
|
| 1134 | Ledertrexato 2,5 MG compriméS | - | - | - | - | 1件: 46 46 💬
|
| 1135 | Leflunomide 20 MG+prednisone 0.5MG/KG/D | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 66 66 💬
|
| 1136 | Lemborexant 5 MG | 1件: Lemborexant Lemborexant | 1件: Lemborexant
Lemborexant
💬
| 2件: HCRTR1 HCRTR1, HCRTR2 💬
| 2件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 127 127 💬
|
| 1137 | Lemtrada 12 MG konzentrat ZUR herstellung einer infusionslösung | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 1138 | Lenabasum 20 MG | 1件: Lenabasum Lenabasum | 1件: Lenabasum
Lenabasum
💬
| 1件: CNR2 CNR2 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 51 51, 299 💬
|
| 1139 | Lenabasum 20 MG powder IN capsule | 1件: Lenabasum Lenabasum | 1件: Lenabasum
Lenabasum
💬
| 1件: CNR2 CNR2 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 💬
|
| 1140 | Lenabasum 5 MG | 1件: Lenabasum Lenabasum | 1件: Lenabasum
Lenabasum
💬
| 1件: CNR2 CNR2 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 51 51, 299 💬
|
| 1141 | Lenabasum 5 MG powder IN capsule | 1件: Lenabasum Lenabasum | 1件: Lenabasum
Lenabasum
💬
| 1件: CNR2 CNR2 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 💬
|
| 1142 | Leqvio 284 MG solution FOR injection IN PRE-filled syringe | 1件: Inclisiran Inclisiran | 2件: Inclisiran
Inclisiran
,
Inclisiran sodium
💬
| 1件: PCSK9 PCSK9 💬
| 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬
|
| 1143 | Letairis 10 MG | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 1144 | Letairis 5 MG | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 1145 | Leuprolide acetate 11.25 MG/ML | 1件: Leuprolide Leuprolide | 3件: Leuprolide acetate
Leuprolide acetate
,
Leuprorelin
,
Leuprolide mesylate
💬
| 1件: GNRHR GNRHR 💬
| 3件: GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 💬
|
| 1146 | Leuprolide acetate 45 MG | 1件: Leuprolide Leuprolide | 3件: Leuprolide acetate
Leuprolide acetate
,
Leuprorelin
,
Leuprolide mesylate
💬
| 1件: GNRHR GNRHR 💬
| 3件: GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 💬
|
| 1147 | Leuprolide mesylate, subcutaneous injection OF 42 MG leuprolide | 1件: Leuprolide Leuprolide | 3件: Leuprolide acetate
Leuprolide acetate
,
Leuprorelin
,
Leuprolide mesylate
💬
| 1件: GNRHR GNRHR 💬
| 3件: GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 💬
|
| 1148 | Levodopa / benserazide 200 + 50 MG | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1149 | Levodopa / carbidopa solution (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1150 | Levodopa 100 MG / benserazide 25 MG | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1151 | Levodopa 100 MG A CAP | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1152 | Levodopa 125 MG A CAP | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1153 | Levodopa 150 MG A CAP | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1154 | Levodopa 75 MG A CAP | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1155 | Levodopa and carbidopa (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1156 | Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1157 | Levodopa, carbidopa, entacapone (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1158 | Levodopa, carbidopa, ODM-104 (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1159 | Levodopa-carbidopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1160 | Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1161 | Levodopa-carbidopa immediate release (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1162 | Levodopa-carbidopa immediate release (LC-IR) tablets (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1163 | Levodopa-carbidopa intestinal GEL (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1164 | Levodopa-carbidopa multilayer extended release tablet (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1165 | Levodopa-carbidopa-entacapone (CARBIDOPA TABLETS, 25 MG) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG),
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1166 | Levodopa/benserazide 100/25 MG | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1167 | Levodopa/carbidopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1168 | Levodopa/carbidopa 100/25 (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1169 | Levodopa/carbidopa oral formulation A (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1170 | Levodopa/carbidopa oral formulation B (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1171 | Levodopa/carbidopa oral formulation C (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1172 | Levodopa/carbidopa solution (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1173 | Levodopa/carbidopa solution FOR SC administration (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1174 | Levodopa/carbidopa/entacapone (CARBIDOPA TABLETS, 25 MG) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG),
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1175 | Levofolene 4 MG 30 CPR | 1件: Levoleucovorin Levoleucovorin | 3件: Levoleucovorin calcium
Levoleucovorin calcium
,
Sodium levofolinate
,
Calcium levofolinate hydrate
💬
| - | - | 1件: 13 13 💬
|
| 1176 | Linerixibat (GSK2330672) 40 MG | 1件: Linerixibat Linerixibat | 1件: Linerixibat
Linerixibat
💬
| 1件: SLC10A2 SLC10A2 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬
|
| 1177 | Linerixibat (GSK2330672) 45 MG | 1件: Linerixibat Linerixibat | 1件: Linerixibat
Linerixibat
💬
| 1件: SLC10A2 SLC10A2 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬
|
| 1178 | Liposomal cyclosporine A 10 MG | - | - | - | - | 1件: 228 228 💬
|
| 1179 | Liposomal cyclosporine A 5 MG | - | - | - | - | 1件: 228 228 💬
|
| 1180 | Liris 400 MG | - | - | - | - | 1件: 226 226 💬
|
| 1181 | Liris® 400 MG | - | - | - | - | 1件: 226 226 💬
|
| 1182 | Lisinopril, losartan, and atorvastatin (LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG) | 1件: Lisinopril Lisinopril | 2件: Lisinopril
Lisinopril
,
Lisinopril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 222 222 💬
|
| 1183 | Lithium carbonate 400 MG | 1件: Lithium carbonate Lithium carbonate | 1件: Lithium carbonate
Lithium carbonate
💬
| - | - | 1件: 2 2 💬
|
| 1184 | LJN452, 0,01 MG | - | - | - | - | 1件: 93 93 💬
|
| 1185 | LJN452, 0,03 MG | - | - | - | - | 1件: 93 93 💬
|
| 1186 | LJN452, 0,1 MG | - | - | - | - | 1件: 93 93 💬
|
| 1187 | Lojuxta 10 MG hard capsules | 1件: Lomitapide Lomitapide | 2件: Lomitapide
Lomitapide
,
Lomitapide mesylate
💬
| 1件: MTTP MTTP 💬
| 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 💬
|
| 1188 | Lojuxta 20 MG hard capsules | 1件: Lomitapide Lomitapide | 2件: Lomitapide
Lomitapide
,
Lomitapide mesylate
💬
| 1件: MTTP MTTP 💬
| 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 💬
|
| 1189 | Lojuxta 5 MG hard capsules | 1件: Lomitapide Lomitapide | 2件: Lomitapide
Lomitapide
,
Lomitapide mesylate
💬
| 1件: MTTP MTTP 💬
| 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 💬
|
| 1190 | Loratadina stada 10 MG | 1件: Loratadine Loratadine | 1件: Loratadine
Loratadine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 89 89 💬
|
| 1191 | Losartan (LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 15件: 17 17, 19, 46, 58, 66, 67, 85, 96, 97, 113, 164, 167, 215, 222, 299 💬
|
| 1192 | Losartan and nebivolol (LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG) | 2件: Losartan Losartan, Nebivolol | 4件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Nebivolol
,
Nebivolol hydrochloride
,
Losartan
💬
| 2件: ADRB1 ADRB1, AGTR1 💬
| 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
| 1193 | Losartan and other angiotensin receptor blockers (LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 19 19 💬
|
| 1194 | Losartan bluefish 50 MG | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
| 1195 | Losartan hexal (LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 36 36 💬
|
| 1196 | Losartan potasico (LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 179 179 💬
|
| 1197 | Losartan potassium (LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 5件: 36 36, 98, 167, 179, 215 💬
|
| 1198 | Losartan tablets & qingremoshen granule (LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG) | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
| 1199 | Losec capsules 20 MG | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 46 46 💬
|
| 1200 | Lovastatin 60 MG | 1件: Lovastatin Lovastatin | 1件: Lovastatin
Lovastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 34 34 💬
|
| 1201 | Lutein (10 or 30 MG/DAY) capsules | 1件: Lutein Lutein | - | - | - | 1件: 90 90 💬
|
| 1202 | LX3305 250 MG capsule | - | - | - | - | 1件: 161 161 💬
|
| 1203 | LY3337641 20 MG | - | - | - | - | 1件: 46 46 💬
|
| 1204 | LY3337641 5 MG | - | - | - | - | 1件: 46 46 💬
|
| 1205 | M2591 25 MG QD | - | - | - | - | 1件: 46 46 💬
|
| 1206 | M2951 50 MG BID | - | - | - | - | 1件: 46 46 💬
|
| 1207 | M2951 75 MG QD | - | - | - | - | 1件: 46 46 💬
|
| 1208 | Mabcampath 10 MG/ML concentrado para solucióN para perfusióN | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 1209 | Mabthera - 1 fiala 500 MG 50 ML | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 14 14 💬
|
| 1210 | Mabthera - 2 fiale 100 MG 10 ML | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 19 19, 65 💬
|
| 1211 | Mabthera 100 MG concentrate FOR solution FOR infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 💬
|
| 1212 | Mabthera 500 MG | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 1213 | Mabthera 500 MG (10 MG/ML) concentrate FOR solution FOR infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 1214 | Mabthera 500 MG concentrado para solucióN para perfusióN | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 1215 | Mabthera 500 MG concentrate FOR solution FOR infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 46 46, 222 💬
|
| 1216 | Mabthera 500 MG konzentrat ZUR herstellung einer infusionslösung | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 1217 | Mabthera®, 100 MG concentrado para solucióN para perfusióN | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 1218 | Mabthera®, 100 MG concentrate FOR solution FOR infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
| 1219 | Macitentan 10 MG | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 86, 88 💬
|
| 1220 | Macitentan 3 MG | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1221 | Macitentan 37.5 MG | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1222 | Macitentan 75 MG | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1223 | Madopar 125 MG T, tablets | - | - | - | - | 1件: 6 6 💬
|
| 1224 | Madopar 125 MG, orodispersible tablet | - | - | - | - | 1件: 6 6 💬
|
| 1225 | Madopar 200+50 MG | - | - | - | - | 1件: 6 6 💬
|
| 1226 | Magnesium sulfate (Conclyte-Mg) | 2件: Magnesium Magnesium, Magnesium sulfate (MgSO4) | 1件: Magnesium sulfate
Magnesium sulfate
(Conclyte-Mg) 💬
| - | - | 3件: 11 11, 296, 297 💬
|
| 1227 | Magnesium sulfate heptahydrate (Conclyte-Mg) | 2件: Magnesium Magnesium, Magnesium sulfate (MgSO4) | 1件: Magnesium sulfate
Magnesium sulfate
(Conclyte-Mg) 💬
| - | - | 1件: 97 97 💬
|
| 1228 | Masitinib 100 MG | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 13 13 💬
|
| 1229 | Masitinib 100 MG tablets | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 💬
|
| 1230 | Masitinib 200 MG | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 13 13 💬
|
| 1231 | Masitinib 200 MG tablets | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 💬
|
| 1232 | Masitinib 3 MG | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 46 46 💬
|
| 1233 | Masitinib 6.0 MG | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 46 46 💬
|
| 1234 | Mavenclad - 10 MG - compressa - USO orale - blister (AL/AL) - 6 compresse | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1235 | Mavenclad 10 MG tablets | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1236 | Mavenclad 6CPR 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 1237 | Mavenclad tabletter 10 MG | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1238 | Mavrilimumab 10 MG | 1件: Mavrilimumab Mavrilimumab | 1件: Mavrilimumab
Mavrilimumab
💬
| 1件: CSF2RA CSF2RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 💬
|
| 1239 | Mavrilimumab 100 MG | 1件: Mavrilimumab Mavrilimumab | 1件: Mavrilimumab
Mavrilimumab
💬
| 1件: CSF2RA CSF2RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 💬
|
| 1240 | Mavrilimumab 150 MG | 1件: Mavrilimumab Mavrilimumab | 1件: Mavrilimumab
Mavrilimumab
💬
| 1件: CSF2RA CSF2RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 💬
|
| 1241 | Mavrilimumab 30 MG | 1件: Mavrilimumab Mavrilimumab | 1件: Mavrilimumab
Mavrilimumab
💬
| 1件: CSF2RA CSF2RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 💬
|
| 1242 | Mavrilimumab 50 MG | 1件: Mavrilimumab Mavrilimumab | 1件: Mavrilimumab
Mavrilimumab
💬
| 1件: CSF2RA CSF2RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 💬
|
| 1243 | Mayzent 0,25 MG compresse rivestite CON film | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1244 | Mayzent 0,25 MG filmtabletten | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1245 | Mayzent 0.25 MG FI | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1246 | Mayzent 2 MG compresse rivestite CON film | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1247 | Mayzent 2 MG FILM-coated tablets | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1248 | Mayzent 2 MG filmtabletten | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1249 | MBF-015 16 MG oral capsules | - | - | - | - | 1件: 8 8 💬
|
| 1250 | MBS2320 20 MG | - | - | - | - | 1件: 46 46 💬
|
| 1251 | MBS2320 40 MG | - | - | - | - | 1件: 46 46 💬
|
| 1252 | MBS2320 5 MG | - | - | - | - | 1件: 46 46 💬
|
| 1253 | MD1003 100 MG capsule | - | - | - | - | 1件: 20 20 💬
|
| 1254 | MEDI-551 100 MG-IV | - | - | - | - | 1件: 13 13 💬
|
| 1255 | MEDI-551 30 MG-IV | - | - | - | - | 1件: 13 13 💬
|
| 1256 | MEDI-551 300 MG-SC | - | - | - | - | 1件: 13 13 💬
|
| 1257 | MEDI-551 60 MG-SC | - | - | - | - | 1件: 13 13 💬
|
| 1258 | MEDI-551 600 MG-IV | - | - | - | - | 1件: 13 13 💬
|
| 1259 | MEDI-570 0.03 MG | - | - | - | - | 1件: 49 49 💬
|
| 1260 | MEDI-570 0.1 MG | - | - | - | - | 1件: 49 49 💬
|
| 1261 | MEDI-570 0.3 MG | - | - | - | - | 1件: 49 49 💬
|
| 1262 | MEDI-570 1 MG | - | - | - | - | 1件: 49 49 💬
|
| 1263 | Medrol - 4 MG compresse 30 compresse | - | - | - | - | 1件: 56 56 💬
|
| 1264 | Medrol 4 MG tablets | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1265 | Medrol A 16 MG tablets | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1266 | Meloxicam 0.125 MG/KG | 1件: Meloxicam Meloxicam | 1件: Meloxicam
Meloxicam
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 1267 | Meloxicam 0.25 MG/KG | 1件: Meloxicam Meloxicam | 1件: Meloxicam
Meloxicam
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 1268 | Mepolizumab 100 MG | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件: 98 98 💬
|
| 1269 | Mepolizumab 300 MG | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件: 98 98 💬
|
| 1270 | Mesalazine - TID 1000 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1271 | Mesalazine - TID 2X 500 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1272 | Mesalazine 1000 MG gastro-resistant tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1273 | Mesalazine 500 MG gastro-resistant tablets (salofa | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1274 | Mesalazine EC 500 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
| 1275 | Metalcaptase® 150 MG gastro-resistant tablet | - | - | - | - | 1件: 171 171 💬
|
| 1276 | Metalcaptase® 300 MG gastro-resistant tablet | - | - | - | - | 1件: 171 171 💬
|
| 1277 | Metaxalone 640 MG oral tablet | 1件: Metaxalone Metaxalone | 1件: Metaxalone
Metaxalone
💬
| - | - | 1件: 70 70 💬
|
| 1278 | Metex 10 MG/ML injektionslösung, fertigspritze | - | - | - | - | 1件: 46 46 💬
|
| 1279 | Metex 2,5 MG tabletten | - | - | - | - | 1件: 44 44 💬
|
| 1280 | Metex 50 MG/ML injeksjonsvæSKE, oppløsning I ferdigfylt SPRøYTE | - | - | - | - | 1件: 46 46 💬
|
| 1281 | Metex® 50 MG/ML injektionslösung, fertigspritze | - | - | - | - | 1件: 46 46 💬
|
| 1282 | Metformin (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 23件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
|
| 1283 | Metformin + standard OF care (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 222 222 💬
|
| 1284 | Metformin 1000 MG oral tablet | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 1285 | Metformin 500 MG oral tablet, UP TO 4 tablets A DAY | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 1286 | Metformin 500 MG TID oral tablet | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 1287 | Metformin 500MG (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬
|
| 1288 | Metformin and clemastine IN combination (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 1289 | Metformin and metformin & L-citrulline (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬
|
| 1290 | Metformin HCL (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 285 285 💬
|
| 1291 | Metformin hydrochloride (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 5件: 81 81, 158, 265, 299, 301 💬
|
| 1292 | Metformin hydrochloride 850 MG oral tablet | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 1293 | Metformin treatment (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 1294 | Metformin XR (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 67 67 💬
|
| 1295 | Metformin/CP-690,550 (METFORMIN ER 500 MG) | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 1296 | Metformina - 500 30 compresse 500 MG | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬
|
| 1297 | Metformine sandoz 850 MG filmomhulde tabletten | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
(METFORMIN ER 500 MG),
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 81 81 💬
|
| 1298 | Methotrexat 2,5 MG tabletten medac | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1299 | Methotrexat hexal® 2,5 MG tabletten | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1300 | Methotrexate - 20 MG/0.8 ML soluzione iniettabile 4 siringhe preriempite monouso DA 1.25 ML | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 96 96 💬
|
| 1301 | Methotrexate 10 MG | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1302 | Methotrexate 10 MG tablets | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1303 | Methotrexate 2.5 MG | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 44 44 💬
|
| 1304 | Methotrexate 2.5 MG tablets | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1305 | Methotrexate 25 MG | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 44 44 💬
|
| 1306 | Methotrexate hospira 2,5 MG tablety | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1307 | Methotrexate hospira 2.5 MG tablety | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1308 | Methotrexate lederle 2.5 MG tablets | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1309 | Methotrexate pfizer 2,5 MG tabletter | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1310 | Methotrexate sodium tablets 2.5 MG | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1311 | Methotrexate tablets 2.5 MG | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1312 | Methotrexate® 2.5 MG tablets | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1313 | Methylphenidate modified release 20 MG | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1314 | Methylphenidate modified release 30 MG | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1315 | Methylphenidate modified release 40 MG | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1316 | Methylprednisolone 1250 MG/24H X3 days | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 1317 | Methylprednisone/prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Methylprednisone Methylprednisone | - | - | - | 1件: 85 85 💬
|
| 1318 | Metilprednisolone hikma - 1000 MG polvere PER soluzione iniettabile 10 flaconcini IN vetro | - | - | - | - | 1件: 300 300 💬
|
| 1319 | Metoclopramide accord - 10 MG compresse 28 compresse IN blister PVC/pvdc/AL | 1件: Metoclopramide Metoclopramide | 3件: Metoclopramide
Metoclopramide
,
Metoclopramide hydrochloride
,
Metoclopramide hydrochloride
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 51 51 💬
|
| 1320 | Metohexal® succ ® 23,75 MG retardtabletten | - | - | - | - | 1件: 113 113 💬
|
| 1321 | Metohexal® succ ® 47,5 MG retardtabletten | - | - | - | - | 1件: 113 113 💬
|
| 1322 | Metohexal® succ ® 95 MG retardtabletten | - | - | - | - | 1件: 113 113 💬
|
| 1323 | Metoject 10 MG/ML | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 50 50 💬
|
| 1324 | Metoject 10 MG/ML, solution injectable EN seringue PRé-remplie | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 44 44 💬
|
| 1325 | Metopirone 250 MG capsules | 1件: Metyrapone Metyrapone | 1件: Metyrapone
Metyrapone
💬
| 1件: CYP11B1 CYP11B1 💬
| 3件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬
|
| 1326 | Metopirone 250 MG capsules/ cormeto | 1件: Metyrapone Metyrapone | 1件: Metyrapone
Metyrapone
💬
| 1件: CYP11B1 CYP11B1 💬
| 3件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬
|
| 1327 | Metopirone 250 MG capsules/cormeto | 1件: Metyrapone Metyrapone | 1件: Metyrapone
Metyrapone
💬
| 1件: CYP11B1 CYP11B1 💬
| 3件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬
|
| 1328 | Metoprolol tartrate 50 MG | 1件: Metoprolol Metoprolol | 4件: Metoprolol tartrate
Metoprolol tartrate
,
Metoprolol succinate
,
Metoprolol
,
Metoprolol fumarate
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 💬
|
| 1329 | Metotrexato-lederle 2,5 MG comprimidos | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1330 | Metronidazole (METRONIDAZOLE250 MG, METRONIDAZOLE500 MG) | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
(METRONIDAZOLE250 MG, METRONIDAZOLE500 MG),
Metronidazole hydrochloride
💬
| - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 💬
|
| 1331 | Metronidazole capsule 50 MG | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
(METRONIDAZOLE250 MG, METRONIDAZOLE500 MG),
Metronidazole hydrochloride
💬
| - | - | 1件: 97 97 💬
|
| 1332 | Metronidazole oral (METRONIDAZOLE250 MG, METRONIDAZOLE500 MG) | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
(METRONIDAZOLE250 MG, METRONIDAZOLE500 MG),
Metronidazole hydrochloride
💬
| - | - | 1件: 96 96 💬
|
| 1333 | Mexiletine 167 MG | 1件: Mexiletine Mexiletine | 2件: Mexiletine hydrochloride
Mexiletine hydrochloride
,
Mexiletine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 113 113 💬
|
| 1334 | Mezavant 1200 MG magensaftresistente retardtabletten | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1335 | Mezavant XL 1200 MG gastro-resistant prolonged release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1336 | Mezavant XL 1200 MG gastro-resistant, prolonged release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1337 | MG-S-2525 | 1件: MG-S-2525 MG-S-2525 (MG-S-2525) | - | - | - | 1件: 85 85 💬
|
| 1338 | MG01CI extended-release tablet | - | - | - | - | 1件: 206 206 💬
|
| 1339 | MGLU5 antagonist | - | - | - | - | 1件: 206 206 💬
|
| 1340 | Midazolam 2 MG | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 96 96, 97 💬
|
| 1341 | Midazolam 3 MG | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 96 96 💬
|
| 1342 | Migalastat HCL 150 MG | 1件: Migalastat Migalastat | 2件: Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 1343 | Migalastat HCL 20 MG | 1件: Migalastat Migalastat | 2件: Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
| 1344 | Minocycline 100 MG FILM-coated tablets | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 1件: 13 13 💬
|
| 1345 | Mirtazapine 15 MG | 1件: Mirtazapine Mirtazapine | 1件: Mirtazapine
Mirtazapine
💬
| 11件: ADRA2A ADRA2A, ADRA2B, ADRA2C, HTR2, HTR2, HTR2, HTR3, HTR3, HTR3, HTR3, HTR3 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1346 | MK-8457 100 MG | - | - | - | - | 1件: 46 46 💬
|
| 1347 | MN-08 24 MG/DAY | - | - | - | - | 1件: 86 86 💬
|
| 1348 | MN-08 60 MG/DAY | - | - | - | - | 1件: 86 86 💬
|
| 1349 | Modafinil generis 100 MG | 1件: Modafinil Modafinil | 1件: Modafinil
Modafinil
💬
| - | - | 1件: 13 13 💬
|
| 1350 | Modamide 5 MG | - | - | - | - | 1件: 225 225 💬
|
| 1351 | Monofer 100 MG/ML | 1件: Iron isomaltoside 1000 Iron isomaltoside 1000 | - | - | - | 1件: 97 97 💬
|
| 1352 | Monomethyl fumarate 190 MG | 1件: Monomethyl fumarate Monomethyl fumarate | 1件: Monomethyl fumarate
Monomethyl fumarate
💬
| - | - | 1件: 13 13 💬
|
| 1353 | Moxifloxacin (MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG) | 1件: Moxifloxacin Moxifloxacin | 3件: Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
(MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG),
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | 7件: 2 2, 6, 46, 49, 85, 240, 299 💬
|
| 1354 | Moxifloxacin 400 MG | 1件: Moxifloxacin Moxifloxacin | 3件: Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
(MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG),
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | 1件: 86 86 💬
|
| 1355 | Moxifloxacin hydrochloride (MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG) | 1件: Moxifloxacin Moxifloxacin | 3件: Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
(MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG),
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | 2件: 113 113, 299 💬
|
| 1356 | Moxifloxacin infusion (MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG) | 1件: Moxifloxacin Moxifloxacin | 3件: Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
(MOXIFLOXACIN HYDROCHLORIDE TABLETS, 400 MG),
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | 1件: 6 6 💬
|
| 1357 | MR prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 46 46 💬
|
| 1358 | MTX hexal 2,5 MG tabletten | - | - | - | - | 1件: 46 46 💬
|
| 1359 | MTX S.C or IM and silymarin 140 MG TAB | - | - | - | - | 1件: 46 46 💬
|
| 1360 | Mycophenolate mofetil plus lower dose OF prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 3件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid, Prednisone | 5件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG),
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 3件: IMPDH IMPDH, IMPDH, NR3C1 💬
| 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | 1件: 66 66 💬
|
| 1361 | Myfortic 180 MG filmtabletten | - | - | - | - | 1件: 162 162 💬
|
| 1362 | Myozyme 50 MG powder FOR concentrate FOR solution FOR infusion | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
| 1363 | Nabilone 0.25 MG | 1件: Nabilone Nabilone | 1件: Nabilone
Nabilone
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
| 1364 | Nalbuphine ER 108 MG | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 1365 | Nalbuphine ER 27 MG | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 1366 | Nalbuphine ER 54 MG | 1件: Nalbuphine Nalbuphine | 2件: Nalbuphine hydrochloride
Nalbuphine hydrochloride
,
Nalbuphine
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 1367 | Nanogam 100 MG/ML | - | - | - | - | 1件: 65 65 💬
|
| 1368 | Nanogam® 50 MG/ML | - | - | - | - | 1件: 65 65 💬
|
| 1369 | Naprosyn 500 MG | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 1370 | Naproxen 10 MG/KG | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 1371 | Naproxen tablet 500 MG | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
| 1372 | Natalizumab 300 MG IN 15 ML injection | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1373 | Natrunix 400 MG | - | - | - | - | 1件: 46 46 💬
|
| 1374 | ND0612 (levodopa/carbidopa solution) + morning oral IR-LD/CD (CARBIDOPA TABLETS, 25 MG) | 1件: Levodopa Levodopa | 1件: Levodopa
Levodopa
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1375 | Nebido® testosterone undecanoate 1000 MG/4 ML solution FOR injection | - | - | - | - | 1件: 13 13 💬
|
| 1376 | Nebivolol 5 MG | 1件: Nebivolol Nebivolol | 2件: Nebivolol
Nebivolol
,
Nebivolol hydrochloride
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 💬
|
| 1377 | Neoral 100 MG, capsule molle | - | - | - | - | 1件: 60 60 💬
|
| 1378 | Neupro - 2 MG/24 H + 4 MG/24 H + 6 MG/24 H+ 8 MG/24 H cerotto otto transdermico 7 cerotti + 7 cerotti + 7 cerotti + 7 cerotti trandermici IN bustina | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 127 127 💬
|
| 1379 | Neupro 2 MG/24 H parche transdérmico | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1380 | Neupro 2 MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1381 | Neupro 4 MG / 24 HR. transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1382 | Neupro 4 MG/24 H parche transdérmico | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1383 | Neupro 4 MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1384 | Neupro 6 MG/24 H parche transdérmico | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1385 | Neupro 6 MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1386 | Neupro 8 MG/24 H parche transdérmico | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1387 | Neupro 8 MG/24 H transdermal patch | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1388 | Neupro® 8 MG/24 H | 1件: Rotigotine Rotigotine | 1件: Rotigotine
Rotigotine
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1389 | Neurontin 300 MG hard capsule | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1390 | Nexium 10 MG | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 234 234 💬
|
| 1391 | Nicorette 15 MG/ 16 H | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 6 6 💬
|
| 1392 | Nicorette 5 MG/ 16 H | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 6 6 💬
|
| 1393 | Nicotinell 17,5 MG/24-stunden-pflaster | - | - | - | - | 1件: 6 6 💬
|
| 1394 | Nicotinell 35 MG/24-stunden-pflaster | - | - | - | - | 1件: 6 6 💬
|
| 1395 | Nilotinib 150 MG | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 8 8 💬
|
| 1396 | Nilotinib 50 MG | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 86 86 💬
|
| 1397 | Nintedanib 150 MG and 100 MG soft capsules | 1件: Nintedanib Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 227 227 💬
|
| 1398 | Nitisinone 10 MG tablet high compritol | 1件: Nitisinone Nitisinone | 1件: Nitisinone
Nitisinone
💬
| 1件: HPD HPD 💬
| 3件: Phenylalanine metabolism Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 241 241 💬
|
| 1399 | Nitrate-rich beetroot juice (70ML with approx. 400 MG nitrate) twice A DAY FOR 3 days | 1件: Nitrate Nitrate | 1件: Nitric acid
Nitric acid
💬
| - | - | 1件: 85 85 💬
|
| 1400 | Nordimet 7,5 MG solution injectable EN stylo PRérempli | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
| 1401 | Norditropin flexpro 10 MG/1.5 ML, solution FOR injection IN PRE-filled PEN | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
| 1402 | Norditropin simplexx 15 MG/1.5 ML | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 3 3 💬
|
| 1403 | Norucholic acid (NCA) 500 MG | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | 1件: 93 93 💬
|
| 1404 | Norvir 100 MG FILM-coated tablets | - | - | - | - | 1件: 299 299 💬
|
| 1405 | Novonorm 0.5 MG | - | - | - | - | 1件: 299 299 💬
|
| 1406 | Novonorm 1 MG | - | - | - | - | 1件: 299 299 💬
|
| 1407 | Novonorm 2 MG | - | - | - | - | 1件: 299 299 💬
|
| 1408 | Noxafil - 40 MG/ML sospensione orale USO orale flacone (vetro) 105 ML 1 flacone | - | - | - | - | 1件: 299 299 💬
|
| 1409 | Noxafil - oral suspension 40 MG/ML | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 299 299 💬
|
| 1410 | Noxafil 100 MG | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 299 299 💬
|
| 1411 | Noxafil 100 MG tablets gastro-resistant | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 299 299 💬
|
| 1412 | Noxafil 40 MG/ML oral solution | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 65 65 💬
|
| 1413 | NTQ5082 capsules 100 MG | - | - | - | - | 1件: 66 66 💬
|
| 1414 | NTQ5082 capsules 200 MG | - | - | - | - | 1件: 66 66 💬
|
| 1415 | NTQ5082 capsules 300 MG | - | - | - | - | 1件: 66 66 💬
|
| 1416 | Nucala 100 MG powder FOR solution FOR injection | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
| 1417 | Nuplazid 34 MG oral capsule | 1件: Pimavanserin Pimavanserin | 1件: Pimavanserin tartrate
Pimavanserin tartrate
💬
| 2件: HTR2 HTR2, HTR2 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬
|
| 1418 | NX-13 250 MG | - | - | - | - | 1件: 97 97 💬
|
| 1419 | Obeticholic acid 10 MG | 1件: Obeticholic acid Obeticholic acid | 1件: Obeticholic acid
Obeticholic acid
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬
|
| 1420 | Obeticholic acid 5 MG | 1件: Obeticholic acid Obeticholic acid | 1件: Obeticholic acid
Obeticholic acid
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬
|
| 1421 | OCA 0.1 MG | - | - | - | - | 1件: 296 296 💬
|
| 1422 | OCA 1,5 MG | - | - | - | - | 1件: 94 94 💬
|
| 1423 | OCA 5 MG | - | - | - | - | 1件: 94 94 💬
|
| 1424 | Ocrelizumab 300 MG | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1425 | Ocrelizumab 600 MG | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1426 | Ocrevus 300 MG, solution à diluer pour perfusion | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1427 | Ocrrelizumab 300 MG | - | - | - | - | 1件: 13 13 💬
|
| 1428 | Octagam 50 MG/ML | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 1件: 13 13 💬
|
| 1429 | Octreotide A azione pronta 0,1 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 227 227 💬
|
| 1430 | Octreotide acetate 30 MG suspension | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1431 | Octreotide acetate prolonged release, 30 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1432 | Octreotide LAR 30 MG injection | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1433 | ODM-101 105MG carbidopa (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1434 | ODM-101 65MG carbidopa (CARBIDOPA TABLETS, 25 MG) | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1435 | ODM-109 capsule 1 MG | - | - | - | - | 1件: 2 2 💬
|
| 1436 | Odsh AT 0.125 MG/KG/H | - | - | - | - | 1件: 210 210 💬
|
| 1437 | Odsh AT 0.250 MG/KG/H | - | - | - | - | 1件: 210 210 💬
|
| 1438 | Odsh AT 0.375 MG/KG/H | - | - | - | - | 1件: 210 210 💬
|
| 1439 | Ofev 100 MG capsule | 1件: Nintedanib Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
| 1440 | Ofev 150 MG capsule | 1件: Nintedanib Nintedanib | 2件: Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| 8件: FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| 33件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
| 1441 | OL adalimumab 40 MG | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 1442 | Oligog CF-5/20 - 17.5 MG | - | - | - | - | 1件: 299 299 💬
|
| 1443 | Oligog CF-5/20, 17,5 MG, hartkapsel MIT pulver ZUR inhalation | - | - | - | - | 1件: 299 299 💬
|
| 1444 | Oligog CF/20 - 27.5 MG | - | - | - | - | 1件: 299 299 💬
|
| 1445 | Oligog CF/20 - 37.5 MG | - | - | - | - | 1件: 299 299 💬
|
| 1446 | Oligog CF/20, 27,5 MG, hartkapsel MIT pulver ZUR inhalation | - | - | - | - | 1件: 299 299 💬
|
| 1447 | Oligog CF/20, 37,5 MG, hartkapsel MIT pulver ZUR inhalation | - | - | - | - | 1件: 299 299 💬
|
| 1448 | Olokizumab 120 MG | 1件: Olokizumab Olokizumab | 1件: Olokizumab
Olokizumab
💬
| 1件: IL6 IL6 💬
| 49件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | 1件: 46 46 💬
|
| 1449 | Olokizumab 240 MG | 1件: Olokizumab Olokizumab | 1件: Olokizumab
Olokizumab
💬
| 1件: IL6 IL6 💬
| 49件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | 1件: 46 46 💬
|
| 1450 | Olokizumab 60 MG | 1件: Olokizumab Olokizumab | 1件: Olokizumab
Olokizumab
💬
| 1件: IL6 IL6 💬
| 49件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | 1件: 46 46 💬
|
| 1451 | Olokizumab 64 MG SC Q2W | 1件: Olokizumab Olokizumab | 1件: Olokizumab
Olokizumab
💬
| 1件: IL6 IL6 💬
| 49件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | 1件: 46 46 💬
|
| 1452 | Olokizumab 64 MG SC Q4W | 1件: Olokizumab Olokizumab | 1件: Olokizumab
Olokizumab
💬
| 1件: IL6 IL6 💬
| 49件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | 1件: 46 46 💬
|
| 1453 | Olumiant 2 MG/4 MG filmtabletten | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
💬
| 2件: JAK1 JAK1, JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 1454 | Olumiant 4 MG | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
💬
| 2件: JAK1 JAK1, JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 1455 | Olumiant® 2 MG compriméS PélliculéS | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
💬
| 2件: JAK1 JAK1, JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 50 50 💬
|
| 1456 | Omaveloxolone capsules, 10 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
| 1457 | Omaveloxolone capsules, 150 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
| 1458 | Omaveloxolone capsules, 160 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
| 1459 | Omaveloxolone capsules, 2.5 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
| 1460 | Omaveloxolone capsules, 20 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
| 1461 | Omaveloxolone capsules, 300 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
| 1462 | Omaveloxolone capsules, 40 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
| 1463 | Omaveloxolone capsules, 5 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
| 1464 | Omaveloxolone capsules, 80 MG | 1件: Omaveloxolone Omaveloxolone | 1件: Omaveloxolone
Omaveloxolone
💬
| 1件: NFE2L2 NFE2L2 💬
| 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 💬
|
| 1465 | Omeprazole 20 MG | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 2件: 96 96, 97 💬
|
| 1466 | Omeprazole 20 MG oral tablet | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 98 98 💬
|
| 1467 | Omeprazole 40 MG | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 96 96 💬
|
| 1468 | OMS721 100 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody | - | - | - | - | 2件: 64 64, 109 💬
|
| 1469 | OMS721 185 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody | - | - | - | - | 2件: 64 64, 109 💬
|
| 1470 | OMS721 drug product 185 MG/ML | - | - | - | - | 1件: 109 109 💬
|
| 1471 | OMS906 study drug - 3 MG/KG | 1件: OMS906 OMS906 | - | - | - | 1件: 62 62 💬
|
| 1472 | OMS906 study drug - 5 MG/KG | 1件: OMS906 OMS906 | - | - | - | 1件: 62 62 💬
|
| 1473 | Ondansetron 8 MG FILM-coated tablets | 1件: Ondansetron Ondansetron | 2件: Ondansetron
Ondansetron
,
Ondansetron hydrochloride hydrate
💬
| 5件: HTR3 HTR3, HTR3, HTR3, HTR3, HTR3 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 💬
|
| 1474 | ONE ML contains horse ANTI-human T lymphocyte immunoglobulin (eatg) 50 MG | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | 1件: Anti-human thymocyte immunoglobulin, equine
Anti-human thymocyte immunoglobulin, equine
💬
| - | - | 1件: 60 60 💬
|
| 1475 | Ongentys 50 MG capsule rigide | 1件: Opicapone Opicapone | 1件: Opicapone
Opicapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1476 | Ongentys 50 MG hard capsules | 1件: Opicapone Opicapone | 1件: Opicapone
Opicapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1477 | OPEN-label cdca 250 MG TID | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: Chenodiol
Chenodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 263 263 💬
|
| 1478 | Opicapone 50 MG | 1件: Opicapone Opicapone | 1件: Opicapone
Opicapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1479 | Opicapone 50 MG hard capsules | 1件: Opicapone Opicapone | 1件: Opicapone
Opicapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1480 | OPS-2071 150 MG | - | - | - | - | 1件: 96 96 💬
|
| 1481 | OPS-2071 300 MG | - | - | - | - | 1件: 96 96 💬
|
| 1482 | OPS-2071 600 MG | - | - | - | - | 1件: 96 96 💬
|
| 1483 | Opsumit 10 MG tablet | - | - | - | - | 1件: 51 51 💬
|
| 1484 | Optinate 5 MG filmcoated tablets | - | - | - | - | 1件: 274 274 💬
|
| 1485 | Oral administration OF 100 MG KH176 twice daily | - | - | - | - | 1件: 21 21 💬
|
| 1486 | Oral levodopa/carbidopa (CARBIDOPA TABLETS, 25 MG) | - | - | - | - | 1件: 6 6 💬
|
| 1487 | Oral methylprednisolone 625 MG/24H X3 days | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 1488 | Oral prednisone 5MG (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | - | - | - | - | 1件: 49 49 💬
|
| 1489 | Orencia 125 MG | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
| 1490 | Orencia 125 MG injektionslösung IM fertigpen | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
| 1491 | Orencia 125 MG solution FOR injection | - | - | - | - | 1件: 46 46 💬
|
| 1492 | Orencia 125 MG solution FOR injection IN PRE-filled syringe | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 3件: 46 46, 49, 53 💬
|
| 1493 | Orencia 125 MG, solution injectable EN seringue PRéremplie | - | - | - | - | 1件: 46 46 💬
|
| 1494 | Orencia 250 MG polvo para concentrado para SOL. para perfusióN | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
| 1495 | Orencia® 125 MG solution FOR injection IN PRE-filled syringe | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 65 65 💬
|
| 1496 | Orkambi 100 MG/125 MG FILM-coated tablets | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1497 | Orkambi 200 MG/125 MG FILM-coated tablets | 2件: Ivacaftor Ivacaftor, Lumacaftor | 2件: Ivacaftor
Ivacaftor
,
Lumacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 1498 | Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 MG/0.250 MG | - | - | - | - | 1件: 299 299 💬
|
| 1499 | Osrhaat 1 MG/KG IV | - | - | - | - | 1件: 231 231 💬
|
| 1500 | Osrhaat 10 MG/KG IV | - | - | - | - | 1件: 231 231 💬
|
| 1501 | Osrhaat 20 MG/KG IV | - | - | - | - | 1件: 231 231 💬
|
| 1502 | Osrhaat 3 MG/KG IV | - | - | - | - | 1件: 231 231 💬
|
| 1503 | Osrhaat 40 MG/KG IV | - | - | - | - | 1件: 231 231 💬
|
| 1504 | Osrhaat 60 MG/KG IV | - | - | - | - | 1件: 231 231 💬
|
| 1505 | Otezla - 10 MG + 20 MG + 30 MG compressa rivestita CON film USO orale - blister (PVC/ALU) IN UN astuccio - 4 compresse DA 10 MG + 4 compresse DA 20 MG +19 compresse DA 30 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 💬
|
| 1506 | Ovastat 1000 MG, powder FOR solution FOR infusion | 1件: Treosulfan Treosulfan | 1件: Treosulfan
Treosulfan
💬
| - | - | 1件: 65 65 💬
|
| 1507 | Ovastat 5000 MG, powder FOR solution FOR infusion | 1件: Treosulfan Treosulfan | 1件: Treosulfan
Treosulfan
💬
| - | - | 1件: 65 65 💬
|
| 1508 | Over encapsulated prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1509 | OVER-encapsulated 150 MG irbesartan tablets | 1件: Irbesartan Irbesartan | 1件: Irbesartan
Irbesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
| 1510 | OVER-encapsulated 75 MG irbesartan tablets | 1件: Irbesartan Irbesartan | 1件: Irbesartan
Irbesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
| 1511 | Overencapsulated azathioprine (imuran) 50 MG tablet | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
| 1512 | OXN 10 MG / 5 MG PR | - | - | - | - | 1件: 6 6 💬
|
| 1513 | OXN 10/5 MG PR | - | - | - | - | 1件: 226 226 💬
|
| 1514 | OXN 20 MG / 10 MG PR | - | - | - | - | 1件: 6 6 💬
|
| 1515 | OXN 20/10 MG PR | - | - | - | - | 1件: 226 226 💬
|
| 1516 | OXN 5 MG/2.5 MG PR | - | - | - | - | 1件: 6 6 💬
|
| 1517 | OXN 5/2.5 MG PR | - | - | - | - | 1件: 226 226 💬
|
| 1518 | Oxycodone/naloxone prolonged release tablets 10 MG /5 MG | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1519 | Oxycodone/naloxone prolonged release tablets 10/5 MG | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
| 1520 | Oxycodone/naloxone prolonged release tablets 20 MG /10 MG | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1521 | Oxycodone/naloxone prolonged release tablets 20/10 MG | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
| 1522 | Oxycodone/naloxone prolonged release tablets 5 MG /2.5 MG | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1523 | Oxycodone/naloxone prolonged release tablets 5/2.5 MG | 2件: Naloxone Naloxone, Oxycodone | 6件: Oxycodone hydrochloride
Oxycodone hydrochloride
,
Naloxone hydrochloride
,
Oxycodone terephthalate
,
Oxycodone
,
Naloxone
,
Naloxone hydrochloride dihydrate
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 💬
|
| 1524 | Ozanimod 0.5 MG | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1525 | Ozanimod 1 MG | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1526 | P2b001 0.6/0.75 MG | - | - | - | - | 1件: 6 6 💬
|
| 1527 | Palovarotene - 10 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1528 | Palovarotene - 2 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1529 | Palovarotene - 2.5 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1530 | Palovarotene - 3 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1531 | Palovarotene - 4 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1532 | Palovarotene - 5 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1533 | Palovarotene 1.5 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1534 | Palovarotene-2 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1535 | Palovarotene-3 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1536 | Palovarotene-4 MG | 1件: Palovarotene Palovarotene | 1件: Palovarotene
Palovarotene
💬
| - | - | 1件: 272 272 💬
|
| 1537 | Pantoprazolo 20 MG gastro-resistant tablets | - | - | - | - | 1件: 65 65 💬
|
| 1538 | Paracetamolo 500 MG | - | - | - | - | 1件: 13 13 💬
|
| 1539 | Paracetamolo DOC generici - 1000 MG compressa 16 compresse | - | - | - | - | 1件: 19 19 💬
|
| 1540 | Paracetamolo nova argentia - 500 MG compresse 20 compresse | - | - | - | - | 1件: 300 300 💬
|
| 1541 | Paroxetine hydrochloride 10 & 20 MG and prednisolone 1 MG BP | 1件: Paroxetine Paroxetine | 4件: Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬
|
| 1542 | Paroxetine hydrochloride tablets 10 & 20 MG and prednisolone 1 MG BP | 1件: Paroxetine Paroxetine | 4件: Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬
|
| 1543 | Part A: 100 MG/ML GSK2618960 | - | - | - | - | 1件: 13 13 💬
|
| 1544 | Part I - etoricoxib 60 MG | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
| 1545 | Part I - etoricoxib 90 MG | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
| 1546 | Part I- naproxen 1000 MG | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
| 1547 | Part II- etoricoxib 60 MG | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
| 1548 | Part II- etoricoxib 90 MG | 1件: Etoricoxib Etoricoxib | 1件: Etoricoxib
Etoricoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
| 1549 | Part II- naproxen 1000 MG | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
| 1550 | Pasireotide 0.6 MG/ML | 1件: Pasireotide Pasireotide | 3件: Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
| 1551 | Pasireotide 0.9 MG | 1件: Pasireotide Pasireotide | 3件: Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
| 1552 | Pasireotide LAR 60 MG | 1件: Pasireotide Pasireotide | 3件: Pasireotide
Pasireotide
,
Pasireotide diaspartate
,
Pasireotide pamoate
💬
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1553 | PBF-999 / 160 MG | - | - | - | - | 1件: 8 8 💬
|
| 1554 | PBF-999 / 320 MG | - | - | - | - | 1件: 8 8 💬
|
| 1555 | Pelubiprofen 30 MG | 1件: Pelubiprofen Pelubiprofen | 1件: Pelubiprofen
Pelubiprofen
💬
| - | - | 1件: 46 46 💬
|
| 1556 | Pembrolizumab, 25 MG/ML solution FOR intravenous (IV) injection | 1件: Pembrolizumab Pembrolizumab | 1件: Pembrolizumab
Pembrolizumab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 1件: 25 25 💬
|
| 1557 | Pemine - 150 MG capsule rigide 50 capsule | - | - | - | - | 1件: 171 171 💬
|
| 1558 | Pentasa 500 MG retardtabletten | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1559 | Pentosan polysulfate sodium 100 MG | 1件: Pentosan polysulfate Pentosan polysulfate | 1件: Pentosan polysulfate sodium
Pentosan polysulfate sodium
💬
| - | - | 1件: 226 226 💬
|
| 1560 | Pentoxifylline 400 MG | 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline
Pentoxifylline
💬
| - | - | 2件: 6 6, 97 💬
|
| 1561 | PERI-neural dexamethasone 1 MG | - | - | - | - | 1件: 46 46 💬
|
| 1562 | Persantin 100 MG and | - | - | - | - | 1件: 46 46 💬
|
| 1563 | PF-04171327 10 MG | - | - | - | - | 1件: 46 46 💬
|
| 1564 | PF-04171327 25 MG | - | - | - | - | 1件: 46 46 💬
|
| 1565 | PF-06342674 0.25 MG/KG | - | - | - | - | 1件: 13 13 💬
|
| 1566 | PF-06342674 1.5 MG/KG | - | - | - | - | 1件: 13 13 💬
|
| 1567 | PF-06342674 6.0 MG/KG | - | - | - | - | 1件: 13 13 💬
|
| 1568 | PF-06480605 100 MG/ML | - | - | - | - | 1件: 97 97 💬
|
| 1569 | PF-06650833 100 MG | 1件: PF-06650833 PF-06650833 | - | - | - | 1件: 46 46 💬
|
| 1570 | PF-06650833 20 MG | 1件: PF-06650833 PF-06650833 | - | - | - | 1件: 46 46 💬
|
| 1571 | PF-06651600 10 MG | - | - | - | - | 1件: 97 97 💬
|
| 1572 | PF-06651600 50 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 1573 | PF-06700841 15 MG | 1件: PF-06700841 PF-06700841 | - | - | - | 1件: 49 49 💬
|
| 1574 | PF-06700841 25 MG | 1件: PF-06700841 PF-06700841 | - | - | - | 2件: 96 96, 97 💬
|
| 1575 | PF-06700841 30 MG | 1件: PF-06700841 PF-06700841 | - | - | - | 1件: 49 49 💬
|
| 1576 | PF-06700841 45 MG | 1件: PF-06700841 PF-06700841 | - | - | - | 1件: 49 49 💬
|
| 1577 | PF-06700841 5 MG | 1件: PF-06700841 PF-06700841 | - | - | - | 2件: 96 96, 97 💬
|
| 1578 | PF-06826647 100 MG QD | - | - | - | - | 1件: 97 97 💬
|
| 1579 | PF-06826647 300 MG QD | - | - | - | - | 1件: 97 97 💬
|
| 1580 | PF-06826647 600 MG QD | - | - | - | - | 1件: 97 97 💬
|
| 1581 | PF-6826647 400 MG QD | - | - | - | - | 1件: 97 97 💬
|
| 1582 | Pimavanserin 34 MG | 1件: Pimavanserin Pimavanserin | 1件: Pimavanserin tartrate
Pimavanserin tartrate
💬
| 2件: HTR2 HTR2, HTR2 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬
|
| 1583 | Pimozide 2 MG PER DAY | 1件: Pimozide Pimozide | 1件: Pimozide
Pimozide
💬
| 2件: ADRA2A ADRA2A, DRD2 💬
| 11件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 💬
|
| 1584 | Pimozide 4 MG PER DAY | 1件: Pimozide Pimozide | 1件: Pimozide
Pimozide
💬
| 2件: ADRA2A ADRA2A, DRD2 💬
| 11件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 💬
|
| 1585 | Pioglitazone 15 MG | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 96 96 💬
|
| 1586 | Pioglitazone or metformin (METFORMIN ER 500 MG) | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 265 265 💬
|
| 1587 | Pirepemat, 100 MG | 1件: Pirepemat Pirepemat | - | - | - | 1件: 6 6 💬
|
| 1588 | Pirepemat, 50 MG | 1件: Pirepemat Pirepemat | - | - | - | 1件: 6 6 💬
|
| 1589 | Pirfenidone (PIRFENIDONE CAPSULE, 267 MG) | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
| 1590 | Pirfenidone and nintedanib (PIRFENIDONE CAPSULE, 267 MG) | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
| 1591 | Pirfenidone modified-release tablets (PIRFENIDONE CAPSULE, 267 MG) | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
| 1592 | Pirfenidone or nintedanib (PIRFENIDONE CAPSULE, 267 MG) | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
| 1593 | Pirfenidone solution FOR inhalation (PIRFENIDONE CAPSULE, 267 MG) | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
| 1594 | Pirfenidone tablets (PIRFENIDONE CAPSULE, 267 MG) | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
| 1595 | Pirfenidone, deuterated (PIRFENIDONE CAPSULE, 267 MG) | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
(PIRFENIDONE CAPSULE, 267 MG) 💬
| 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 85 85 💬
|
| 1596 | Placentex ¿ polydeoxyribonucleotide 5.625 MG/3 ML | - | - | - | - | 1件: 51 51 💬
|
| 1597 | Plaquenil 200 MG filmdrasjerte tabletter | - | - | - | - | 1件: 46 46 💬
|
| 1598 | Plenadren 20 MG modified-release tablets | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 💬
|
| 1599 | Plenadren 5 MG modified-release tablets | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 💬
|
| 1600 | Plovamer acetate 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 1601 | Plovamer acetate 20 MG | - | - | - | - | 1件: 13 13 💬
|
| 1602 | Plovamer acetate 3 MG | - | - | - | - | 1件: 13 13 💬
|
| 1603 | Pomalidomide 4 MG | 1件: Pomalidomide Pomalidomide | 1件: Pomalidomide
Pomalidomide
💬
| 2件: IL6 IL6, TNF 💬
| 78件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 28 28 💬
|
| 1604 | Ponesimod 10 MG | 1件: Ponesimod Ponesimod | 1件: Ponesimod
Ponesimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1605 | Ponesimod 20 MG | 1件: Ponesimod Ponesimod | 1件: Ponesimod
Ponesimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1606 | Ponesimod 40 MG | 1件: Ponesimod Ponesimod | 1件: Ponesimod
Ponesimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1607 | Posaconazole 40 MG/ML | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 299 299 💬
|
| 1608 | Pramipexole 0.125 MG tablets | 1件: Pramipexole Pramipexole | 2件: Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1609 | Pramipexole 0.5 MG tablets | 1件: Pramipexole Pramipexole | 2件: Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1610 | Pramipexole 0.6 MG | 1件: Pramipexole Pramipexole | 2件: Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1611 | Prednisolene tablets BP 1 MG | - | - | - | - | 1件: 46 46 💬
|
| 1612 | Prednisolon 1 MG jenapharm | - | - | - | - | 1件: 41 41 💬
|
| 1613 | Prednisolon 10 MG jenapharm | - | - | - | - | 1件: 41 41 💬
|
| 1614 | Prednisolon 20 MG jenapharm | - | - | - | - | 1件: 41 41 💬
|
| 1615 | Prednisolon 5 MG jenapharm | - | - | - | - | 1件: 41 41 💬
|
| 1616 | Prednisolone 2,5 MG tablets | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 1617 | Prednisolone 20 MG | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1618 | Prednisolone 40 MG | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1619 | Prednisolone 5 MG | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 51 💬
|
| 1620 | Prednisolone 5 MG tablets | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
| 1621 | Prednisolone tablets BP 1 MG | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1622 | Prednisolone tablets USP 5 MG | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1623 | Prednisolone/prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 💬
|
| 1624 | Prednison 10 MG galen | - | - | - | - | 1件: 35 35 💬
|
| 1625 | Prednison 5 MG galen | - | - | - | - | 1件: 35 35 💬
|
| 1626 | Prednison 50 MG galen | - | - | - | - | 1件: 35 35 💬
|
| 1627 | Prednison acis® 20 MG | - | - | - | - | 2件: 43 43, 44 💬
|
| 1628 | Prednison acis® 5 MG | - | - | - | - | 2件: 43 43, 44 💬
|
| 1629 | Prednison acis¿ 20 MG | - | - | - | - | 2件: 43 43, 44 💬
|
| 1630 | Prednison acis¿ 5 MG | - | - | - | - | 2件: 43 43, 44 💬
|
| 1631 | Prednison20 MG galen | - | - | - | - | 1件: 35 35 💬
|
| 1632 | Prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
| 1633 | Prednisone - azathioprine (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 11 11 💬
|
| 1634 | Prednisone 0,5 MG/KG orally ON alternate days | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬
|
| 1635 | Prednisone 1 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1636 | Prednisone 15 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1637 | Prednisone 2 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1638 | Prednisone 3 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1639 | Prednisone 4 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1640 | Prednisone 5 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 66 💬
|
| 1641 | Prednisone 5 MG tablets | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 1642 | Prednisone 7.5 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
| 1643 | Prednisone acetate (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 2件: Prednisone Prednisone, Prednisone acetate | 2件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG),
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 6件: 35 35, 46, 49, 63, 162, 222 💬
|
| 1644 | Prednisone acetate tablets (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 2件: Prednisone Prednisone, Prednisone acetate | 2件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG),
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 40 40, 224 💬
|
| 1645 | Prednisone alone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 11 11, 66 💬
|
| 1646 | Prednisone and belimumab (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 300 300 💬
|
| 1647 | Prednisone and cyclophosphamide (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
| 1648 | Prednisone and mycophenolate mofetil (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 300 300 💬
|
| 1649 | Prednisone and ustekinumab treatment (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1650 | Prednisone arrow 20MG (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
| 1651 | Prednisone arrow 5 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
| 1652 | Prednisone capsule (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1653 | Prednisone capsules (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1654 | Prednisone discontinuation (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 💬
|
| 1655 | Prednisone DOC generici (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 💬
|
| 1656 | Prednisone DOC generici - 5 MG compresse 10 compresse IN blister PVC-pvdc/ALU | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 19 19 💬
|
| 1657 | Prednisone DOC generici - 5 MG compresse 30 compresse IN blister PVC-pvdc/ALU | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 300 300 💬
|
| 1658 | Prednisone IN full dose (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
| 1659 | Prednisone or prednisolone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 66 66, 84 💬
|
| 1660 | Prednisone oral product (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 1661 | Prednisone plus cyclophosphamide (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
| 1662 | Prednisone plus exercise (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 1663 | Prednisone tablet (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 💬
|
| 1664 | Prednisone tablets USP, 1 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 41 41, 46 💬
|
| 1665 | Prednisone tablets USP, 10 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1666 | Prednisone tablets USP, 1MG (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1667 | Prednisone tablets USP, 2.5 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1668 | Prednisone tablets USP, 2.5MG (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1669 | Prednisone tablets USP, 20MG (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1670 | Prednisone tablets USP, 5 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 41 41, 46 💬
|
| 1671 | Prednisone tablets USP, 5MG (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1672 | Prednisone tablets, USP (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 41 41, 43, 44 💬
|
| 1673 | Prednisone tablets, USP 10 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1674 | Prednisone tablets, USP 2.5 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1675 | Prednisone tablets, USP 5 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1676 | Prednisone tablets, USP, 1 MG | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1677 | Prednisone therapy and pharmacokinetic (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1678 | Prednisone treatment (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
| 1679 | Prednisone, ciclosporin and mycophenolate mofetil (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬
|
| 1680 | Prednisone, cyclophosphamide (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 40 40 💬
|
| 1681 | Prednisone, FK506, MMF (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬
|
| 1682 | Prednisone, LOW dose rituximab (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 💬
|
| 1683 | Prednisone, methylprednisolone,cyclophosphamides (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 42 42, 43, 45 💬
|
| 1684 | Prednisone,methylprednisone and cyclophosphamide (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 💬
|
| 1685 | Prednisone/methylprenisolone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 1686 | Prednisone/prednisolone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 💬
|
| 1687 | Preladenant 10 MG tablet | 1件: Preladenant Preladenant | 1件: Preladenant
Preladenant
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1688 | Preladenant 2 MG tablet | 1件: Preladenant Preladenant | 1件: Preladenant
Preladenant
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1689 | Preladenant 5 MG tablet | 1件: Preladenant Preladenant | 1件: Preladenant
Preladenant
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1690 | Privigen 100 MG/ML, solution pour perfusion | - | - | - | - | 1件: 53 53 💬
|
| 1691 | PRN1008 100 MG tablet | - | - | - | - | 1件: 63 63 💬
|
| 1692 | PRN1008 300 MG tablet | - | - | - | - | 1件: 63 63 💬
|
| 1693 | PRN1008 400 MG tablet | - | - | - | - | 1件: 63 63 💬
|
| 1694 | PRO044 IV 6 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
| 1695 | PRO044 IV 9 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
| 1696 | PRO044 SC 6 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
| 1697 | PRO045, 0.15 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
| 1698 | PRO045, 1.0 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
| 1699 | PRO045, 3.0 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
| 1700 | PRO045, 6.0 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
| 1701 | PRO045, 9.0 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
| 1702 | Procaptan - 10 MG compresse rivestite CON film 60 compresse IN contenitore PER compresse PP | - | - | - | - | 1件: 58 58 💬
|
| 1703 | Procaptan - 5 MG compresse rivestite CON film 10 compresse IN contenitore PER compresse PP | - | - | - | - | 1件: 58 58 💬
|
| 1704 | Prolastin-C, 120 MG/KG | - | - | - | - | 1件: 231 231 💬
|
| 1705 | Prolastin-C, 60 MG/KG | - | - | - | - | 1件: 231 231 💬
|
| 1706 | Propionic acid 1000 MG capsule | 1件: Propanoic acid Propanoic acid | 3件: Propionic acid
Propionic acid
,
Sodium propionate
,
Sodium propionate
💬
| - | - | 1件: 13 13 💬
|
| 1707 | Propranolol HCL CF 40 MG tablet | 1件: Propranolol Propranolol | 2件: Propranolol hydrochloride
Propranolol hydrochloride
,
Propranolol
💬
| 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬
| 14件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 1708 | Proton pump inhibitor 1 MG/KG/DAY IN 2 divided doses 1 month | - | - | - | - | 1件: 63 63 💬
|
| 1709 | Provigil - 100 MG compresse 30 compresse | - | - | - | - | 1件: 113 113 💬
|
| 1710 | PRX-102 1 MG/KG every 2 weeks | - | - | - | - | 1件: 19 19 💬
|
| 1711 | PRX-102 1 MG/KG every TWO weeks | - | - | - | - | 1件: 19 19 💬
|
| 1712 | PRX-102 2 MG/KG every 4 weeks | - | - | - | - | 1件: 19 19 💬
|
| 1713 | Psilocybin, 1.5 MG | 1件: Psilocybin Psilocybin | 1件: Psilocybin
Psilocybin
💬
| 1件: HTR2 HTR2 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 206 206 💬
|
| 1714 | PT320 2.0 MG | - | - | - | - | 1件: 6 6 💬
|
| 1715 | PT320 2.5 MG | - | - | - | - | 1件: 6 6 💬
|
| 1716 | PTC518 tablet 20 MG | - | - | - | - | 1件: 8 8 💬
|
| 1717 | PTC518 tablet 5 MG | - | - | - | - | 1件: 8 8 💬
|
| 1718 | PTC857 60 MG/ML oral solution | - | - | - | - | 1件: 2 2 💬
|
| 1719 | PTW-002 10 MG/G GEL | 1件: QR-313 QR-313 | - | - | - | 1件: 36 36 💬
|
| 1720 | Puerarin injection 400 MG | 1件: Puerarin Puerarin | - | - | - | 1件: 46 46 💬
|
| 1721 | Puerarin tablet 50 MG | 1件: Puerarin Puerarin | - | - | - | 1件: 46 46 💬
|
| 1722 | PUR 0110 rectal enema 1000 MG | - | - | - | - | 1件: 97 97 💬
|
| 1723 | PUR 0110 rectal enema 250 MG | - | - | - | - | 1件: 97 97 💬
|
| 1724 | PUR 0110 rectal enema 500 MG | - | - | - | - | 1件: 97 97 💬
|
| 1725 | PURI-nethol 50 MG | - | - | - | - | 1件: 96 96 💬
|
| 1726 | Purinethol - 50 MG compresse25 compresse | - | - | - | - | 1件: 96 96 💬
|
| 1727 | Pyridostigmine, prednisone, tacrolimus (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Pyridostigmine Pyridostigmine | 1件: Pyridostigmine bromide
Pyridostigmine bromide
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 11 11 💬
|
| 1728 | QCC374 0.015 MG | - | - | - | - | 1件: 86 86 💬
|
| 1729 | QCC374 0.06 MG | - | - | - | - | 1件: 86 86 💬
|
| 1730 | RAD001 2,5 MG | - | - | - | - | 1件: 158 158 💬
|
| 1731 | Radotinib HCL 50 MG | 1件: Radotinib Radotinib | - | - | - | 1件: 6 6 💬
|
| 1732 | Ranidil - 50 MG/5 ML soluzione iniettabile PER USO endovenoso 10 fiale | - | - | - | - | 1件: 28 28 💬
|
| 1733 | Ranolazine 1000 MG | 1件: Ranolazine Ranolazine | 2件: Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | 1件: 2 2 💬
|
| 1734 | Ranolazine 1000 MG PR tablets | 1件: Ranolazine Ranolazine | 2件: Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | 1件: 58 58 💬
|
| 1735 | Ranolazine 500 MG | 1件: Ranolazine Ranolazine | 2件: Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | 1件: 2 2 💬
|
| 1736 | Ranolazine 500 MG PR tablets | 1件: Ranolazine Ranolazine | 2件: Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | 1件: 58 58 💬
|
| 1737 | Ranolazine 750 MG PR tablets | 1件: Ranolazine Ranolazine | 2件: Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | 1件: 58 58 💬
|
| 1738 | Ranolazine PR (prolonged-release) 500 MG 1 tablet BIS IN DIE and 750 MG 1 tablet BIS IN DIE | 1件: Ranolazine Ranolazine | 2件: Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | 1件: 58 58 💬
|
| 1739 | Rapamune - 1 MG 100 compresse rivestite IN blister USO orale | - | - | - | - | 1件: 2 2 💬
|
| 1740 | Rapamune 0.5 MG coated tablets | - | - | - | - | 1件: 280 280 💬
|
| 1741 | Rapamune 1 MG/ML oral solution | - | - | - | - | 3件: 137 137, 158, 280 💬
|
| 1742 | Rapamune 1 MG/ML solucióN oral | - | - | - | - | 1件: 158 158 💬
|
| 1743 | Raptiva 100 MG/ML powder and solvent FOR solution FOR injection | 1件: Efalizumab Efalizumab | 1件: Efalizumab
Efalizumab
💬
| 1件: ITGAL ITGAL 💬
| 12件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | 8件: 11 11, 13, 46, 53, 61, 95, 96, 221 💬
|
| 1744 | Rasagiline 0.75 MG | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1745 | Rasagiline 1 MG capsule | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1746 | Rasagiline 2 MG tablet | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1747 | Rasagiline mesylate 1.0 MG | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 1748 | Ravpal-PEG 0.001 MG/KG | 1件: Pegvaliase Pegvaliase | 1件: Pegvaliase
Pegvaliase
💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 1749 | Ravpal-PEG 0.003 MG/KG | 1件: Pegvaliase Pegvaliase | 1件: Pegvaliase
Pegvaliase
💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 1750 | Ravpal-PEG 0.01 MG/KG | 1件: Pegvaliase Pegvaliase | 1件: Pegvaliase
Pegvaliase
💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 1751 | Ravpal-PEG 0.03 MG/KG | 1件: Pegvaliase Pegvaliase | 1件: Pegvaliase
Pegvaliase
💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 1752 | Ravpal-PEG 0.1 MG/KG | 1件: Pegvaliase Pegvaliase | 1件: Pegvaliase
Pegvaliase
💬
| 1件: phhA phhA 💬
| 3件: Folate biosynthesis Folate biosynthesis, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 💬
|
| 1753 | Raxone - 150 MG- compresse rivestite CON FILM- USO orale- flacone (hdpe)- 180 compresse | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 1件: 113 113 💬
|
| 1754 | RC18 160 MG | - | - | - | - | 2件: 13 13, 53 💬
|
| 1755 | RC18 160 MG plus MTX | - | - | - | - | 1件: 46 46 💬
|
| 1756 | RC18 160 MG plus standard therapy | - | - | - | - | 1件: 49 49 💬
|
| 1757 | RC18 240 MG | - | - | - | - | 2件: 11 11, 53 💬
|
| 1758 | RC18 240 MG plus standard therapy | - | - | - | - | 1件: 49 49 💬
|
| 1759 | RC18 80 MG plus standard therapy | - | - | - | - | 1件: 49 49 💬
|
| 1760 | REGN1500 250 MG SC/15 MG/KG IV/450 MG SC | - | - | - | - | 1件: 79 79 💬
|
| 1761 | Reldesemtiv 150 MG | 1件: Reldesemtiv Reldesemtiv | 1件: Reldesemtiv
Reldesemtiv
💬
| 3件: TNNC2 TNNC2, TNNI2, TNNT3 💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 3 3 💬
|
| 1762 | Reldesemtiv 450 MG | 1件: Reldesemtiv Reldesemtiv | 1件: Reldesemtiv
Reldesemtiv
💬
| 3件: TNNC2 TNNC2, TNNI2, TNNT3 💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 3 3 💬
|
| 1763 | Remicade - 100 MG polvere PER concentrato PER infusione endovenosa 1 flacone vetro 20 ML USO EV | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 1764 | Remicade 100 MG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 56 56, 96, 97 💬
|
| 1765 | Remicade 100 MG infuusiokuiva-aine, konsentraattiliuosta varten | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 1766 | Remicade 100 MG polvo para concentrado para solucióN para perfusióN | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 271 💬
|
| 1767 | Remicade 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 1768 | Remodulin® (treprostinil) 1 MG/ML solution FOR infusion | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
| 1769 | Remodulin® (treprostinil) 10 MG/ML solution FOR infusion | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
| 1770 | Remodulin® (treprostinil) 2.5 MG/ML solution FOR infusion | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
| 1771 | Remodulin® (treprostinil) 5 MG/ML solution FOR infusion | 1件: Treprostinil Treprostinil | 3件: Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
| 1772 | Remsima 100 MG powder FOR solution FOR infusion | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 1773 | Remsima 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 1774 | Remsima 120 MG solution FOR injection IN PRE-filled syringe | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 1775 | Repatha 140 MG solution FOR injection IN PRE-filled PEN | 1件: Evolocumab Evolocumab | 1件: Evolocumab
Evolocumab
💬
| 1件: PCSK9 PCSK9 💬
| 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬
|
| 1776 | Repatha 420 MG solution FOR injection IN cartridge | 1件: Evolocumab Evolocumab | 1件: Evolocumab
Evolocumab
💬
| 1件: PCSK9 PCSK9 💬
| 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬
|
| 1777 | Repatha 420 MG soluzione PER iniezione IN cartuccia | 1件: Evolocumab Evolocumab | 1件: Evolocumab
Evolocumab
💬
| 1件: PCSK9 PCSK9 💬
| 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬
|
| 1778 | Rescue medication cdca 250 MG TID | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: Chenodiol
Chenodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 263 263 💬
|
| 1779 | Revatio - 0.8 MG/ML - soluzione iniettabile - USO endovenoso - flaconcino(vetro) 1 flaconcino DA 20 ML | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 294 294 💬
|
| 1780 | Revatio 10 MG/ML powder FOR oral suspension | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1781 | Revatio 20 MG | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 1782 | Revatio 20 MG film coated tablets | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1783 | Revatio 20 MG FILM-coated tablets | - | - | - | - | 1件: 86 86 💬
|
| 1784 | Revatio 20 MG filmtabletten | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1785 | Revatio 20 MG, comprimidos recubiertos CON PELícula | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1786 | Revolade - 25 MG - compressa rivestita CON film - USO orale - blister(PA/ALU/PVC/ALU) 28 compresse | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
| 1787 | Revolade - 50 MG - compressa rivestita CON film - USO orale - blister(PA/ALU/PVC/ALU | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
| 1788 | Revolade 25 MG FILM-coated tablets | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
| 1789 | Revolade 50 MG FILM-coated tablets | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
| 1790 | Revolade 75 MG | 1件: Eltrombopag Eltrombopag | 2件: Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
| 1791 | Rhhns-10 MG | 1件: Heparan-N-sulfatase (human, recombinant) Heparan-N-sulfatase (human, recombinant) | - | - | - | 1件: 19 19 💬
|
| 1792 | Rhhns-45 MG | 1件: Heparan-N-sulfatase (human, recombinant) Heparan-N-sulfatase (human, recombinant) | - | - | - | 1件: 19 19 💬
|
| 1793 | Rhhns-90 MG | 1件: Heparan-N-sulfatase (human, recombinant) Heparan-N-sulfatase (human, recombinant) | - | - | - | 1件: 19 19 💬
|
| 1794 | Rhudex 100 MG (127 MG rhudex choline salt) granules | - | - | - | - | 1件: 93 93 💬
|
| 1795 | Rhudex 25 MG (31.75 MG rhudex choline salt) granules | - | - | - | - | 1件: 93 93 💬
|
| 1796 | Rhudex 50 MG (63.5 MG rhudex choline salt) granules | - | - | - | - | 1件: 93 93 💬
|
| 1797 | Rifaximin 550 MG | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 1件: 6 6 💬
|
| 1798 | Rifaximin delayed release 400 MG film coated tablet | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 1件: 96 96 💬
|
| 1799 | Rilonacept 160 MG | 1件: Rilonacept Rilonacept | 1件: Rilonacept
Rilonacept
💬
| 2件: IL1A IL1A, IL1B 💬
| 44件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 1件: 106 106 💬
|
| 1800 | Rilutek 50 MG FILM-coated tablets | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
| 1801 | Rilutek 50 MG, FILM-coated tablets | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
| 1802 | Riluzole 50 MG | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
| 1803 | Riluzole oral soluble film (rosf) 50 MG | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
| 1804 | Riluzolo teva - 50 MG compresse rivestite CON film 90 compresse IN blister AL/PVC | - | - | - | - | 1件: 114 114 💬
|
| 1805 | Riociguat 0.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1806 | Riociguat 1.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1807 | Riociguat 1.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1808 | Riociguat 2.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1809 | Riociguat 2.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1810 | Riociguat coated tablet 0.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1811 | Riociguat coated tablet 1.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1812 | Riociguat coated tablet 1.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1813 | Riociguat coated tablet 2.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1814 | Riociguat coated tablet 2.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
| 1815 | Risankizumab 10 MG/ML | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 1816 | Risankizumab 180 MG SC | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 1817 | Risankizumab 600 MG IV | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 1818 | Risankizumab 90 MG/ML | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 1819 | Risankizumab-800CW 15 MG | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 1820 | Risankizumab-800CW 25 MG | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 1821 | Risankizumab-800CW 4.5 MG | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 1822 | Ritlecitinib 10 MG | 1件: Ritlecitinib Ritlecitinib | 1件: Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| 1件: JAK3 JAK3 💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
| 1823 | Ritlecitinib 5 MG | 1件: Ritlecitinib Ritlecitinib | 1件: Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| 1件: JAK3 JAK3 💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | 1件: 97 97 💬
|
| 1824 | Ritlecitinib 50 MG | 1件: Ritlecitinib Ritlecitinib | 1件: Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| 1件: JAK3 JAK3 💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | 2件: 96 96, 97 💬
|
| 1825 | Rituxan, cyclophosphamide, vincristine, prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬
|
| 1826 | Rituximab konsentrat TIL infusjonsvaeske oppløsning 10 MG/ML | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1827 | RIV-TDS 13.3 MG/24 H | - | - | - | - | 1件: 6 6 💬
|
| 1828 | Rivaroxaban 20 MG | 1件: Rivaroxaban Rivaroxaban | 1件: Rivaroxaban
Rivaroxaban
💬
| 1件: F10 F10 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 91 91 💬
|
| 1829 | Rivastigmine transdermal system 13.3 MG/24 H | 1件: Rivastigmine Rivastigmine | 2件: Rivastigmine tartrate
Rivastigmine tartrate
,
Rivastigmine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 6 6 💬
|
| 1830 | Rixathon 500 MG | - | - | - | - | 1件: 85 85 💬
|
| 1831 | RO4917523 0.5 MG | - | - | - | - | 1件: 206 206 💬
|
| 1832 | RO4917523 1.5 MG | - | - | - | - | 1件: 206 206 💬
|
| 1833 | RO7490677 160 MG/8 ML | - | - | - | - | 1件: 85 85 💬
|
| 1834 | RO7490677 160 MG/8ML | - | - | - | - | 1件: 85 85 💬
|
| 1835 | Roactemra - 162 MG - soluzione iniettabile - USO sottocutaneo - siringa preriempita 0,9ML (vetro) - 4 siringhe preriempite | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 51 💬
|
| 1836 | Roactemra - 20 MG/ML concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) 4ML 1 flaconcino | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
| 1837 | Roactemra 162 MG | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 51 💬
|
| 1838 | Roactemra 162 MG solution FOR injection IN PRE-filled syringe | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 41 41 💬
|
| 1839 | Roactemra 162 MG solution injectable EN seringue PRéremplie | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 56 💬
|
| 1840 | Roactemra 162 MG soluzione iniettabile IN siringa preriempita | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 50 50 💬
|
| 1841 | Roactemra 20 MG/ML concentrado para solucióN para perfusióN | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
| 1842 | Roactemra 20 MG/ML concentrate FOR solution FOR infusion | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
| 1843 | Roactemra 20 MG/ML, concentrado para solucióN para perfusióN | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 3件: 46 46, 107, 271 💬
|
| 1844 | Rodatristat ethyl 300 MG tablet BID | 2件: Rodatristat Rodatristat, Rodatristat ethyl | 2件: Rodatristat
Rodatristat
,
Rodatristat ethyl
💬
| 1件: TPH1_2 TPH1_2 💬
| 3件: Folate biosynthesis Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬 | 1件: 86 86 💬
|
| 1845 | Rodatristat ethyl 600 MG BID | 2件: Rodatristat Rodatristat, Rodatristat ethyl | 2件: Rodatristat
Rodatristat
,
Rodatristat ethyl
💬
| 1件: TPH1_2 TPH1_2 💬
| 3件: Folate biosynthesis Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬 | 1件: 86 86 💬
|
| 1846 | Rokan (R) novo 120 MG | - | - | - | - | 1件: 18 18 💬
|
| 1847 | Rosuvastatin 10 MG | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 96 96 💬
|
| 1848 | ROT-TDS 8 MG/24 H | - | - | - | - | 1件: 6 6 💬
|
| 1849 | Ruxolitinib 5 MG BID oral tablet | 1件: Ruxolitinib Ruxolitinib | 2件: Ruxolitinib
Ruxolitinib
,
Ruxolitinib phosphate
💬
| 2件: JAK1 JAK1, JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 60 60 💬
|
| 1850 | RVT-101 35 MG | - | - | - | - | 1件: 6 6 💬
|
| 1851 | RWJ-445380 100 MG | - | - | - | - | 1件: 46 46 💬
|
| 1852 | RWJ-445380 200 MG | - | - | - | - | 1件: 46 46 💬
|
| 1853 | RWJ-445380 300 MG | - | - | - | - | 1件: 46 46 💬
|
| 1854 | RWJ-445380 capsule 100 MG | - | - | - | - | 1件: 46 46 💬
|
| 1855 | RWJ-445380 capsules 150 MG | - | - | - | - | 1件: 46 46 💬
|
| 1856 | RWJ-445380 capsules 50 MG | - | - | - | - | 1件: 46 46 💬
|
| 1857 | RXC007 20 MG capsule | - | - | - | - | 1件: 85 85 💬
|
| 1858 | RXC007 50 MG capsule | - | - | - | - | 1件: 85 85 💬
|
| 1859 | Rytary 145 MG | - | - | - | - | 1件: 6 6 💬
|
| 1860 | Rytary 195 MG | - | - | - | - | 1件: 6 6 💬
|
| 1861 | Sabril 500 MG, granules FOR oral solution | - | - | - | - | 1件: 158 158 💬
|
| 1862 | Safinimide 50-100 MG/DAY | - | - | - | - | 1件: 6 6 💬
|
| 1863 | Salazopyrin EN 500 MG enterotabletter | - | - | - | - | 1件: 46 46 💬
|
| 1864 | Salbutamol (AS salbutamol sulfate) 2 MG oral tablet | 1件: Albuterol Albuterol | 2件: Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 111 111 💬
|
| 1865 | Salbutamol WZF 4 MG | 1件: Albuterol Albuterol | 2件: Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬
|
| 1866 | Salofalk 500 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
| 1867 | Salofalk granu-stix 500 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1868 | Salofalk® 500 MG gastro-resistant tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1869 | Salofalk® 500 MG tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
| 1870 | Samsca 15 MG tablets | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 1871 | Samsca 30 MG tablets | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 1872 | Samsca 7.5 MG oral tablet | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 1873 | SAN-300 0.5 MG/KG QW | - | - | - | - | 1件: 46 46 💬
|
| 1874 | SAN-300 1.0 MG/KG QW | - | - | - | - | 1件: 46 46 💬
|
| 1875 | SAN-300 2.0 MG/KG QOW | - | - | - | - | 1件: 46 46 💬
|
| 1876 | SAN-300 4.0 MG/KG QOW | - | - | - | - | 1件: 46 46 💬
|
| 1877 | SAN-300 4.0 MG/KG QW | - | - | - | - | 1件: 46 46 💬
|
| 1878 | Sandimmun 50 MG/ML, infuusiokonsentraatti | - | - | - | - | 1件: 97 97 💬
|
| 1879 | Sandimmun neoral - 100 MG capsule molli 30 capsule | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 💬
|
| 1880 | Sandimmun neoral - 25 MG capsule molli 50 capsule | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 💬
|
| 1881 | Sandimmun neoral - 50 MG capsule molli 50 capsule | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 💬
|
| 1882 | Sandostatin LAR 10 MG polvo para suspensióN inyectable | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1883 | Sandostatin LAR 20 MG | - | - | - | - | 1件: 227 227 💬
|
| 1884 | Sandostatin LAR 20 MG polvo para suspensióN inyectable | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1885 | Sandostatin LAR 30 MG polvo para suspensióN inyectable | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1886 | Sandostatin LAR monatsdepot 20 MG | - | - | - | - | 1件: 77 77 💬
|
| 1887 | Sandostatin LAR ® (octreotide acetate LAR) 30 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1888 | Sandostatin LAR, 10 MG, 20 MG and 30 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1889 | Sandostatin LAR-monatsdepot 10 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1890 | Sandostatin LAR-monatsdepot 20 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1891 | Sandostatin LAR-monatsdepot 30 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1892 | Sandostatina - LAR 20 MG/2.5 ML polvere E solvente PER sospensione iniettabile flacone polvere + siringa preriempita 2.5 ML + 2 aghi | - | - | - | - | 2件: 67 67, 77 💬
|
| 1893 | Sandostatina - LAR 30 MG/2.5 ML polvere E solvente PER sospensione iniettabile flacone polvere + siringa preriempita 2.5 ML + 2 aghi | - | - | - | - | 1件: 77 77 💬
|
| 1894 | Sandostatine L.P. 30 MG, poudre ET solvant EN seringue | - | - | - | - | 1件: 77 77 💬
|
| 1895 | Sandostatine L.P. 30 MG, poudre ET solvant pour suspension injectable à LIBération prolongéE | - | - | - | - | 1件: 77 77 💬
|
| 1896 | Sandostatine LAR 20 MG | - | - | - | - | 1件: 77 77 💬
|
| 1897 | Sandostatine long acting repeatable 30 MG | - | - | - | - | 1件: 77 77 💬
|
| 1898 | Sandostatin® LAR®-monatsdepot 10 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1899 | Sandostatin® LAR®-monatsdepot 20 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1900 | Sandostatin® LAR®-monatsdepot 30 MG | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1901 | Saroglitazar magnesium 1 MG | 1件: Saroglitazar Saroglitazar | 2件: Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| 3件: NR1C1 NR1C1, NR1C2, NR1C3 💬
| 22件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 1902 | Saroglitazar magnesium 2 MG | 1件: Saroglitazar Saroglitazar | 2件: Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| 3件: NR1C1 NR1C1, NR1C2, NR1C3 💬
| 22件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 1903 | Saroglitazar magnesium 4 MG | 1件: Saroglitazar Saroglitazar | 2件: Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| 3件: NR1C1 NR1C1, NR1C2, NR1C3 💬
| 22件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 💬
|
| 1904 | Sativex 2,7MG/2,5 MG solucion para pulverizacion bucal | 2件: Cannabidiol Cannabidiol, Dronabinol | 2件: Dronabinol
Dronabinol
,
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 1905 | Satralizumab 120 MG | 1件: Satralizumab Satralizumab | 1件: Satralizumab
Satralizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 1906 | SB-497115-GR 50 MG | - | - | - | - | 1件: 63 63 💬
|
| 1907 | SC belimumab 200 MG | - | - | - | - | 1件: 49 49 💬
|
| 1908 | SCH 420814 10 MG | - | - | - | - | 1件: 6 6 💬
|
| 1909 | SCH 420814 100 MG | - | - | - | - | 1件: 6 6 💬
|
| 1910 | Sebelipase alfa 0.35 MG/KG | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬
| 1件: LIPA LIPA 💬
| 4件: Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬
|
| 1911 | Sebelipase alfa 1 MG/KG | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬
| 1件: LIPA LIPA 💬
| 4件: Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬
|
| 1912 | Sebelipase alfa 3 MG/KG | 1件: Sebelipase alfa Sebelipase alfa | 1件: Sebelipase alfa
Sebelipase alfa
💬
| 1件: LIPA LIPA 💬
| 4件: Cholesterol metabolism Cholesterol metabolism, Efferocytosis, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 💬
|
| 1913 | Secukinumab 150 MG | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬
|
| 1914 | Secukinumab 150 MG (2 injections PER dose | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 269 269 💬
|
| 1915 | Secukinumab 150 MG/1 ML solution FOR injection | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 2件: 37 37, 271 💬
|
| 1916 | Secukinumab 150 MG/ML | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬
|
| 1917 | Secukinumab 300 MG | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬
|
| 1918 | Secukinumab 75 MG/0.5 ML solution FOR injection | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 271 271 💬
|
| 1919 | Seladelpar / MBX-8025 200 MG | 1件: Seladelpar Seladelpar | 2件: Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 💬
|
| 1920 | Seladelpar / MBX-8025 50 MG | 1件: Seladelpar Seladelpar | 2件: Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 💬
|
| 1921 | Seladelpar 10 MG | 1件: Seladelpar Seladelpar | 2件: Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 💬
|
| 1922 | Seladelpar 10 MG capsule | 1件: Seladelpar Seladelpar | 2件: Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 💬
|
| 1923 | Seladelpar 10 MG or less | 1件: Seladelpar Seladelpar | 2件: Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 💬
|
| 1924 | Seladelpar 5 MG | 1件: Seladelpar Seladelpar | 2件: Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 💬
|
| 1925 | Seladelpar 5 MG capsule | 1件: Seladelpar Seladelpar | 2件: Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 💬
|
| 1926 | Seladelpar 5-10 MG | 1件: Seladelpar Seladelpar | 2件: Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 💬
|
| 1927 | Selumetinib granules IN sprinkle capsules FOR opening 5 MG | 1件: Selumetinib Selumetinib | 2件: Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| 2件: MAP2K1 MAP2K1, MAP2K2 💬
| 88件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 💬
|
| 1928 | Selumetinib granules IN sprinkle capsules FOR opening 7.5 MG | 1件: Selumetinib Selumetinib | 2件: Selumetinib
Selumetinib
,
Selumetinib sulfate
💬
| 2件: MAP2K1 MAP2K1, MAP2K2 💬
| 88件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 💬
|
| 1929 | Sevasemten 10 MG | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
| 1930 | Sevasemten 12.5 MG | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
| 1931 | Sevasemten 5 MG | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
| 1932 | Sifalimumab 1,200 MG | 1件: Sifalimumab Sifalimumab | 1件: Sifalimumab
Sifalimumab
💬
| 13件: IFNA IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA 💬
| 25件: Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 49 49 💬
|
| 1933 | Sifalimumab 200 MG | 1件: Sifalimumab Sifalimumab | 1件: Sifalimumab
Sifalimumab
💬
| 13件: IFNA IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA 💬
| 25件: Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 49 49 💬
|
| 1934 | Sifalimumab 600 MG | 1件: Sifalimumab Sifalimumab | 1件: Sifalimumab
Sifalimumab
💬
| 13件: IFNA IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA, IFNA 💬
| 25件: Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 49 49 💬
|
| 1935 | Sifrol, 0,35 MG tablette | 1件: Pramipexole Pramipexole | 2件: Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1936 | Sifrol, 0,70 MG tablette | 1件: Pramipexole Pramipexole | 2件: Pramipexole dihydrochloride
Pramipexole dihydrochloride
,
Pramipexole
💬
| 3件: DRD2 DRD2, DRD3, DRD4 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1937 | Sildenafil (revatio) 20 MG TID | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 1938 | Sildenafil 20 MG tablets | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 278 278 💬
|
| 1939 | Sildenafil and losartan (LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG) | 2件: Losartan Losartan, Sildenafil | 4件: Losartan potassium
Losartan potassium
(LOSARTAN POTASSIUM TABLETS, 100 MG, LOSARTAN POTASSIUM TABLETS, 25 MG, LOSARTAN POTASSIUM TABLETS, 50 MG),
Sildenafil citrate
,
Losartan
,
Sildenafil
💬
| 2件: AGTR1 AGTR1, PDE5 💬
| 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
| 1940 | Sildenafil25 MG | - | - | - | - | 1件: 17 17 💬
|
| 1941 | Simponi 100 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 1942 | Simponi 50 MG | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
| 1943 | Simponi 50 MG solucióN inyectable EN pluma precargada | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
| 1944 | Simvahexal® 40 MG filmtabletten | - | - | - | - | 1件: 13 13 💬
|
| 1945 | Simvastatin 20 MG | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 46 46 💬
|
| 1946 | Simvastatin 40 MG FILM-coated tablets | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1947 | Simvastatin 40 MG tablets | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 86 86 💬
|
| 1948 | Simvastatina sandoz 40 MG comprimidos recubiertos CON PELícula EFG | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1949 | Simvastatine sandoz 40 MG filmomhulde tabletten | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1950 | Sinemet - 100 MG + 25 MG compresse 50 compresse divisibili | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1951 | Sinemet 100 MG + 25 MG compresse | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1952 | Sinemet 100 MG + 25 MG tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1953 | Sinemet 125 MG | - | - | - | - | 1件: 6 6 💬
|
| 1954 | Sinemet plus 25 MG/ 100 MG tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1955 | Sinemet® 100/25 MG | - | - | - | - | 1件: 6 6 💬
|
| 1956 | Sinemet® plus 25 MG/100 MG tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1957 | Sinvastatina sandoz 40 MG comprimidos revestidos POR PELícula | - | - | - | - | 1件: 13 13 💬
|
| 1958 | Siponimod 0,25 MG | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1959 | Siponimod 0.25 MG tablet | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 50 💬
|
| 1960 | Siponimod 0.5 MG tablet | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 50 💬
|
| 1961 | Siponimod 1 MG | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1962 | Siponimod 1 MG tablet | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 50 💬
|
| 1963 | Siponimod 2 MG | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1964 | Siponimod 2 MG tablet | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 50 💬
|
| 1965 | Sirolimus 2 MG | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 17 17 💬
|
| 1966 | Sirolimus and hydroxychloroquine 200 MG | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 89 89 💬
|
| 1967 | Sirolimus and hydroxychloroquine 400 MG | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 89 89 💬
|
| 1968 | Sirukumab 100 MG | 1件: Sirukumab Sirukumab | 1件: Sirukumab
Sirukumab
💬
| 1件: IL6 IL6 💬
| 49件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | 1件: 46 46 💬
|
| 1969 | Sirukumab 50 MG | 1件: Sirukumab Sirukumab | 1件: Sirukumab
Sirukumab
💬
| 1件: IL6 IL6 💬
| 49件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | 1件: 46 46 💬
|
| 1970 | Sivatin 40 MG FILM-coated tablets | - | - | - | - | 1件: 13 13 💬
|
| 1971 | Sodium bicarbonate 600 MG oral tablet | 1件: Sodium bicarbonate Sodium bicarbonate | 1件: Sodium bicarbonate
Sodium bicarbonate
💬
| - | - | 1件: 67 67 💬
|
| 1972 | Sodium valproate 200 MG gastro-resistant tablets | - | - | - | - | 1件: 233 233 💬
|
| 1973 | Sogroya 10 MG/1.5 ML solution FOR injection IN PRE-filled PEN | 1件: Somapacitan Somapacitan | 1件: Somapacitan
Somapacitan
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
| 1974 | Sogroya 10 MG/1.5 ML soluzione PER iniezione IN penna PRE-riempita | 1件: Somapacitan Somapacitan | 1件: Somapacitan
Somapacitan
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
| 1975 | Sogroya 5 MG/1.5 ML solution FOR injection IN PRE-filled PEN | 1件: Somapacitan Somapacitan | 1件: Somapacitan
Somapacitan
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
| 1976 | Soldesam - 4 MG/ML soluzione iniettabile 3 fiale 1 ML | - | - | - | - | 1件: 28 28 💬
|
| 1977 | Soliris 300 MG concentrado para solucióN para perfusióN | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 109 109 💬
|
| 1978 | Soliris 300 MG concentrate FOR solution FOR infusion | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 1979 | Soliris 300 MG solution à diluer pour perfusion | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 109 109 💬
|
| 1980 | Solu medrol - 1000 MG/16 ML polvere E solvente PER soluzione iniettabile 1 flacone DI polvere DA 1000 MG+ 1 flacone solvente DA 16 ML | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 💬
|
| 1981 | Solu medrol - 125 MG/2 ML polvere E solvente PER soluzione iniettabile 1 flacone A doppia camera DA 125 MG/2 ML | - | - | - | - | 2件: 13 13, 14 💬
|
| 1982 | Solu medrol - 40 MG/ML polvere E solvente PER soluzione iniettabile 1 flacone A doppia camera DA 40 MG/ML | - | - | - | - | 1件: 56 56 💬
|
| 1983 | Solu medrol - 500 MG/8 ML polvere E solvente PER soluzione iniettabile 1 flacone DI polvere DA 500 MG+ fiala solvente DA 8 ML | - | - | - | - | 1件: 56 56 💬
|
| 1984 | SOLU-cortef 100 MG injection | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 83 83 💬
|
| 1985 | SOLU-medrol 250 MG | - | - | - | - | 1件: 49 49 💬
|
| 1986 | Soluzione DI levodopa/carbidopa (CARBIDOPA TABLETS, 25 MG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG) 💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 1987 | SOM230 LAR 10 MG | - | - | - | - | 1件: 75 75 💬
|
| 1988 | SOM230 LAR 30 MG | - | - | - | - | 1件: 75 75 💬
|
| 1989 | SOM230 LAR, 20 MG | - | - | - | - | 2件: 75 75, 77 💬
|
| 1990 | Somapacitan 15 MG/1.5 ML PDS290 | 1件: Somapacitan Somapacitan | 1件: Somapacitan
Somapacitan
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
| 1991 | Somapacitan 5 MG/1.5 ML PDS290 | 1件: Somapacitan Somapacitan | 1件: Somapacitan
Somapacitan
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 💬
|
| 1992 | Somatuline autogel 120 MG | 1件: Lanreotide Lanreotide | 1件: Lanreotide acetate
Lanreotide acetate
💬
| 2件: SSTR2 SSTR2, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
| 1993 | Somatuline autogel 90 MG | 1件: Lanreotide Lanreotide | 1件: Lanreotide acetate
Lanreotide acetate
💬
| 2件: SSTR2 SSTR2, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 298 298 💬
|
| 1994 | Somatuline autogel® 60, 90 or 120 MG | - | - | - | - | 1件: 77 77 💬
|
| 1995 | Somatuline L.P. 120 MG, solution injectable à LIBération prolongéE EN seringue PRéremplie | - | - | - | - | 1件: 77 77 💬
|
| 1996 | Somatuline® autogel® 120 MG solution FOR injection | - | - | - | - | 1件: 77 77 💬
|
| 1997 | Somavert 10 MG | 1件: Pegvisomant Pegvisomant | 1件: Pegvisomant
Pegvisomant
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 77 77 💬
|
| 1998 | Somavert 15 MG | 1件: Pegvisomant Pegvisomant | 1件: Pegvisomant
Pegvisomant
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 77 77 💬
|
| 1999 | Somavert 20 MG | 1件: Pegvisomant Pegvisomant | 1件: Pegvisomant
Pegvisomant
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 77 77 💬
|
| 2000 | Sortis 10 MG | - | - | - | - | 1件: 93 93 💬
|
| 2001 | Sotatercept - 45 MG/vial | 1件: Sotatercept Sotatercept | 1件: Sotatercept
Sotatercept
💬
| 1件: ACVR2A ACVR2A 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 86 86 💬
|
| 2002 | Sotatercept - 60 MG/vial | 1件: Sotatercept Sotatercept | 1件: Sotatercept
Sotatercept
💬
| 1件: ACVR2A ACVR2A 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 86 86 💬
|
| 2003 | Spironolactone mylan 25 MG comprimé pelliculé Sécable | 1件: Spironolactone Spironolactone | 1件: Spironolactone
Spironolactone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 1件: 46 46 💬
|
| 2004 | Sporanox 10 MG/ML oral solution | 1件: Itraconazole Itraconazole | 1件: Itraconazole
Itraconazole
💬
| - | - | 1件: 299 299 💬
|
| 2005 | SSP-004184 100 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2006 | SSP-004184 250 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2007 | SSP-004184 375 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2008 | SSP-004184 50 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2009 | SSP-004184 500 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2010 | SSP-004184AQ 100 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2011 | SSP-004184AQ 200 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2012 | SSP-004184AQ 250 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2013 | SSP-004184AQ 375 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2014 | SSP-004184AQ 50 MG capsule | - | - | - | - | 1件: 284 284 💬
|
| 2015 | Stalevo 100 MG/ 25 MG/ 200 MG filmtabletten | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG),
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 2016 | Stalevo 100 MG/25 MG / 200 MG | - | - | - | - | 1件: 6 6 💬
|
| 2017 | Stalevo 100/25/200 MG | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG),
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 2018 | Stalevo 150/37.5/200 MG | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
(CARBIDOPA TABLETS, 25 MG),
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 2019 | Stelara - 45 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 0.5 ML (90 MG/ML) 1 flaconcino | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
| 2020 | Stelara - 90 MG - soluzione iniettabile IN siringhe preriempite - USO sottocutaneo - siringa preriempita(vetro) 1 ML(90MG/ML) 1 siringa preriempita DA 1 ML | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
| 2021 | Stelara - 90 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 1.0 ML (90 MG/ML) 1 flaconcino | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
| 2022 | Stelara 130 MG concentrate FOR solution FOR infusion | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 2023 | Stelara 45 MG solution FOR injection | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 2024 | Stelara 90 MG solution FOR injection IN PRE-filled syringe | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 2025 | Stelara 90 MG solution FOR injection N PRE-filled syringue | - | - | - | - | 1件: 96 96 💬
|
| 2026 | STNM01 1.84 MG | - | - | - | - | 1件: 97 97 💬
|
| 2027 | SUB-study: pirfenidone (PIRFENIDONE CAPSULE, 267 MG) | - | - | - | - | 1件: 85 85 💬
|
| 2028 | Sublingual tizanidine 12 MG | - | - | - | - | 1件: 13 13 💬
|
| 2029 | Sulphasalazine 500 MG EN-tabs | - | - | - | - | 1件: 271 271 💬
|
| 2030 | Sustained-release carbidopa/levodopa (CARBIDOPA TABLETS, 25 MG) | - | - | - | - | 1件: 6 6 💬
|
| 2031 | SYN115 tablets, 60 MG | - | - | - | - | 1件: 6 6 💬
|
| 2032 | TA-650 10 MG/KG | - | - | - | - | 1件: 46 46 💬
|
| 2033 | TA-650 3 MG/KG | - | - | - | - | 1件: 46 46 💬
|
| 2034 | TA-650 6 MG/KG | - | - | - | - | 1件: 46 46 💬
|
| 2035 | Tachipirina - 500 MG compresse10 compresse | - | - | - | - | 1件: 28 28 💬
|
| 2036 | Tachipirina - 500 MG compresse20 compresse | - | - | - | - | 1件: 13 13 💬
|
| 2037 | Tacrolimus combined with prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
| 2038 | Tadalafil 20 MG | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬
|
| 2039 | Tadalafil 20 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 2040 | Tadalafil 40 MG | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 2041 | Tafamidis meglumine 20 MG soft gelatin capsules | 1件: Tafamidis Tafamidis | 2件: Tafamidis
Tafamidis
,
Tafamidis meglumine
💬
| 1件: TTR TTR 💬
| 1件: Thyroid hormone synthesis Thyroid hormone synthesis 💬 | 1件: 28 28 💬
|
| 2042 | Tamoxifen 40 MG daily FOR ONE year | 1件: Tamoxifen Tamoxifen | 2件: Tamoxifen citrate
Tamoxifen citrate
,
Tamoxifen
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 2 2 💬
|
| 2043 | Targinact 10 MG/5 MG prolonged-release tablets | - | - | - | - | 2件: 6 6, 226 💬
|
| 2044 | Targinact 20 MG/10 MG prolonged-release tablets | - | - | - | - | 1件: 6 6 💬
|
| 2045 | Targinact 20MG/10 MG prolonged-release tablets | - | - | - | - | 1件: 226 226 💬
|
| 2046 | Targinact 5 MG/2.5 MG prolonged-release tablets | - | - | - | - | 1件: 6 6 💬
|
| 2047 | Targinact 5MG/2.5 MG prolonged-release tablets | - | - | - | - | 1件: 226 226 💬
|
| 2048 | Tarpeyo 4 MG delayed release oral capsule | - | - | - | - | 1件: 66 66 💬
|
| 2049 | Tasigna 50 MG | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 34 34 💬
|
| 2050 | Tasigna® 150 MG | 1件: Nilotinib Nilotinib | 1件: Nilotinib
Nilotinib
💬
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| 32件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 86 86 💬
|
| 2051 | Tavapadon 0.25 MG | 1件: Tavapadon Tavapadon | 1件: Tavapadon
Tavapadon
💬
| 2件: DRD1 DRD1, DRD5 💬
| 12件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 2052 | Tavapadon 5 MG | 1件: Tavapadon Tavapadon | 1件: Tavapadon
Tavapadon
💬
| 2件: DRD1 DRD1, DRD5 💬
| 12件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 2053 | TCP-25 GEL 0.86 MG/ML | - | - | - | - | 1件: 36 36 💬
|
| 2054 | TCP-25 GEL 2.9 MG/ML | - | - | - | - | 1件: 36 36 💬
|
| 2055 | TCP-25 GEL 8.6 MG/ML | - | - | - | - | 1件: 36 36 💬
|
| 2056 | Tecfidera - 240 MG - capsula rigida gastroresistente - USO orale - blister (PVC/PE/PVDC-PVC alluminio) - 56 capsule | - | - | - | - | 1件: 13 13 💬
|
| 2057 | Tecfidera® 120 MG | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 2058 | Tecfidera® 240 MG | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 2059 | Teduglutide 0.1 MG dose | 1件: Teduglutide Teduglutide | 1件: Teduglutide
Teduglutide
💬
| 1件: GLP2R GLP2R 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 2060 | Teduglutide 0.2 MG | 1件: Teduglutide Teduglutide | 1件: Teduglutide
Teduglutide
💬
| 1件: GLP2R GLP2R 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 2061 | Teicoplanina sandoz - 200 MG polvere E solvente PER soluzione iniettabile O infusione 1 flaconcino vetro DA 200 MG E 1 fiala vetro DA 3 ML | 1件: Teicoplanin Teicoplanin | 1件: Teicoplanin
Teicoplanin
💬
| - | - | 1件: 299 299 💬
|
| 2062 | Teicoplanina sandoz 200 MG | 1件: Teicoplanin Teicoplanin | 1件: Teicoplanin
Teicoplanin
💬
| - | - | 1件: 299 299 💬
|
| 2063 | Telitacicept 160 MG | 1件: Telitacicept Telitacicept | - | - | - | 1件: 53 53 💬
|
| 2064 | Telitacicept 80 MG | 1件: Telitacicept Telitacicept | - | - | - | 1件: 53 53 💬
|
| 2065 | Terazosin 5 MG | 1件: Terazosin Terazosin | 2件: Terazosin hydrochloride
Terazosin hydrochloride
,
Terazosin
💬
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 2066 | Terguride 0.5 MG tablet | 1件: Terguride Terguride | 1件: Terguride
Terguride
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 86 86 💬
|
| 2067 | Teriflunomide 14 MG | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 2068 | Test group (group A): FCN-159 8 MG, orally, once daily | - | - | - | - | 1件: 34 34 💬
|
| 2069 | Thalidomide celgene - 50 MG capsula rigida - USO orale - blister (PVC/PE/aclar/ALU) 28 capsule | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 2070 | Thalidomide, cyclophosphamide and prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 331 331 💬
|
| 2071 | THE investigational medicinal product (IMP) will BE labeled AS PF-04236921 106 MG/vial, clonal SC lyophilized form, which IS equivalent TO PF-04236921 powder FOR injection, 106 MG/vial AS described IN THE enclosed CTA | - | - | - | - | 1件: 96 96 💬
|
| 2072 | Thymectomy plus prednisone (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
(PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) 💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 11 11 💬
|
| 2073 | Thymoglobuline - 5 MG/ML polvere PER concentrato PER soluzione PER infusione 1 fiala DA 10 ML | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 1件: 51 51 💬
|
| 2074 | Thymoglobuline 5 MG/ML, poudre pour solution pour perfusion | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 1件: 60 60 💬
|
| 2075 | Tildrakizumab 100 MG/ML | 1件: Tildrakizumab Tildrakizumab | 1件: Tildrakizumab
Tildrakizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 271 271 💬
|
| 2076 | Tobi 300 MG / 5 ML nebuliser solution | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2077 | Tobi 300 MG/5 ML Lösung FüR einen | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2078 | Tobi 300 MG/5 ML Lösung FüR einen vernebler | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2079 | Tobi 300 MG/5 ML nebuliser solution | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2080 | Tobi 300 MG/5 ML solucióN para inhalacióN POR nebulizador | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2081 | Tobi 300 MG/5 ML, solution pour inhalation PAR Nébuliseur | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2082 | Tobi podhaler 28 MG hartkapseln MIT pulver ZUR inhalation | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2083 | Tobi podhaler 28 MG inhaláCIóS POR, KEMéNY kapszula | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2084 | Tobi™ podhaler™ 112 MG inhaled twice daily | - | - | - | - | 1件: 299 299 💬
|
| 2085 | Tobramycin solution FOR inhalation 300 MG | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2086 | Tobramycin steri-NEB 300 MG/5 ML, inhalation solution | 1件: Tobramycin Tobramycin | 2件: Tobramycin
Tobramycin
,
Tobramycin sulfate
💬
| - | - | 1件: 299 299 💬
|
| 2087 | Tocilizumab 162 MG | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
| 2088 | Tofacitinib 10 MG | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 271 271 💬
|
| 2089 | Tofacitinib 2 MG | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 271 271 💬
|
| 2090 | Tofacitinib 5 MG | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 5件: 11 11, 40, 46, 50, 271 💬
|
| 2091 | Tofacitinib 5 MG twice daily | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 84 💬
|
| 2092 | Tolvaptan 15 MG tablet | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 2093 | Tolvaptan 15 MG tablets | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 2094 | Tolvaptan 30 MG tablet | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 2095 | Tolvaptan 30 MG tablets | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 2096 | Tolvaptan 7.5 MG tablet | 1件: Tolvaptan Tolvaptan | 1件: Tolvaptan
Tolvaptan
💬
| 1件: AVPR2 AVPR2 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 💬
|
| 2097 | Tominersen 100 MG | 1件: Tominersen Tominersen | 1件: Tominersen
Tominersen
💬
| 1件: HD HD 💬
| 2件: Huntington disease Huntington disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 8 8 💬
|
| 2098 | Tominersen 60 MG | 1件: Tominersen Tominersen | 1件: Tominersen
Tominersen
💬
| 1件: HD HD 💬
| 2件: Huntington disease Huntington disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 8 8 💬
|
| 2099 | Tozadenant (SYN115) 120 MG BID | 1件: Tozadenant Tozadenant | 1件: Tozadenant
Tozadenant
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 2100 | Tozadenant (SYN115) 180 MG BID | 1件: Tozadenant Tozadenant | 1件: Tozadenant
Tozadenant
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 2101 | Tozadenant (SYN115) 240 MG BID | 1件: Tozadenant Tozadenant | 1件: Tozadenant
Tozadenant
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 2102 | Tozadenant (SYN115) 60 MG BID | 1件: Tozadenant Tozadenant | 1件: Tozadenant
Tozadenant
💬
| 1件: ADORA2A ADORA2A 💬
| 8件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 2103 | TPI 287 2 MG/M2 | - | - | - | - | 2件: 5 5, 7 💬
|
| 2104 | TPI-287 20 MG/M2 | 1件: TPI-287 TPI-287 | - | - | - | 2件: 5 5, 7 💬
|
| 2105 | TPI-287 6.3 MG/M2 | 1件: TPI-287 TPI-287 | - | - | - | 2件: 5 5, 7 💬
|
| 2106 | TPN-101, 100 MG/DAY | - | - | - | - | 1件: 5 5 💬
|
| 2107 | TPN-101, 200 MG/DAY | - | - | - | - | 1件: 5 5 💬
|
| 2108 | TPN-101, 400 MG/DAY | - | - | - | - | 3件: 2 2, 5, 127 💬
|
| 2109 | TQH3821 tablets 200 MG | - | - | - | - | 1件: 46 46 💬
|
| 2110 | Tranexamic acid 100 MG/ML | 1件: Tranexamic acid Tranexamic acid | 1件: Tranexamic acid
Tranexamic acid
💬
| 1件: PLG PLG 💬
| 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 1件: 70 70 💬
|
| 2111 | Transcon CNP 3.9 MG CNP-38/vial | 1件: ACP-015 ACP-015 | - | - | - | 1件: 276 276 💬
|
| 2112 | Translarna 1000 MG granules FOR oral suspension | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
| 2113 | Translarna 125 MG granules FOR oral suspension | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
| 2114 | Translarna 250 MG granules FOR oral suspension | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
| 2115 | Treat with lansoprazole 30 MG BID FOR 2 weeks, endoscopic examination with esophageal biopsy FOR patients with persistent symptoms | - | - | - | - | 1件: 98 98 💬
|
| 2116 | Treatment :abacavir 600 MG/lamivudine 300 MG | - | - | - | - | 1件: 49 49 💬
|
| 2117 | Trexan INJ 25 MG/ML | - | - | - | - | 1件: 97 97 💬
|
| 2118 | Triam 40 MG lichtenstein | - | - | - | - | 1件: 46 46 💬
|
| 2119 | Triamcinolone hexacetonide 20 MG/ML | 1件: Triamcinolone Triamcinolone | 4件: Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 107 107 💬
|
| 2120 | Trimeton - 10 MG/1 ML soluzione iniettabile 5 fiale 1 ML | - | - | - | - | 1件: 14 14 💬
|
| 2121 | Trulicity 0,75 MG injekcný roztok naplnený V injekcnom pere | - | - | - | - | 1件: 13 13 💬
|
| 2122 | Twice daily 90 MG hydrocortisone acetate suppository administered with sephure applicator | 3件: Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | 2件: Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬
|
| 2123 | TYRA-300 0.125 MG/KG | - | - | - | - | 1件: 276 276 💬
|
| 2124 | TYRA-300 0.25 MG/KG | - | - | - | - | 1件: 276 276 💬
|
| 2125 | TYRA-300 0.375 MG/KG | - | - | - | - | 1件: 276 276 💬
|
| 2126 | TYRA-300 0.50 MG/KG | - | - | - | - | 1件: 276 276 💬
|
| 2127 | Tysabri 300 MG concentrado para solucióN para perfusióN | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 2128 | Tysabri 300 MG concentrate FOR solution FOR infusion | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 2129 | Tysabri 300 MG solution à diluer pour perfusion | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 2130 | Ultomiris - 300 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) 3 ML (100 MG / ML) - 1 flaconcino | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 2131 | Ultomiris 1,100 MG/11 ML | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 11 11 💬
|
| 2132 | Ultomiris 300 MG/30 ML | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 66 66 💬
|
| 2133 | Upadacitinib 15 MG | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
| 2134 | Urbason 40 MG | - | - | - | - | 1件: 13 13 💬
|
| 2135 | Urbason 40 MG comprimidos | - | - | - | - | 1件: 13 13 💬
|
| 2136 | Urbason® solubile forte 1000 MG | - | - | - | - | 1件: 13 13 💬
|
| 2137 | Ursodeoxycholic acid (udca) 500 MG | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 46 46 💬
|
| 2138 | Ursofalk® 500 MG FILM-coated tablets | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬
|
| 2139 | Ursofalk® 500 MG filmtabletten | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 💬
|
| 2140 | Ustekinumab 130 MG IV | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
| 2141 | Ustekinumab 180 MG | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 93 93 💬
|
| 2142 | Ustekinumab 4.5 MG/KG | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 2143 | Ustekinumab 45 MG | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 93 93 💬
|
| 2144 | Ustekinumab 6 MG/KG | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 50 50 💬
|
| 2145 | Ustekinumab 90 MG | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 5件: 49 49, 50, 93, 96, 97 💬
|
| 2146 | Ustekinumab 90 MG (SC) group 1 | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 2147 | Ustekinumab 90 MG (SC) group 2 | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 2148 | Ustekinumab 90 MG SC Q12W | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
| 2149 | Ustekinumab 90 MG SC Q8W | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
| 2150 | UT-15C 0.25 MG | - | - | - | - | 1件: 86 86 💬
|
| 2151 | UT-15C 1 MG | - | - | - | - | 1件: 86 86 💬
|
| 2152 | UT-15C 5 MG | - | - | - | - | 1件: 86 86 💬
|
| 2153 | Valsartan 40 MG | 1件: Valsartan Valsartan | 1件: Valsartan
Valsartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 2154 | Valsartanum 40 MG / placebo 1 | - | - | - | - | 2件: 167 167, 168 💬
|
| 2155 | Valsartanum 80 MG / placebo 2 | - | - | - | - | 2件: 167 167, 168 💬
|
| 2156 | Vamorolone 0.25 MG/DAY/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 2157 | Vamorolone 0.25 MG/KG/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 2158 | Vamorolone 0.75 MG/DAY/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 2159 | Vamorolone 0.75 MG/KG/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 2160 | Vamorolone 2.0 MG/DAY/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 2161 | Vamorolone 2.0 MG/KG/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 2162 | Vamorolone 40 MG/ML oral suspension | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 2163 | Vamorolone 6.0 MG/DAY/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 2164 | Vamorolone 6.0 MG/KG/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
| 2165 | Vedolizumab 108 MG SC | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 97 97 💬
|
| 2166 | Vedolizumab 300 MG | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
| 2167 | Vedolizumab 300 MG IV | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 97 97 💬
|
| 2168 | Vedolizumab IV 300 MG | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 96 96 💬
|
| 2169 | Vedolizumab SC 108 MG | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
| 2170 | Venetoclax oral tablet, 200 MG | 1件: Venetoclax Venetoclax | 1件: Venetoclax
Venetoclax
💬
| 1件: BCL2 BCL2 💬
| 40件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | 1件: 28 28 💬
|
| 2171 | Venetoclax oral tablet, 400 MG | 1件: Venetoclax Venetoclax | 1件: Venetoclax
Venetoclax
💬
| 1件: BCL2 BCL2 💬
| 40件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬 | 1件: 28 28 💬
|
| 2172 | Venofer solution FOR injection, 100 MG iron | 1件: Iron sucrose Iron sucrose | 1件: Iron sucrose
Iron sucrose
💬
| - | - | 1件: 97 97 💬
|
| 2173 | Venofer solution FOR injection, 20 MG iron/ML | 1件: Iron sucrose Iron sucrose | 1件: Iron sucrose
Iron sucrose
💬
| - | - | 1件: 97 97 💬
|
| 2174 | Venofer solution FOR injection, 20 MG/ML iron | 1件: Iron sucrose Iron sucrose | 1件: Iron sucrose
Iron sucrose
💬
| - | - | 1件: 97 97 💬
|
| 2175 | Verenafusp alfa 12 MG/KG | - | - | - | - | 1件: 19 19 💬
|
| 2176 | Verenafusp alfa 6 MG/KG | - | - | - | - | 1件: 19 19 💬
|
| 2177 | Verenafusp alfa 9 MG/KG | - | - | - | - | 1件: 19 19 💬
|
| 2178 | Vfend 40 MG/ML powder FOR oral suspension | 1件: Voriconazole Voriconazole | 1件: Voriconazole
Voriconazole
💬
| - | - | 1件: 299 299 💬
|
| 2179 | Vildagliptin 50 MG BID | 1件: Vildagliptin Vildagliptin | 1件: Vildagliptin
Vildagliptin
💬
| 1件: DPP4 DPP4 💬
| 2件: Protein digestion and absorption Protein digestion and absorption, Virion - Hepatitis viruses 💬 | 1件: 6 6 💬
|
| 2180 | Vinblastine, vincristine, prednisone, daunorubicin (PREDNISONE TABLETS, USP, 10 MG, PREDNISONE TABLETS, USP, 20 MG, PREDNISONE TABLETS, USP, 5 MG) | 1件: Vinblastine Vinblastine | 2件: Vinblastine sulfate
Vinblastine sulfate
,
Vinblastine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 65 65 💬
|
| 2181 | Viread - 245 MG 30 compresse rivestite CON film IN flacone USO orale | - | - | - | - | 1件: 46 46 💬
|
| 2182 | Viread 30 CPR 245 MG | - | - | - | - | 1件: 46 46 💬
|
| 2183 | Vitamin B6 25 MG | 1件: Pyridoxine Pyridoxine | 2件: Pyridoxine hydrochloride
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | 1件: 6 6 💬
|
| 2184 | Vitamin K 10 MG | 1件: Phylloquinone Phylloquinone | 1件: Phytonadione
Phytonadione
💬
| - | - | 2件: 96 96, 97 💬
|
| 2185 | Volibris 10 MG comprimidos recubiertos CON PELícula | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 2186 | Volibris 5 MG comprimidos recubiertos CON PELícula | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
| 2187 | VX-661/ivacaftor (VX-770) 100MG/150 MG | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 2188 | VX-661/ivacaftor 100 MG/ 150 MG | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 2189 | VX-661/ivacaftor 100MG/150 MG | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 2190 | VX-661/ivacaftor 50 MG/ 75 MG | 1件: Ivacaftor Ivacaftor | 1件: Ivacaftor
Ivacaftor
💬
| 1件: CFTR CFTR 💬
| 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
| 2191 | Warfarin 10 MG | 1件: Warfarin Warfarin | 3件: Warfarin sodium
Warfarin sodium
,
Warfarin potassium
,
Warfarin
💬
| 2件: NQO1 NQO1, VKORC1 💬
| 5件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 2件: 96 96, 97 💬
|
| 2192 | WD-1603 carbidopa and levodopa extended-release tablets (CARBIDOPA TABLETS, 25 MG) | - | - | - | - | 1件: 6 6 💬
|
| 2193 | WD-1603 carbidopa-levodopa extended-release tablets (CARBIDOPA TABLETS, 25 MG) | - | - | - | - | 1件: 6 6 💬
|
| 2194 | WD-1603 carbidopa/levodopa extended-release tablets (CARBIDOPA TABLETS, 25 MG) | - | - | - | - | 1件: 6 6 💬
|
| 2195 | Xadago - 100 MG- compressa rivestita CON FILM- USO orale- blister (PVC/pvdc/alluminio)- 30 compresse | 1件: Safinamide Safinamide | 2件: Safinamide
Safinamide
,
Safinamide mesylate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 2196 | Xadago - 50 MG- compressa rivestita CON FILM- USO orale- blister (PVC/pvdc/alluminio)- 30 compresse | 1件: Safinamide Safinamide | 2件: Safinamide
Safinamide
,
Safinamide mesylate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
| 2197 | Xeljanz 5 MG FILM-coated tablets | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 97 💬
|
| 2198 | Xgeva - 120 MG - soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) - 1.7 ML 4 flaconcini | 1件: Denosumab Denosumab | 1件: Denosumab
Denosumab
💬
| 1件: TNFSF11 TNFSF11 💬
| 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 1件: 274 274 💬
|
| 2199 | Xolair 150 MG pulver UND injektionslösung ZUR herstellung einer injektionslösung | 1件: Omalizumab Omalizumab | 1件: Omalizumab
Omalizumab
💬
| 1件: FCER1A FCER1A 💬
| 4件: Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 1件: 299 299 💬
|
| 2200 | Xyosted 75 milligram (MG) IN 0.5 ML AUTO-injector | - | - | - | - | 1件: 13 13 💬
|
| 2201 | Yondelis 0,25 MG polvo para concentrado para solucióN para perfusióN | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬
| - | - | 1件: 159 159 💬
|
| 2202 | Yondelis 1 MG polvo para concentrado para solucióN para perfusióN | 1件: Trabectedin Trabectedin | 1件: Trabectedin
Trabectedin
💬
| - | - | 1件: 159 159 💬
|
| 2203 | Zanubrutinib 80 MG | 1件: Zanubrutinib Zanubrutinib | 1件: Zanubrutinib
Zanubrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 300 300 💬
|
| 2204 | Zeposia 0,92 MG capsule rigide | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 2205 | Zithomax 40 MG/ML enfants | - | - | - | - | 1件: 299 299 💬
|
| 2206 | Zoledronic acid kern pharma 4 MG/100 ML solution FOR infusion, generic medicinal product | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
| 2207 | Zoledronic acid kern pharma 4 MG/100 ML solution FOR infusion,generic medicinal product | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
| 2208 | ZSP1603 12.5 MG | - | - | - | - | 1件: 85 85 💬
|
| 2209 | ZSP1603 25 MG | - | - | - | - | 1件: 85 85 💬
|
| 2210 | ZSP1603 50 MG | - | - | - | - | 1件: 85 85 💬
|
| 2211 | ZSP1603 7.5 MG | - | - | - | - | 1件: 85 85 💬
|
| 2212 | Zuglimet - 500 MG compresse rivestite CON film 30 compresse IN blister PVC/AL | - | - | - | - | 1件: 67 67 💬
|
| 2213 | ZX008 - 0.2 MG/KG/DAY | - | - | - | - | 1件: 140 140 💬
|
| 2214 | ZX008 - 0.8 MG/KG/DAY | - | - | - | - | 1件: 140 140 💬
|
| 2215 | ZX008 0.2 or 0.8 MG/KG/DAY | - | - | - | - | 1件: 144 144 💬
|
| 2216 | ZX008 0.2 TO 0.8 MG/KG/DAY | - | - | - | - | 2件: 140 140, 144 💬
|
| 2217 | ZYIL1 capsules 25 MG and ZYIL1 capsules 50 MG | - | - | - | - | 1件: 2 2 💬
|
| 2218 | Zytiga - 250 MG - compressa - USO orale - flacone 120 compresse | 1件: Abiraterone Abiraterone | 1件: Abiraterone acetate
Abiraterone acetate
💬
| 1件: CYP17A CYP17A 💬
| 5件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬
|